#Patient Identifier	Protocol	ICDO	SNOMED	ICDO Snomed Description	Diagnosis Age (days)	Diagnosis Age	Year of Diagnosis	INSS Stage	Tumor Sample Histology	Diagnosis	EFS-CENS	SCENS	EFS Time	STIME	Sex	Ethnicity Category	Race Category	Risk Group	Percent Tumor Purity	First Event	Overall Survival Status	Overall Survival Days	Overall Survival (Months)	Year of Last Followup	Percent Necrosis	Percent Tumor Vs. Stroma	Percent Tumor Cells from patient's relapse biopsy	Relapse Percent Necrosis	Relapse Percent Tumor Vs Stroma
#Identifier to uniquely specify a patient.	Protocol.	ICDO.	SNOMED	ICDO snomed description.	Age at which a condition or disease was first diagnosed.	Age at which a condition or disease was first diagnosed.	Year of Diagnosis	Staging according to the International Neuroblastoma Staging System	Tumor Sample Histology	Diagnosis.	Event Free Survival Censored	SCENS.	EFS time.	STIME.	Sex	The text for reporting information about ethnicity.	The text for reporting information about race.	Risk group.	Percent tumor purity.	First Event	Overall patient survival status.	Overall patient survival days	Overall survival in months since initial diagonosis.	Year of Last Followup	Percent necrosis.	Numeric representation of the ratio of tumor to stroma.	Numeric value to represent the percentage of malignant cell tumor nuclei content in a tumor sample or specimen obtained at relapse stage	Numeric value to represent the percentage of cell death in a malignant tumor sample or specimen for the first relapse tissue.	Numeric representation of the percent of tumor versus stroma for first relapse sample.
#STRING	STRING	STRING	STRING	STRING	NUMBER	NUMBER	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	NUMBER	STRING	STRING	STRING	STRING	NUMBER	STRING
#1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	1	1	1	1	1	1	1	1
PATIENT_ID	PROTOCOL	ICDO	SNOMED	ICDO_SNOMED_DESCRIPTION	AGE_IN_DAYS	AGE	YEAR_OF_DIAGNOSIS	INSS_STAGE	TUMOR_SAMPLE_HISTOLOGY	DIAGNOSIS	EFSCENS	SCENS	EFS_TIME	STIME	SEX	ETHNICITY	RACE	RISK_GROUP	PERCENTAGE_TUMOR_PURITY	FIRST_EVENT	OS_STATUS	OS_DAYS	OS_MONTHS	LAST_FOLLOWUP_YEAR	PERCENTAGE_NECROSIS	PERCENT_TUMOR_VS_STROMA	PERCENT_TUMOR_CELLS_RELAPSE	RELAPSE_PERCENT_NECROSIS	RELAPSE_PERCENT_STROMA
TARGET-30-PALPKZ	ANBL00B1	C38.2		Posterior mediastinum	1157	4	2002	Stage 4	Unfavorable	Neuroblastoma			1566.0		Male	Not Hispanic or Latino	White	High Risk		Progression	1:DECEASED	2103.0	70.0	2008.0					
TARGET-30-PASFWL	ANBL00B1, AEPI07N1	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	184	1	2008	Stage 2b	Favorable	Neuroblastoma			2449.0		Female	Not Hispanic or Latino	White	Low Risk	85	Censored	0:LIVING	2449.0	81.0	2015.0					
TARGET-30-PAURYJ	ANBL00B1	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	10	1	2012	Stage 4s	Favorable	Neuroblastoma			1294.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1294.0	43.0	2015.0					
TARGET-30-PARVHG	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	730	2	2008	Stage 4	Unknown	Neuroblastoma			1913.0		Male	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	1913.0	63.0	2013.0					
TARGET-30-PALNMX	ANBL00B1, A3973	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1607	5	2002	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4679.0	2331.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4679.0	154.0	2015.0					
TARGET-30-PAMZSH	ANBL00B1, P9641	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	315	1	2004	Stage 1	Favorable	Neuroblastoma			3334.0		Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	3334.0	110.0	2013.0					
TARGET-30-PADIRB	3891, B003, B954, E18	Unknown	999	Right sided Abdominal adrenal tumor -no intraspinal ext.-6.5x5.5x5.5cm - Bone/BM mets	1191	4	1992	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	798.0	3853.0	Female	Not Hispanic or Latino	Not Reported	High Risk		Event	0:LIVING	3855.0	127.0	2003.0					
TARGET-30-PASFDJ	ANBL00B1, ANBL0531	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	149	1	2008	Stage 3	Favorable	Neuroblastoma			2373.0		Male	Unknown	Unknown	Intermediate Risk	90	Censored	0:LIVING	2373.0	79.0	2015.0					
TARGET-30-PATRMB	ANBL00B1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1086	3	2010	Stage 4	Unfavorable	Neuroblastoma			1788.0		Male	Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1788.0	59.0	2015.0					
TARGET-30-PATUNX	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	135	1	2010	Stage 4s	Favorable	Neuroblastoma			1098.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1098.0	37.0	2013.0					
TARGET-30-PASVKE	ANBL00B1, ANBL0531	C38.1		 Anterior mediastinum	157	1	2009	Stage 4	Favorable	Neuroblastoma			1958.0		Female	Not Hispanic or Latino	White	Intermediate Risk	65	Censored	0:LIVING	1958.0	65.0	2014.0					
TARGET-30-PASMUB	ANBL00B1, AEPI07N1	C38.2		 Posterior mediastinum	80	1	2009	Stage 2b	Favorable	Neuroblastoma			2047.0		Male	Hispanic or Latino	White	Low Risk	70	Censored	0:LIVING	2047.0	68.0	2014.0					
TARGET-30-PAIXNC	9047	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	723	2	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	607.0	602.0	Male	Unknown	White	High Risk		Death	1:DECEASED	607.0	20.0	2002.0					
TARGET-30-PASDDP	ANBL00B1, ANBL0531, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	282	1	2008	Stage 3	Favorable	Neuroblastoma			1841.0		Male	Not Hispanic or Latino	White	Intermediate Risk	60	Censored	0:LIVING	1841.0	61.0	2013.0					
TARGET-30-PASXGP	ANBL00B1, ANBL0532, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	834	3	2009	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	1898.0	590.0	Male	Not Hispanic or Latino	White	High Risk	20	Censored	0:LIVING	1898.0	63.0	2014.0	10	20/80			
TARGET-30-PAUBDC	ANBL00B1, ANBL0532, ANBL0032, ANBL1221	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	818	3	2011	Stage 4	Unfavorable	Neuroblastoma			910.0		Female	Hispanic or Latino	White	High Risk	75	Relapse	0:LIVING	1465.0	49.0	2015.0					
TARGET-30-PASMDM	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	25	1	2009	Stage 4s	Favorable	Neuroblastoma			1324.0		Male	Not Hispanic or Latino	White	Low Risk	40	Censored	0:LIVING	1324.0	44.0	2012.0	10	40/60			
TARGET-30-PASUYL	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	429	2	2009	Stage 4	Unfavorable	Neuroblastoma			369.0		Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	554.0	19.0	2010.0					
TARGET-30-PAMXGF	ANBL00B1	C47.6		Peripheral nerves and Autonomic nervous system of trunk, NOS Peripheral nerves and Autonomic nervous system of (see list under C47): . Back . Flank . Trunk Lumbar nerve	1327	4	2004	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			3982.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3982.0	131.0	2015.0					
TARGET-30-PARNLJ	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	662	2	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	511.0	543.0	Female	Not Hispanic or Latino	White	High Risk	25	Relapse	1:DECEASED	543.0	18.0	2009.0	100	25/75			
TARGET-30-PAKGCI	9047, P9641	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	300	1	2000	Stage 1	Favorable	Neuroblastoma	0.0	0.0	3723.0	2934.0	Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	3723.0	123.0	2010.0					
TARGET-30-PAIXLC	9047, P9641	C38.3	999	Mediastinum, NOS	270	1	2000	Stage 1	Favorable	Neuroblastoma	0.0	0.0	5048.0	3223.0	Male	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	5048.0	166.0	2014.0	0	60/40			
TARGET-30-PAPRXW	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	888	3	2006	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3187.0	1705.0	Male	Unknown	White	High Risk	60	Censored	0:LIVING	3187.0	105.0	2015.0	20	60/40			
TARGET-30-PAUPDY	ANBL00B1, ANBL0532, ACCL0934, ANBL0032, ALTE05N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1629	5	2011	Stage 4	Unfavorable	Neuroblastoma			1216.0		Male	Not Hispanic or Latino	Black or African American	High Risk	70	Censored	0:LIVING	1216.0	40.0	2015.0					
TARGET-30-PATPNR	ANBL00B1	C47.6		 Peripheral nerves and Autonomic nervous system of trunk, NOS	303	1	2010	Stage 2b	Favorable	Neuroblastoma			132.0		Female	Not Hispanic or Latino	White	Low Risk	70	Progression	0:LIVING	1777.0	59.0	2015.0					
TARGET-30-PAISNS	9047, P9462	Unknown	93	ADRENAL GLAND	1070	3	1998	Stage 4	Unknown	Unknown	1.0	1.0	410.0	421.0	Male	Unknown	White	High Risk	80-90	Event	1:DECEASED	421.0	14.0	1999.0	5				
TARGET-30-PANRHJ	ANBL00B1	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	1117	4	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	363.0	411.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	416.0	14.0	2006.0					
TARGET-30-PARYEH	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	200	1	2008	Stage 4	Favorable	Neuroblastoma			2526.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	2526.0	84.0	2015.0					
TARGET-30-PATXWS	ANBL00B1, ANBL0532, ANBL0032	C48.8		Overlapping lesion of retroperitoneum and peritoneum (See n	818	3	2010	Stage 4	Unfavorable	Neuroblastoma			1717.0		Male	Not Hispanic or Latino	Not Reported	High Risk	60	Censored	0:LIVING	1717.0	57.0	2015.0					
TARGET-30-PASWFB	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	727	2	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	87.0	83.0	Female	Not Hispanic or Latino	Black or African American	High Risk	90	Death	1:DECEASED	87.0	3.0	2009.0	10	90/10			
TARGET-30-PATTPW	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	2789	8	2010	Stage 4	Unfavorable	Neuroblastoma			1197.0		Male	Not Hispanic or Latino	White	High Risk	70	Relapse	0:LIVING	1796.0	60.0	2015.0					
TARGET-30-PATYMK	ANBL00B1, ANBL0532	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1760	5	2011	Stage 4	Unfavorable	Neuroblastoma			1578.0		Female	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1578.0	52.0	2015.0					
TARGET-30-PACSNL	321P2, B003, S31, B954	Unknown	999	Metastatic NBL	2157	6	1988	Stage 4	Unfavorable	Unknown	1.0	1.0	205.0	312.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	322.0	11.0	1989.0					
TARGET-30-PALXTE	ANBL00B1, P9641	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	45	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2916.0	2350.0	Female	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	2916.0	96.0	2010.0	0	90/10			
TARGET-30-PAKGKH	9047	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	882	3	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	1795.0	1782.0	Male	Not Hispanic or Latino	Black or African American	High Risk	10	Death	1:DECEASED	1795.0	60.0	2005.0	90	90/10			
TARGET-30-PAULMT	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C38.2		 Posterior mediastinum	1279	4	2011	Stage 4	Unfavorable	Neuroblastoma			610.0		Female	Not Hispanic or Latino	White	High Risk	90	Relapse	0:LIVING	1423.0	47.0	2015.0					
TARGET-30-PADUWR	3891, B003, R9702, ALTE03N1	Unknown	999	Abdominal retroperitoneal left adrenal no intraspinal ext. Size: 9.5cm x8cm x 5cm METS: BM	1682	5	1995	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4908.0	2980.0	Male	Not Hispanic or Latino	Asian	High Risk		Event	0:LIVING	5216.0	172.0	2009.0					
TARGET-30-PAUGZD	ANBL00B1, ACCL0431, ACCL05C1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2015	6	2011	Stage 4	Unfavorable	Neuroblastoma			953.0		Male	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	High Risk	70	Relapse	0:LIVING	953.0	32.0	2014.0					
TARGET-30-PADKXS	3891, B003, E18	Unknown	999	Abdominal Right adrenal crossing the midline-no intraspinal ext-Size; 17x10x11cm-Mets: BM/Lung/ pelvis	648	2	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	310.0	338.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	341.0	12.0	1994.0					
TARGET-30-PANBMJ	ANBL00B1, P9641, A3973, ANBL0032, ALTE05N1, ADVL0813, ADVL0921	C47.6	999	Peripheral nerves and Autonomic nervous system of trunk, NOS Peripheral nerves and Autonomic nervous system of (see list under C47): . Back . Flank . Trunk Lumbar nerve	993	3	2004	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	0.0	577.0	1808.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	3776.0	125.0	2014.0					
TARGET-30-PAUJPC	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	769	3	2011	Stage 4	Unfavorable	Neuroblastoma			1429.0		Male	Not Hispanic or Latino	Not Reported	High Risk	90	Censored	0:LIVING	1429.0	47.0	2015.0					
TARGET-30-PASPIK	ANBL00B1, ANBL0531	C38.3		 Mediastinum, NOS	253	1	2009	Stage 4	Favorable	Neuroblastoma			2344.0		Male	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2344.0	78.0	2015.0					
TARGET-30-PAMIIU	ANBL00B1, A3973, ALTE05N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1499	5	2003	Stage 4	Unknown	Neuroblastoma			4433.0		Male	Not Hispanic or Latino	Asian	High Risk		Censored	0:LIVING	4433.0	146.0	2015.0					
TARGET-30-PARVMU	ANBL00B1	C72.9		Nervous system, NOS Epidural Central nervous system Extra	122	1	2008	Stage 3	Favorable	Neuroblastoma			958.0		Female	Not Hispanic or Latino	White	Intermediate Risk	80	Progression	1:DECEASED	2285.0	76.0	2014.0					
TARGET-30-PALJUV	ANBL00B1, AADM01P1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1301	4	2002	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	385.0	474.0	Female	Not Hispanic or Latino	White	High Risk		Progression	1:DECEASED	486.0	16.0	2003.0					
TARGET-30-PATPXJ	ANBL00B1, ANBL0532, ANBL0032	C48.8		Overlapping lesion of retroperitoneum and peritoneum (See n	1124	4	2010	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1716.0		Female	Not Hispanic or Latino	Asian	High Risk	60	Censored	0:LIVING	1716.0	57.0	2015.0					
TARGET-30-PAMZMG	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	614	2	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	533.0	759.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	763.0	26.0	2006.0					
TARGET-30-PASKFV	ANBL00B1, ANBL0532, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	992	3	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	351.0	390.0	Male	Hispanic or Latino	White	High Risk	90	Progression	1:DECEASED	400.0	14.0	2010.0	10	90/10			
TARGET-30-PADSXE	3891, B003, B903	Unknown	999	superior mediastinum, no intraspinal ext. Size: 2cm x 2cm. Mets: Bones, LN Pt. was dx with horners syndrome which led to NBL dx.	1174	4	1994	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4286.0	4284.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4286.0	141.0	2006.0					
TARGET-30-PARNNG	ANBL00B1, ANBL0531, ANBL0532	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	1336	4	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1703.0	1216.0	Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1703.0	56.0	2012.0	10	70/30			
TARGET-30-PALAWZ	ANBL00B1	C74.1	999	Medulla of adrenal gland	1338	4	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	956.0	949.0	Male	Not Hispanic or Latino	Black or African American	High Risk	95	Death	1:DECEASED	956.0	32.0	2004.0	5	20/80			
TARGET-30-PASNZU	ANBL00B1, ANBL0532, ANBL0032, ACCL0934, ANBL1021	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1099	4	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	954.0	630.0	Male	Not Hispanic or Latino	Black or African American	High Risk	90	Relapse	1:DECEASED	1692.0	56.0	2013.0	20	90/10			
TARGET-30-PASKCS	ANBL00B1, ANBL0531, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	98	1	2009	Stage 4	Favorable	Neuroblastoma			2047.0		Female	Not Hispanic or Latino	White	Intermediate Risk	75	Censored	0:LIVING	2047.0	68.0	2014.0					
TARGET-30-PAUWEV	ANBL00B1	C38.3		 Mediastinum, NOS	148	1	2012	Stage 2b	Favorable	Neuroblastoma			1111.0		Female	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	1111.0	37.0	2015.0					
TARGET-30-PAIJGC	9047	Unknown		ADRENAL GLAND	1410	4	1996	Stage 4	Unknown	Neuroblastoma			3240.0		Male	Unknown	White	High Risk	30	Censored	0:LIVING	3240.0	107.0	2005.0	70	90/10			
TARGET-30-PALPSY	ANBL00B1	C38.2	999	Posterior mediastinum	307	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2679.0	2348.0	Female	Not Hispanic or Latino	White	Low Risk	50	Censored	0:LIVING	2679.0	89.0	2009.0	50	70/30			
TARGET-30-PARFRE	ANBL00B1	C75.5	999	Aortic body and other paraganglia Coccygeal body Coccygeal	60	1	2007	Stage 4s	Favorable	Neuroblastoma			2451.0		Female	Unknown	Unknown	Low Risk	90	Censored	0:LIVING	2451.0	81.0	2014.0					
TARGET-30-PASEGF	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	950	3	2008	Stage 2b	Unfavorable	Ganglioneuroblastoma, nodular			137.0		Female	Not Hispanic or Latino	White	Low Risk	90	Relapse	0:LIVING	2433.0	80.0	2015.0					
TARGET-30-PALZZV	ANBL00B1	C74.1	999	Medulla of adrenal gland	699	2	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	1494.0	1920.0	Female	Not Hispanic or Latino	Black or African American	High Risk	95	Event	0:LIVING	1934.0	64.0	2008.0	5	90/10			
TARGET-30-PAIXRK	9047, P9462, P9963	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	564	2	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	144.0	1367.0	Male	Hispanic or Latino	White	High Risk		Event	1:DECEASED	1368.0	45.0	2004.0					
TARGET-30-PAUFIM	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C42.1		 Bone marrow	840	3	2011	Stage 4	Unfavorable	Neuroblastoma			1451.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1451.0	48.0	2015.0					
TARGET-30-PARBLH	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1360	4	2007	Stage 4	Unknown	Unknown	0.0	0.0	3061.0	1476.0	Female	Hispanic or Latino	Not Reported	High Risk	40	Censored	0:LIVING	3061.0	101.0	2015.0	10	40/60			
TARGET-30-PAUICI	ANBL00B1, ANBL0032	C38.2		 Posterior mediastinum	1494	5	2011	Stage 3	Unfavorable	Neuroblastoma			1524.0		Female	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1524.0	51.0	2015.0					
TARGET-30-PARXLL	ANBL00B1, ANBL0531	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	292	1	2008	Stage 4	Favorable	Neuroblastoma			2089.0		Male	Not Hispanic or Latino	Black or African American	Intermediate Risk	70	Censored	0:LIVING	2089.0	69.0	2013.0					
TARGET-30-PAPVRN	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2300	7	2006	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2889.0	1405.0	Male	Not Hispanic or Latino	White	High Risk	30	Censored	0:LIVING	2889.0	95.0	2014.0					
TARGET-30-PATSXC	ANBL00B1, ANBL0532, ANBL0032, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	110	1	2010	Stage 4	Favorable	Neuroblastoma			1666.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1666.0	55.0	2015.0					
TARGET-30-PAMMXF	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1661	5	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	140.0	189.0	Male	Not Hispanic or Latino	Unknown	High Risk	75	Relapse	1:DECEASED	197.0	7.0	2004.0	25	90/10			
TARGET-30-PANKFE	ANBL00B1, ACCL0331	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1280	4	2004	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	402.0	391.0	Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	402.0	14.0	2006.0	10	90/10			
TARGET-30-PAIWVG	9047, ADVL0212	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	645	2	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	775.0	1621.0	Female	Unknown	White	High Risk	100	Event	1:DECEASED	1624.0	54.0	2004.0	0	15/85			
TARGET-30-PASYYM	ANBL00B1, ANBL0532	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	333	1	2009	Stage 4	Unfavorable	Neuroblastoma			226.0		Male	Not Hispanic or Latino	White	High Risk	90	Progression	1:DECEASED	323.0	11.0	2010.0					
TARGET-30-PALUDH	ANBL00B1	C74.1	999	Medulla of adrenal gland	1105	4	2002	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4306.0	2431.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4306.0	142.0	2014.0					
TARGET-30-PASAAN	ANBL00B1, ANBL0532, AEPI07N1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1525	5	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2400.0	982.0	Male	Not Hispanic or Latino	White	High Risk	10	Censored	0:LIVING	2400.0	79.0	2014.0					
TARGET-30-PADTJJ	3891, B003	Unknown	999	Abdominal Right adrenal crossing midline-no intraspinal ext. Size: 8.5cm x 7.7cm x 11cm Mets: BM, LN	529	2	1995	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2740.0	2738.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2740.0	91.0	2002.0					
TARGET-30-PAUZSB	ANBL00B1, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	858	3	2012	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1027.0		Female	Unknown	Unknown	High Risk	80	Censored	0:LIVING	1027.0	34.0	2015.0					
TARGET-30-PATDCJ	ANBL00B1, ANBL0531, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	200	1	2009	Stage 3	Favorable	Neuroblastoma			1906.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	1906.0	63.0	2015.0					
TARGET-30-PAMBMJ	ANBL00B1, A3973	C47.6	999	Peripheral nerves and Autonomic nervous system of trunk, NOS Peripheral nerves and Autonomic nervous system of (see list under C47): . Back . Flank . Trunk Lumbar nerve	954	3	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	449.0	489.0	Male	Not Hispanic or Latino	White	High Risk	100	Relapse	1:DECEASED	491.0	17.0	2004.0	0	80/20			
TARGET-30-PASAZJ	ANBL00B1, ANBL0532, ANBL0032	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	1764	5	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2365.0	431.0	Male	Not Hispanic or Latino	Not Reported	High Risk	80	Censored	0:LIVING	2365.0	78.0	2014.0	0	80/20			
TARGET-30-PASWAU	ANBL00B1, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1261	4	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2549.0	976.0	Female	Unknown	Unknown	High Risk	90	Censored	0:LIVING	2549.0	84.0	2015.0	10	90/10			
TARGET-30-PASGGI	ANBL00B1, ANBL0531, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	15	1	2008	Stage 2a	Favorable	Neuroblastoma			2208.0		Female	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	2208.0	73.0	2014.0					
TARGET-30-PASJTA	ANBL00B1, AEPI07N1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	358	1	2008	Stage 2b	Favorable	Neuroblastoma			2230.0		Male	Not Hispanic or Latino	White	Low Risk	75	Censored	0:LIVING	2230.0	74.0	2015.0					
TARGET-30-PAMZCE	ANBL00B1, A3973, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	847	3	2004	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3978.0	1786.0	Male	Hispanic or Latino	White	High Risk		Censored	0:LIVING	3978.0	131.0	2015.0					
TARGET-30-PANIPC	ANBL00B1	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	921	3	2004	Stage 4	Unknown	Neuroblastoma	1.0	1.0	159.0	199.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	209.0	7.0	2005.0					
TARGET-30-PAMJED	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	909	3	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	663.0	2166.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	0:LIVING	3910.0	129.0	2014.0					
TARGET-30-PARNTS	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1035	3	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2062.0	744.0	Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	2062.0	68.0	2013.0	70	80/20			
TARGET-30-PATMRZ	ANBL00B1, ANBL0532, AEPI07N1, ALTE05N1, ALTE03N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1022	3	2010	Stage 4	Unfavorable	Neuroblastoma			1423.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1423.0	47.0	2014.0					
TARGET-30-PALEZI	AADM01P1, A3973, ANBL00B1	C74.1		Medulla of adrenal gland	1119	4	2001	Stage 4	Unknown	Unknown			3253.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3253.0	107.0	2010.0					
TARGET-30-PASFRV	ANBL00B1, ANBL0532, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1057	3	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	305.0	319.0	Female	Not Hispanic or Latino	White	High Risk	90	Progression	1:DECEASED	398.0	14.0	2009.0	10	90/10			
TARGET-30-PAUGVZ	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C77.9		 Lymph node, NOS	1613	5	2011	Stage 4	Unfavorable	Neuroblastoma			1418.0		Female	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1418.0	47.0	2015.0					
TARGET-30-PAUUZU	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	3484	10	2012	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			923.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Progression	1:DECEASED	1001.0	33.0	2014.0					
TARGET-30-PAMZYM	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1191	4	2004	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3586.0	1885.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3586.0	118.0	2014.0					
TARGET-30-PADWSM	3891, B003, 0935	Unknown	999	Abdominal right adrenal no intraspinal extension Size: 8.2cm x 7.8cm x 4.8cm METS; BM, Bones, LN	2957	9	1996	Stage 4	Unfavorable	Unknown	0.0	0.0	2282.0	2282.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2282.0	76.0	2002.0					
TARGET-30-PADMXD	3891, B003, B954, E18	Unknown	999	Right sided abdominal adrenal with ext across midline-no intraspinal ext. SIZE: 6cm x 7.9cm x 5.6cm METS: LN, BM, Liver	1084	3	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	838.0	2050.0	Male	Not Hispanic or Latino	White	High Risk		Event	0:LIVING	2052.0	68.0	1999.0					
TARGET-30-PARKGJ	ANBL00B1	C42.1	999	Bone marrow	1616	5	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	841.0	1227.0	Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	1636.0	54.0	2012.0	90	80/20			
TARGET-30-PANGTS	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1639	5	2004	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	3929.0	1409.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3929.0	130.0	2015.0					
TARGET-30-PASFDU	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	757	3	2008	Stage 3	Unfavorable	Neuroblastoma			2559.0		Female	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	2559.0	85.0	2015.0					
TARGET-30-PADENF	3891, B003	Unknown	999	Shimada unfavorable -stroma poor; NMYC: Not done or unknown. MKI < 200/5000 cells. Abdominal adrenal primary Right side 5 cm x 5cm x 3 cm / stg IV. Celiac and periaortic nodes + BM mets No intraspinal extens.	987	3	1991	Stage 4	Unfavorable	Unknown	0.0	0.0	4863.0	4858.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4863.0	160.0	2004.0					
TARGET-30-PARXZA	ANBL00B1	C47.3		Peripheral nerves and Autonomic nervous system of thorax Pe	366	2	2008	Stage 4	Favorable	Neuroblastoma			2389.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	2389.0	79.0	2014.0					
TARGET-30-PANWAT	ANBL00B1, A3973	C80.9		Unknown primary site	1128	4	2005	Stage 4	Unfavorable	Neuroblastoma			241.0		Female	Not Hispanic or Latino	White	High Risk		Progression	0:LIVING	3559.0	118.0	2015.0					
TARGET-30-PASLMN	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	8	1	2009	Stage 4	Favorable	Neuroblastoma			2333.0		Male	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2333.0	77.0	2015.0					
TARGET-30-PARAMT	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	885	3	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	493.0	475.0	Male	Not Hispanic or Latino	White	High Risk	80	Death	1:DECEASED	493.0	17.0	2008.0	10	80/20			
TARGET-30-PALZRB	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1687	5	2002	Stage 4	Unfavorable	Neuroblastoma			4012.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	4012.0	132.0	2013.0	10	80/20			
TARGET-30-PASPGB	ANBL00B1, ANBL0532, ALTE05N1, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	457	2	2009	Stage 4	Unfavorable	Neuroblastoma			2019.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2019.0	67.0	2014.0					
TARGET-30-PASWNG	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	291	1	2009	Stage 1	Favorable	Neuroblastoma			1939.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1939.0	64.0	2014.0					
TARGET-30-PATPHR	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1470	5	2010	Stage 2a	Unfavorable	Ganglioneuroblastoma, nodular			66.0		Female	Not Hispanic or Latino	Black or African American	Low Risk	80	Progression	1:DECEASED	412.0	14.0	2011.0					
TARGET-30-PASYYX	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1255	4	2009	Stage 3	Favorable	Ganglioneuroblastoma, intermixed			1877.0		Male	Not Hispanic or Latino	Asian	Intermediate Risk	100	Censored	0:LIVING	1877.0	62.0	2014.0					
TARGET-30-PATRUL	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	4343	12	2010	Stage 3	Unfavorable	Ganglioneuroblastoma, nodular			1180.0		Female	Unknown	Not Reported	High Risk	100	Censored	0:LIVING	1180.0	39.0	2013.0					
TARGET-30-PASGDB	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1651	5	2008	Stage 2a	Unfavorable	Neuroblastoma			2413.0		Male	Not Hispanic or Latino	Unknown	Low Risk	75	Censored	0:LIVING	2413.0	80.0	2015.0					
TARGET-30-PATAYJ	ANBL00B1	C38.2	999	Posterior mediastinum	52	1	2009	Stage 4s	Favorable	Neuroblastoma	0.0	0.0	1744.0	751.0	Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1744.0	58.0	2014.0					
TARGET-30-PAKIPY	9047	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1116	4	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	505.0	830.0	Male	Not Hispanic or Latino	White	High Risk	95	Event	1:DECEASED	830.0	28.0	2003.0	5	90/10			
TARGET-30-PAMKHK	ANBL00B1, P9641	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	314	1	2003	Stage 1	Favorable	Neuroblastoma			3828.0		Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	3828.0	126.0	2013.0					
TARGET-30-PASWYR	ANBL00B1, ANBL0032, AEPI07N1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	958	3	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1893.0	617.0	Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1893.0	63.0	2014.0	10	60/40			
TARGET-30-PATNZJ	ANBL00B1, AEPI07N1, ANBL0032, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	746	3	2010	Stage 2b	Unfavorable	Ganglioneuroblastoma, nodular			115.0		Male	Not Hispanic or Latino	White	Low Risk	80	Relapse	0:LIVING	1865.0	62.0	2015.0					
TARGET-30-PARZCJ	ANBL00B1, ANBL0531, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	242	1	2008	Stage 3	Favorable	Neuroblastoma			2435.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	2435.0	81.0	2015.0	15-20	70/30	50-95	0.0	
TARGET-30-PASPSE	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	94	1	2009	Stage 3	Favorable	Neuroblastoma			2357.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	2357.0	78.0	2015.0					
TARGET-30-PALBFV	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1500	5	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	152.0	306.0	Female	Not Hispanic or Latino	White	High Risk	100	Progression	1:DECEASED	315.0	11.0	2002.0	0	85/15			
TARGET-30-PASUEA	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1065	3	2009	Stage 3	Unfavorable	Neuroblastoma			2301.0		Female	Not Hispanic or Latino	White	High Risk	95	Censored	0:LIVING	2301.0	76.0	2015.0					
TARGET-30-PAUTVX	ANBL00B1, ANBL0532, ANBL0032	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	1419	4	2012	Stage 3	Unfavorable	Neuroblastoma			1171.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1171.0	39.0	2015.0					
TARGET-30-PATWGR	ANBL00B1, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1038	3	2010	Stage 4	Unknown	Neuroblastoma			1675.0		Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1675.0	56.0	2015.0					
TARGET-30-PAPKXS	ANBL00B1, ADVL0821	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2547	7	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	978.0	1759.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	2384.0	79.0	2012.0					
TARGET-30-PAKYRJ	ANBL00B1, P9641	C38.3		Mediastinum, NOS	102	1	2001	Stage 1	Favorable	Neuroblastoma			4614.0		Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	4614.0	152.0	2014.0					
TARGET-30-PARWAM	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1120	4	2008	Stage 1	Favorable	Ganglioneuroblastoma, intermixed			2729.0		Female	Unknown	White	Low Risk	95	Censored	0:LIVING	2729.0	90.0	2015.0					
TARGET-30-PASSXA	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1033	3	2009	Stage 3	Favorable	Neuroblastoma			2175.0		Female	Not Hispanic or Latino	White	Intermediate Risk	60	Censored	0:LIVING	2175.0	72.0	2015.0					
TARGET-30-PALSAE	ANBL00B1	C74.1	999	Medulla of adrenal gland	782	3	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	598.0	647.0	Male	Not Hispanic or Latino	White	High Risk	90	Progression	1:DECEASED	656.0	22.0	2004.0	10	65/35			
TARGET-30-PACUGP	321P2, B003, 321P3	Unknown	999	Unknown	773	3	1988	Stage 4	Unfavorable	Unknown	1.0	1.0	401.0	466.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	467.0	16.0	1989.0					
TARGET-30-PASXHE	ANBL00B1, ANBL0532, ANBL0931, AEPI07N1	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	1438	4	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2098.0	536.0	Male	Not Hispanic or Latino	Black or African American	High Risk	80	Censored	0:LIVING	2098.0	69.0	2015.0	10	80/20			
TARGET-30-PAMBAC	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	945	3	2002	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2842.0	2290.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2842.0	94.0	2010.0					
TARGET-30-PAIMDT	9047	Unknown	71	KIDNEY	1408	4	1997	Stage 4	Unknown	Unknown	1.0	1.0	878.0	875.0	Female	Unknown	White	High Risk	60	Death	1:DECEASED	878.0	29.0	1999.0	40	90/10			
TARGET-30-PALWSJ	ANBL00B1, P9641	C38.3	999	Mediastinum, NOS	12	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4136.0	2195.0	Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	4136.0	136.0	2014.0					
TARGET-30-PAPEFE	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	990	3	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	138.0	144.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Progression	1:DECEASED	150.0	5.0	2006.0					
TARGET-30-PAPTLY	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1514	5	2006	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2955.0	785.0	Female	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	2955.0	98.0	2014.0	0	60/40			
TARGET-30-PASNVM	ANBL00B1	C38.3		 Mediastinum, NOS	289	1	2009	Stage 2a	Favorable	Neuroblastoma			2233.0		Male	Not Hispanic or Latino	White	Low Risk	60	Censored	0:LIVING	2233.0	74.0	2015.0					
TARGET-30-PALWVJ	ANBL00B1	C74.1	999	Medulla of adrenal gland	1544	5	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	417.0	796.0	Male	Not Hispanic or Latino	Black or African American	High Risk	40	Relapse	1:DECEASED	803.0	27.0	2004.0	60	90/10			
TARGET-30-PARUPN	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	3636	10	2008	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	416.0	413.0	Female	Not Hispanic or Latino	White	High Risk	20	Death	1:DECEASED	416.0	14.0	2009.0	90	20/80			
TARGET-30-PATJHU	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1590	5	2010	Stage 4	Unfavorable	Neuroblastoma			355.0		Female	Not Hispanic or Latino	White	High Risk	75	Relapse	1:DECEASED	500.0	17.0	2011.0					
TARGET-30-PAIRLN	9047	Unknown	93	ADRENAL GLAND	854	3	1998	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2828.0	2826.0	Male	Unknown	White	High Risk	80	Censored	0:LIVING	2828.0	93.0	2006.0	20	90/10			
TARGET-30-PAPWFY	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	757	3	2006	Stage 4	Unknown	Unknown	1.0	1.0	651.0	1003.0	Male	Hispanic or Latino	White	High Risk	70	Relapse	1:DECEASED	1014.0	34.0	2009.0	60-70	70/30			
TARGET-30-PALFPI	ANBL00B1, A3973, ANBL0032	C38.2	999	Posterior mediastinum	1152	4	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	651.0	666.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	670.0	23.0	2003.0					
TARGET-30-PAPGJR	ANBL00B1, A3973	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	611	2	2006	Stage 4	Unfavorable	Neuroblastoma			26.0		Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	26.0	1.0	2006.0					
TARGET-30-PAIRIK	9047, 9640	Unknown	93	ADRENAL GLAND	594	2	1998	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2894.0	2884.0	Male	Unknown	White	High Risk	95	Censored	0:LIVING	2894.0	96.0	2006.0	5	90/10			
TARGET-30-PASBPN	ANBL00B1, ANBL0531, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	278	1	2008	Stage 4	Favorable	Neuroblastoma			2381.0		Female	Hispanic or Latino	Not Reported	Intermediate Risk	70	Censored	0:LIVING	2381.0	79.0	2015.0					
TARGET-30-PATZBH	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	4626	13	2011	Stage 4	Unfavorable	Neuroblastoma			1469.0		Male	Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	1469.0	49.0	2015.0					
TARGET-30-PAUJLH	ANBL00B1, ANBL0532	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1041	3	2011	Stage 4	Unfavorable	Neuroblastoma			442.0		Male	Not Hispanic or Latino	White	High Risk	50	Relapse	1:DECEASED	750.0	25.0	2013.0					
TARGET-30-PAUIHH	ANBL00B1, ANBL0532, AEPI07N1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	193	1	2011	Stage 4	Unfavorable	Neuroblastoma			317.0		Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	339.0	12.0	2012.0					
TARGET-30-PASLAE	ANBL00B1, ANBL00P3	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	802	3	2009	Stage 2b	Unfavorable	Ganglioneuroblastoma, nodular			2188.0		Female	Not Hispanic or Latino	Black or African American	Low Risk	90	Censored	0:LIVING	2188.0	72.0	2015.0					
TARGET-30-PALNHR	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	569	2	2002	Stage 4	Unfavorable	Neuroblastoma			589.0		Female	Not Hispanic or Latino	White	High Risk	20	Relapse	1:DECEASED	750.0	25.0	2004.0	80	50/50			
TARGET-30-PALJXU	ANBL00B1, P9641	C74.1		Medulla of adrenal gland	366	2	2002	Stage 1	Favorable	Neuroblastoma			2585.0		Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	2585.0	85.0	2009.0					
TARGET-30-PASATK	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	893	3	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	441.0	296.0	Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	1459.0	48.0	2012.0	10	90/10			
TARGET-30-PASTCN	ANBL00B1, ANBL0532	C48.8	999	Overlapping lesion of retroperitoneum and peritoneum (See note page 1)	1900	6	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	870.0	559.0	Male	Not Hispanic or Latino	White	High Risk	50	Relapse	1:DECEASED	1033.0	34.0	2012.0	10	50/50			
TARGET-30-PATYMS	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1595	5	2011	Stage 4	Unfavorable	Neuroblastoma			1611.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1611.0	53.0	2015.0					
TARGET-30-PAKWCJ	ANBL00B1, P9641	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	392	2	2001	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4773.0	2537.0	Female	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	4773.0	157.0	2014.0	0	85/15			
TARGET-30-PADMYD	3891, B003, 0925, B954, R9702, E18	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1528	5	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	203.0	441.0	Male	Not Hispanic or Latino	White	High Risk	95	Event	1:DECEASED	443.0	15.0	1995.0	5	95/5			
TARGET-30-PALEEK	ANBL00B1, A3973, ANBL0032, AADM01P1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	848	3	2001	Stage 4	Unfavorable	Neuroblastoma			981.0		Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1131.0	38.0	2004.0					
TARGET-30-PASUTC	ANBL00B1, ANBL0532, AEPI07N1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1067	3	2009	Stage 3	Unfavorable	Neuroblastoma			2105.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	2105.0	70.0	2015.0					
TARGET-30-PARDIW	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2048	6	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2829.0	1418.0	Male	Not Hispanic or Latino	White	High Risk	10	Censored	0:LIVING	2829.0	94.0	2015.0	90	10/90			
TARGET-30-PALUYS	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1214	4	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	693.0	1273.0	Female	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	1284.0	43.0	2006.0	10	40/60			
TARGET-30-PAILZJ	9047, 9464	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	1261	4	1997	Stage 4	Unknown	Unknown	1.0	1.0	242.0	763.0	Male	Unknown	White	High Risk	95	Event	1:DECEASED	765.0	26.0	1999.0	5	30/70			
TARGET-30-PASCZY	ANBL00B1, ANBL0531	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	492	2	2008	Stage 3	Favorable	Neuroblastoma			2242.0		Female	Not Hispanic or Latino	White	Intermediate Risk	60	Censored	0:LIVING	2242.0	74.0	2014.0					
TARGET-30-PAUUGT	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	3713	11	2012	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			627.0		Female	Not Hispanic or Latino	White	High Risk	60	Progression	1:DECEASED	732.0	25.0	2014.0					
TARGET-30-PASLTC	ANBL00B1, AEPI07N1	C80.9		 Unknown primary site	739	3	2009	Stage 1	Unfavorable	Neuroblastoma			2160.0		Male	Not Hispanic or Latino	Black or African American	Low Risk	80	Censored	0:LIVING	2160.0	72.0	2015.0					
TARGET-30-PASEGA	ANBL00B1, ANBL0532, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1091	3	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	469.0	803.0	Male	Not Hispanic or Latino	White	High Risk	70	Progression	1:DECEASED	809.0	27.0	2010.0	10	70/30			
TARGET-30-PASHFA	ANBL00B1, ANBL0531, ANBL0532	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	406	2	2008	Stage 3	Unfavorable	Neuroblastoma			201.0		Female	Not Hispanic or Latino	White	High Risk	60	Progression	1:DECEASED	333.0	11.0	2009.0	10	60/40	98-99	10.0	
TARGET-30-PATIWH	ANBL00B1, ANBL0931, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	516	2	2010	Stage 4	Unfavorable	Neuroblastoma			1840.0		Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1840.0	61.0	2015.0					
TARGET-30-PATYPH	ANBL00B1, ANBL1021	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2700	8	2011	Stage 4	Unfavorable	Neuroblastoma			183.0		Female	Not Hispanic or Latino	White	High Risk	50	Progression	0:LIVING	1354.0	45.0	2014.0					
TARGET-30-PASBZV	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	35	1	2008	Stage 4	Favorable	Neuroblastoma			15.0		Female	Not Hispanic or Latino	White	Intermediate Risk	80	Death	1:DECEASED	15.0	1.0	2008.0					
TARGET-30-PASJZC	ANBL00B1	C22.0	999	Liver Hepatic, NOS	74	1	2009	Stage 4s	Favorable	Neuroblastoma			367.0		Female	Not Hispanic or Latino	White	High Risk	55	Relapse	0:LIVING	2083.0	69.0	2014.0					
TARGET-30-PAKPAL	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1807	5	2001	Stage 4	Unfavorable	Neuroblastoma			2811.0		Male	Not Hispanic or Latino	White	High Risk		Relapse	0:LIVING	4947.0	163.0	2014.0					
TARGET-30-PATVDI	ANBL00B1, ANBL0532, ANBL0032, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	3002	9	2010	Stage 4	Unfavorable	Neuroblastoma			619.0		Female	Not Hispanic or Latino	White	High Risk	90	Relapse	0:LIVING	1728.0	57.0	2015.0					
TARGET-30-PANUIF	ANBL00B1, A3973, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2234	7	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3726.0	1865.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3726.0	123.0	2015.0					
TARGET-30-PANLET	ANBL00B1, ANBL0421	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1973	6	2005	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	830.0	1210.0	Female	Unknown	Unknown	High Risk		Relapse	1:DECEASED	1212.0	40.0	2008.0					
TARGET-30-PATWGC	ANBL00B1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	958	3	2010	Stage 4	Unfavorable	Neuroblastoma			1942.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1942.0	64.0	2015.0					
TARGET-30-PATXKG	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	703	2	2010	Stage 4	Unfavorable	Neuroblastoma			1584.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1584.0	53.0	2015.0					
TARGET-30-PARVLK	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	6021	17	2008	Stage 4	Unknown	Ganglioneuroblastoma, intermixed	1.0	1.0	428.0	861.0	Female	Hispanic or Latino	White	High Risk	70	Event	1:DECEASED	875.0	29.0	2010.0	10	70/30			
TARGET-30-PANZRV	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	72	1	2005	Stage 4s	Favorable	Neuroblastoma			3434.0		Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	3434.0	113.0	2015.0					
TARGET-30-PATKSX	ANBL00B1, ANBL0532, ADVL0918, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	3443	10	2010	Stage 4	Unfavorable	Neuroblastoma			733.0		Female	Not Hispanic or Latino	Black or African American	High Risk	50	Relapse	1:DECEASED	1479.0	49.0	2014.0					
TARGET-30-PAUGGK	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	883	3	2011	Stage 4	Unfavorable	Neuroblastoma			1251.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1251.0	42.0	2014.0					
TARGET-30-PADPMU	3891, B003, 0901, 0937	Unknown	999	Left abdominal adrenal & retroperitoneal mass with intraspinal extension ( epidural extn). METS: LN, BM, Bone, Soft Tissue (Pancrease, Liver, spleen)	1589	5	1994	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	141.0	601.0	Female	Hispanic or Latino	Unknown	High Risk		Event	0:LIVING	609.0	21.0	1995.0					
TARGET-30-PAUTKJ	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	428	2	2012	Stage 4	Unfavorable	Neuroblastoma			20.0		Female	Not Hispanic or Latino	White	High Risk	80	Death	1:DECEASED	20.0	1.0	2012.0					
TARGET-30-PASRWE	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	497	2	2009	Stage 1	Favorable	Neuroblastoma			2187.0		Female	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2187.0	72.0	2015.0					
TARGET-30-PARRLH	ANBL00B1	C47.4	999	Peripheral nerves and Autonomic nervous system of abdomen Peripheral nerves and Autonomic nervous system of (see list under C47): . abdominal wall . Umbilicus	1299	4	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	542.0	542.0	Female	Not Hispanic or Latino	White	High Risk	90	Death	1:DECEASED	542.0	18.0	2009.0	10	90/10			
TARGET-30-PAPTAN	ANBL00B1	C38.2	999	Posterior mediastinum	1462	5	2006	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2054.0	1654.0	Male	Not Hispanic or Latino	Black or African American	High Risk	40	Censored	0:LIVING	2054.0	68.0	2012.0	20	40/60			
TARGET-30-PARVWL	ANBL00B1, ANBL0532, ANBL0032, ADVL0912	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1267	4	2008	Stage 4	Unfavorable	Neuroblastoma			804.0		Female	Unknown	Unknown	High Risk	60	Relapse	1:DECEASED	966.0	32.0	2010.0					
TARGET-30-PATCEM	ANBL00B1, ANBL0931	C41.2		Vertebral column (excludes Sacrum and Coccyx C41.4) Atlas	1256	4	2009	Stage 4	Unfavorable	Neuroblastoma			1821.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1821.0	60.0	2014.0					
TARGET-30-PAUBVN	ANBL00B1, ANBL0532, AEPI07N1	C48.2		Peritoneum, NOS Peritoneal cavity	1064	3	2011	Stage 4	Unfavorable	Neuroblastoma			142.0		Male	Not Hispanic or Latino	White	High Risk	90	Progression	1:DECEASED	847.0	28.0	2013.0					
TARGET-30-PAUHIK	ANBL00B1	C76.3		Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa P	16	1	2011	Stage 2a	Favorable	Neuroblastoma			117.0		Male	Not Hispanic or Latino	White	Low Risk	90	Relapse	0:LIVING	1392.0	46.0	2015.0					
TARGET-30-PAULVH	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	306	1	2011	Stage 4	Unfavorable	Neuroblastoma			438.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Relapse	0:LIVING	1452.0	48.0	2015.0					
TARGET-30-PASRIB	ANBL00B1	C76.3		Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa P	45	1	2009	Stage 1	Favorable	Neuroblastoma			2255.0		Female	Not Hispanic or Latino	White	Low Risk	70	Censored	0:LIVING	2255.0	75.0	2015.0					
TARGET-30-PASCEW	ANBL00B1, ANBL0532, ALTE05N1, ADVL0812, ADVL0911	C47.4		Peripheral nerves and Autonomic nervous system of abdomen P	1476	5	2008	Stage 4	Unfavorable	Neuroblastoma			700.0		Male	Not Hispanic or Latino	Black or African American	High Risk	60	Relapse	1:DECEASED	1129.0	38.0	2011.0					
TARGET-30-PAUMBB	ANBL00B1, ANBL0532	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	824	3	2011	Stage 4	Unfavorable	Neuroblastoma			208.0		Male	Not Hispanic or Latino	White	High Risk	60	Death	1:DECEASED	208.0	7.0	2012.0					
TARGET-30-PAKSWB	ANBL00B1, P9641, ALTE03N1	C38.2	999	Posterior mediastinum	156	1	2001	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4998.0	2851.0	Male	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	4998.0	165.0	2014.0	0	85/15			
TARGET-30-PARGDJ	ANBL00B1, ANBL0032, ANBL0421, ADVL0525	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1112	4	2007	Stage 4	Favorable	Neuroblastoma	1.0	1.0	386.0	774.0	Male	Not Hispanic or Latino	Black or African American	High Risk	60	Relapse	1:DECEASED	781.0	26.0	2009.0					
TARGET-30-PADLPR	3891, B003, B954, E18	Unknown	999	Retroperitoneal Right adrenal tumor crossing midlineFilling Right upper quadrant above a fairly nl. Looking kidney extending all the way to the spleen encasing all major vessels.. No intraspinal ext, size: 15cm x 13.8 cm x 8.7 cm. Mets to BM and LN.	806	3	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	336.0	441.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Event	1:DECEASED	444.0	15.0	1994.0					
TARGET-30-PATVYZ	ANBL00B1, ANBL00P3, AEPI07N1	C38.3		 Mediastinum, NOS	1229	4	2010	Stage 2b	Unfavorable	Ganglioneuroblastoma, nodular			1605.0		Female	Not Hispanic or Latino	Black or African American	Low Risk	90	Censored	0:LIVING	1605.0	53.0	2015.0					
TARGET-30-PADLIC	3891, B003, B903, B954, E18	Unknown	999	Retroperitoneal abdominal Right adrenal-no intraspinal ext-Size: 3x1.8x2.4cm-Mets: BM/bone/LN/Liver	1837	6	1993	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4670.0	4665.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4670.0	154.0	2006.0					
TARGET-30-PALHTR	ANBL00B1, ANBL00P1	C74.1		Medulla of adrenal gland	956	3	2002	Stage 4	Unfavorable	Neuroblastoma			883.0		Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	883.0	30.0	2004.0					
TARGET-30-PATMXC	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1583	5	2010	Stage 4	Unfavorable	Neuroblastoma			617.0		Female	Not Hispanic or Latino	White	High Risk	60	Progression	1:DECEASED	767.0	26.0	2012.0					
TARGET-30-PATYEJ	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1176	4	2011	Stage 4	Unfavorable	Neuroblastoma			786.0		Male	Not Hispanic or Latino	White	High Risk	60	Relapse	1:DECEASED	1128.0	38.0	2014.0					
TARGET-30-PARSRJ	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1905	6	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1329.0	572.0	Male	Not Hispanic or Latino	White	High Risk	5	Relapse	0:LIVING	2597.0	86.0	2015.0	90	5/95			
TARGET-30-PANGXK	ANBL02P1, ANBL00B1, ALTE03N1	C47.3	999	Peripheral nerves and Autonomic nervous system of thorax Peripheral nerves and Autonomic nervous system of (see list under C47): . Axilla . Chest . chest wall . thoracic wall . infraclavicular region . scapular region Intercostal nerve	1266	4	2004	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	1855.0	1521.0	Male	Not Hispanic or Latino	White	High Risk	95	Event	0:LIVING	3792.0	125.0	2015.0	5	95/5			
TARGET-30-PASCJJ	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1319	4	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1515.0	948.0	Female	Not Hispanic or Latino	Black or African American	High Risk	40	Relapse	1:DECEASED	2002.0	66.0	2014.0	10	40/60			
TARGET-30-PASUYG	ANBL00B1, ANBL0532, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1418	4	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	505.0	532.0	Male	Not Hispanic or Latino	Black or African American	High Risk	60	Relapse	0:LIVING	2193.0	73.0	2015.0	10	60/40			
TARGET-30-PAPAKS	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	677	2	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2777.0	1112.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2777.0	92.0	2013.0					
TARGET-30-PAMXWF	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	932	3	2004	Stage 4	Unknown	Unknown	1.0	1.0	1039.0	1732.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Relapse	1:DECEASED	1735.0	58.0	2008.0					
TARGET-30-PASXRJ	ANBL00B1, ANBL0532, AEPI07N1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	583	2	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	266.0	447.0	Female	Not Hispanic or Latino	White	High Risk	60	Progression	0:LIVING	1837.0	61.0	2014.0	10	60/40			
TARGET-30-PATGJU	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	59	1	2010	Stage 4s	Favorable	Neuroblastoma			1219.0		Female	Not Hispanic or Latino	White	Low Risk	40	Censored	0:LIVING	1219.0	41.0	2013.0					
TARGET-30-PARYVD	ANBL00B1, ANBL0532	C42.1		 Bone marrow	768	3	2008	Stage 3	Unfavorable	Neuroblastoma			2421.0		Female	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	2421.0	80.0	2014.0					
TARGET-30-PAIEFC	9047	Unknown		LIVER	605	2	1995	Stage 4	Unfavorable	Neuroblastoma			34.0		Female	Unknown	White	High Risk		Death	1:DECEASED	34.0	2.0	1995.0		0/100			
TARGET-30-PAUGRP	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	198	1	2011	Stage 4	Favorable	Neuroblastoma			1414.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1414.0	47.0	2015.0					
TARGET-30-PAISSH	9047	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	656	2	1998	Stage 4	Unknown	Unknown	1.0	1.0	878.0	878.0	Female	Unknown	Unknown	High Risk	5	Death	1:DECEASED	878.0	29.0	2001.0	95	90/10			
TARGET-30-PAPEJW	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	757	3	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	392.0	385.0	Female	Not Hispanic or Latino	Asian	High Risk		Death	1:DECEASED	392.0	13.0	2007.0					
TARGET-30-PASSWW	ANBL00B1, ANBL0531, AEPI07N1	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	7	1	2009	Stage 4s	Favorable	Neuroblastoma			2095.0		Male	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	2095.0	69.0	2015.0	20	90/10			
TARGET-30-PAUFPG	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	564	2	2011	Stage 4	Unfavorable	Neuroblastoma			168.0		Female	Not Hispanic or Latino	White	High Risk	90	Progression	1:DECEASED	288.0	10.0	2012.0					
TARGET-30-PAKPLH	9047	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1417	4	2001	Stage 4	Unfavorable	Neuroblastoma			507.0		Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	974.0	33.0	2003.0					
TARGET-30-PALPIN	ANBL00B1, P9641	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	46	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2155.0	2147.0	Male	Not Hispanic or Latino	White	Low Risk	95	Censored	0:LIVING	2155.0	71.0	2008.0	5	90/10			
TARGET-30-PAUKAP	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1272	4	2011	Stage 4	Unfavorable	Neuroblastoma			1442.0		Male	Not Hispanic or Latino	White	High Risk	100	Censored	0:LIVING	1442.0	48.0	2015.0					
TARGET-30-PAUWDK	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1492	5	2012	Stage 2b	Unfavorable	Neuroblastoma			1021.0		Female	Not Hispanic or Latino	Black or African American	Low Risk	90	Censored	0:LIVING	1021.0	34.0	2015.0					
TARGET-30-PARZMY	ANBL00B1, ANBL0532	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1691	5	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2529.0	994.0	Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	2529.0	84.0	2015.0	10	70/30			
TARGET-30-PATHYK	ANBL00B1, ANBL0531	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	255	1	2010	Stage 4	Favorable	Neuroblastoma			76.0		Male	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	76.0	3.0	2010.0					
TARGET-30-PAKRKL	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	515	2	2001	Stage 1	Favorable	Neuroblastoma			3143.0		Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	3143.0	104.0	2009.0					
TARGET-30-PACLJN	323P, 321P3, I03, B954	Unknown	999	Unknown	1475	5	1986	Stage 4	Unknown	Unknown	0.0	0.0	5553.0	5424.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	5553.0	183.0	2001.0					
TARGET-30-PAPTCR	ANBL00B1, ANBL0621	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	754	3	2006	Stage 4	Unknown	Neuroblastoma	1.0	1.0	394.0	446.0	Female	Not Hispanic or Latino	White	High Risk	20	Event	1:DECEASED	456.0	15.0	2007.0	10	20/80			
TARGET-30-PATSPZ	ANBL00B1, ANBL0532	C48.2		Peritoneum, NOS Peritoneal cavity	1008	3	2010	Stage 4	Unfavorable	Neuroblastoma			348.0		Male	Hispanic or Latino	White	High Risk	80	Progression	1:DECEASED	488.0	17.0	2012.0					
TARGET-30-PARGHY	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1229	4	2007	Stage 4	Unknown	Unknown	1.0	0.0	105.0	1189.0	Male	Not Hispanic or Latino	Asian	High Risk	20	Progression	0:LIVING	2819.0	93.0	2015.0	10	20/80			
TARGET-30-PATISU	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	424	2	2010	Stage 4	Unfavorable	Neuroblastoma			827.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Relapse	1:DECEASED	893.0	30.0	2012.0					
TARGET-30-PARXVA	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	83	1	2008	Stage 4s	Favorable	Neuroblastoma			2248.0		Male	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2248.0	74.0	2014.0					
TARGET-30-PASLPG	ANBL00B1, AEPI07N1	C75.5		Aortic body and other paraganglia Coccygeal body Coccygeal	776	3	2009	Stage 2a	Favorable	Neuroblastoma			2012.0		Male	Unknown	Unknown	Low Risk	90	Censored	0:LIVING	2012.0	67.0	2014.0					
TARGET-30-PAMVCL	ANBL00B1, P9641	C76.3	999	Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa Pelvic wall, NOS Perineum, NOS Rectovaginal septum Rectovesical septum Gluteal region, NOS Inguinal region, NOS Perirectal region, NOS Presacral region, NOS Sacrococcygeal region, NOS	87	1	2004	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2387.0	1812.0	Female	Not Hispanic or Latino	Black or African American	Low Risk		Censored	0:LIVING	2387.0	79.0	2010.0					
TARGET-30-PATHKB	ANBL00B1, ANBL0531	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	7	1	2010	Stage 4s	Favorable	Neuroblastoma			1998.0		Male	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	1998.0	66.0	2015.0					
TARGET-30-PARZIP	ANBL00B1, ANBL0532, ANBL0032	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	2273	7	2008	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	632.0	966.0	Male	Unknown	Unknown	High Risk	80	Relapse	0:LIVING	2511.0	83.0	2015.0	20	80/20			
TARGET-30-PAPTJB	ANBL00B1	C40.2	999	Long bones of lower limb and associated joints Bone of leg Femur Fibula Knee joint, NOS Semilunar cartilage Lateral meniscus of knee joint Medial meniscus of knee joint Tibia	1991	6	2006	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3220.0	1472.0	Male	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	3220.0	106.0	2015.0	5	50/50			
TARGET-30-PAPYNZ	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1024	3	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	312.0	332.0	Male	Not Hispanic or Latino	White	High Risk	0	Relapse	1:DECEASED	336.0	12.0	2007.0	0	0/100			
TARGET-30-PAMMWD	ANBL00B1, A3973, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	812	3	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	351.0	405.0	Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	409.0	14.0	2004.0	20	90/10			
TARGET-30-PAINRC	9047	Unknown		ADRENAL GLAND	1605	5	1997	Stage 4	Unknown	Unknown			454.0		Female	Unknown	White	High Risk		Event	1:DECEASED	456.0	15.0	1999.0	100				
TARGET-30-PATVTL	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	930	3	2010	Stage 4	Unfavorable	Neuroblastoma			73.0		Male	Not Hispanic or Latino	White	High Risk	70	Death	1:DECEASED	73.0	3.0	2011.0					
TARGET-30-PALHVD	ANBL00B1, AADM01P1	C74.1	999	Medulla of adrenal gland	1634	5	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	347.0	429.0	Female	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	433.0	15.0	2003.0	20	90/10			
TARGET-30-PATPJD	ANBL00B1, ANBL0532, AEPI07N1	C80.9		 Unknown primary site	1582	5	2010	Stage 4	Unfavorable	Neuroblastoma			367.0		Male	Not Hispanic or Latino	White	High Risk	55	Progression	1:DECEASED	369.0	13.0	2011.0					
TARGET-30-PAPUAR	ANBL00B1	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	515	2	2006	Stage 4	Favorable	Neuroblastoma	0.0	0.0	3065.0	747.0	Female	Not Hispanic or Latino	Asian	High Risk	70	Censored	0:LIVING	3065.0	101.0	2015.0	10	70/30			
TARGET-30-PAIFCS	9047, 9340, 9341	Unknown	93	ADRENAL GLAND	1540	5	1995	Stage 4	Unfavorable	Unknown	1.0	1.0	200.0	916.0	Male	Unknown	White	High Risk	95	Event	1:DECEASED	919.0	31.0	1998.0	5	75/25			
TARGET-30-PANVAN	ANBL00B1, A3973, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1518	5	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	646.0	1392.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	0:LIVING	3630.0	120.0	2015.0					
TARGET-30-PATDXC	ANBL00B1, ANBL0931	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1659	5	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	444.0	457.0	Male	Not Hispanic or Latino	White	High Risk	80	Event	1:DECEASED	916.0	31.0	2012.0	10	80/20			
TARGET-30-PASJYB	ANBL00B1, ANBL0532, ADVL06B1, ALTE05N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	522	2	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	455.0	49.0	Female	Not Hispanic or Latino	White	High Risk	80-90	Relapse	1:DECEASED	682.0	23.0	2010.0	10	80-90/10-20			
TARGET-30-PARZKK	ANBL00B1	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	411	2	2008	Stage 4	Unknown	Neuroblastoma			461.0		Male	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	High Risk	60	Relapse	0:LIVING	560.0	19.0	2009.0					
TARGET-30-PATHUU	AREN03B2, ANBL00B1	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	704	2	2010	Stage 3	Unfavorable	Neuroblastoma			369.0		Female	Not Hispanic or Latino	Black or African American	High Risk	70	Death	1:DECEASED	369.0	13.0	2011.0					
TARGET-30-PASEYW	ANBL00B1	C72.0		Spinal cord Cervical cord Conus medullaris Filum terminal	703	2	2008	Stage 2a	Favorable	Neuroblastoma			250.0		Male	Not Hispanic or Latino	White	Low Risk	60	Relapse	0:LIVING	2311.0	76.0	2015.0					
TARGET-30-PASJRT	ANBL00B1, ANBL0532, ANBL0032, ALTE05N1, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	741	3	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1411.0	170.0	Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1411.0	47.0	2012.0	10	80/20			
TARGET-30-PAIVMJ	9047	Unknown	93	ADRENAL GLAND	202	1	1999	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2359.0	2352.0	Male	Unknown	White	Low Risk	100	Censored	0:LIVING	2359.0	78.0	2005.0	0	90/10			
TARGET-30-PARAHE	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1326	4	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	646.0	735.0	Male	Not Hispanic or Latino	White	High Risk	10	Relapse	1:DECEASED	2232.0	74.0	2013.0	10	10/90			
TARGET-30-PARUTX	ANBL00B1, ANBL0531, ANBL0532	C48.2		Peritoneum, NOS Peritoneal cavity	380	2	2008	Stage 3	Unfavorable	Neuroblastoma			372.0		Female	Not Hispanic or Latino	White	High Risk	90	Progression	0:LIVING	2568.0	85.0	2015.0					
TARGET-30-PADKVV	3891, B003, E18	Unknown	999	Retroperitoneal right sided abdominal celiac mass -no intraspinal ext. Size: 13x8x5cm-Mets: LN/BM/Bone	807	3	1993	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	354.0	433.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	437.0	15.0	1994.0					
TARGET-30-PARVFJ	ANBL00B1, ANBL0532, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1364	4	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2723.0	1213.0	Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	2723.0	90.0	2015.0	10	70/30			
TARGET-30-PATBRX	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	179	1	2009	Stage 4s	Favorable	Neuroblastoma			2010.0		Female	Not Hispanic or Latino	Black or African American	Low Risk	80	Censored	0:LIVING	2010.0	67.0	2015.0					
TARGET-30-PASUXH	ANBL00B1	C38.2		 Posterior mediastinum	2102	6	2009	Stage 3	Favorable	Ganglioneuroblastoma, intermixed			2252.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	2252.0	75.0	2015.0					
TARGET-30-PATJIN	ANBL00B1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1247	4	2010	Stage 4	Unfavorable	Neuroblastoma			1850.0		Female	Hispanic or Latino	Not Reported	High Risk	90	Censored	0:LIVING	1850.0	61.0	2015.0					
TARGET-30-PASCFC	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	18	1	2008	Stage 4s	Favorable	Neuroblastoma			2522.0		Male	Not Hispanic or Latino	White	Low Risk	75	Censored	0:LIVING	2522.0	83.0	2015.0					
TARGET-30-PALLJJ	ANBL00B1, P9641	C74.1	999	Medulla of adrenal gland	388	2	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	3355.0	2501.0	Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	3355.0	111.0	2011.0	10	95/5			
TARGET-30-PATZIG	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	529	2	2011	Stage 3	Favorable	Neuroblastoma			259.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Progression	0:LIVING	1405.0	47.0	2014.0					
TARGET-30-PASJWA	ANBL00B1, ANBL0531	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	345	1	2009	Stage 4	Favorable	Neuroblastoma			1570.0		Female	Hispanic or Latino	Not Reported	Intermediate Risk	70	Censored	0:LIVING	1570.0	52.0	2013.0					
TARGET-30-PALVUC	ANBL00B1, P9641	C74.1	999	Medulla of adrenal gland	194	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4368.0	2273.0	Male	Not Hispanic or Latino	White	Low Risk	95	Censored	0:LIVING	4368.0	144.0	2014.0	5	80/20			
TARGET-30-PATMPC	ANBL00B1, ANBL0532, ANBL1021, ADVL1112	C48.2		Peritoneum, NOS Peritoneal cavity	1318	4	2010	Stage 4	Unfavorable	Neuroblastoma			572.0		Male	Not Hispanic or Latino	White	High Risk	80	Event	0:LIVING	1755.0	58.0	2015.0					
TARGET-30-PASSPI	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	743	3	2009	Stage 3	Unfavorable	Neuroblastoma			1506.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1506.0	50.0	2013.0					
TARGET-30-PAPWUC	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	983	3	2006	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3186.0	722.0	Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	3186.0	105.0	2015.0	10	80/20			
TARGET-30-PASGES	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1462	5	2008	Stage 1	Unfavorable	Ganglioneuroblastoma, nodular			2114.0		Male	Not Hispanic or Latino	Unknown	Low Risk	80	Censored	0:LIVING	2114.0	70.0	2014.0					
TARGET-30-PASKRA	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	248	1	2009	Stage 2b	Unfavorable	Neuroblastoma			2281.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2281.0	75.0	2015.0					
TARGET-30-PAMNLH	ANBL00B1, A3973	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	1531	5	2003	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	361.0	828.0	Female	Not Hispanic or Latino	White	High Risk	85	Relapse	1:DECEASED	837.0	28.0	2005.0	35				
TARGET-30-PAKJRE	9047	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1100	4	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	1485.0	1484.0	Male	Hispanic or Latino	White	High Risk		Death	1:DECEASED	1485.0	49.0	2004.0					
TARGET-30-PAMVAG	ANBL00B1, A3973	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	663	2	2004	Stage 4	Unfavorable	Neuroblastoma			22.0		Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	22.0	1.0	2004.0					
TARGET-30-PADLKJ	3891, B003, B903, E18, R9702	C47.0	999	Peripheral nerves and Autonomic nervous system of head, face, and neck (excludes Peripheral nerves and Autonomic nervous system of Orbit C69.6) Peripheral nerves and Autonomic nervous system of (see list under C47): . Cheek . Chin . Face . Forehead .	780	3	1993	Stage 4	Unknown	Neuroblastoma	0.0	0.0	1749.0	1747.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	1749.0	58.0	1998.0					
TARGET-30-PARXLN	ANBL00B1, ANBL0531	C38.3		 Mediastinum, NOS	217	1	2008	Stage 3	Favorable	Neuroblastoma			2725.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	2725.0	90.0	2015.0					
TARGET-30-PATKHS	ANBL00B1, ANBL0532, ANBL0931	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	439	2	2010	Stage 4	Favorable	Neuroblastoma			1607.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1607.0	53.0	2014.0					
TARGET-30-PATXDV	ANBL00B1	C65.9		Renal pelvis Pelvis of kidney Renal calyces Renal calyx	801	3	2010	Stage 4	Unfavorable	Neuroblastoma			1452.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1452.0	48.0	2014.0					
TARGET-30-PATJZF	ANBL00B1, ANBL0032	C77.9		 Lymph node, NOS	1032	3	2010	Stage 4	Unfavorable	Neuroblastoma			1818.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1818.0	60.0	2015.0					
TARGET-30-PAUWED	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	324	1	2012	Stage 2b	Favorable	Neuroblastoma			1119.0		Female	Hispanic or Latino	White	Intermediate Risk	80	Death	1:DECEASED	1119.0	37.0	2015.0					
TARGET-30-PAURGD	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1508	5	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1343.0		Female	Not Hispanic or Latino	Unknown	High Risk	90	Censored	0:LIVING	1343.0	45.0	2015.0					
TARGET-30-PATYCM	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	400	2	2011	Stage 4	Unfavorable	Neuroblastoma			642.0		Female	Not Hispanic or Latino	White	High Risk	90	Event	0:LIVING	1573.0	52.0	2015.0					
TARGET-30-PAPSSE	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1267	4	2006	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			2518.0		Male	Not Hispanic or Latino	Unknown	High Risk	100	Censored	0:LIVING	2518.0	83.0	2013.0	10	100/10			
TARGET-30-PASTWY	ANBL00B1, AEPI07N1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	115	1	2009	Stage 1	Favorable	Neuroblastoma			10.0		Female	Not Hispanic or Latino	White	Low Risk	90	Death	1:DECEASED	10.0	1.0	2009.0					
TARGET-30-PAUVVE	ANBL00B1	C76.0		Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Ce	146	1	2012	Stage 4s	Favorable	Neuroblastoma			1229.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1229.0	41.0	2015.0					
TARGET-30-PAMTBI	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1526	5	2003	Stage 4	Unfavorable	Neuroblastoma			4174.0		Male	Not Hispanic or Latino	Black or African American	High Risk		Censored	0:LIVING	4174.0	138.0	2015.0					
TARGET-30-PAUZMG	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	184	1	2012	Stage 4	Favorable	Neuroblastoma			851.0		Male	Not Hispanic or Latino	White	Intermediate Risk	95	Censored	0:LIVING	851.0	28.0	2014.0					
TARGET-30-PATTPL	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2602	8	2010	Stage 4	Unfavorable	Neuroblastoma			609.0		Male	Not Hispanic or Latino	White	High Risk	60	Relapse	1:DECEASED	1297.0	43.0	2014.0					
TARGET-30-PAPTLD	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1244	4	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	617.0	963.0	Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	2679.0	89.0	2014.0	0	90/10			
TARGET-30-PARKNP	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	3214	9	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	649.0	639.0	Female	Unknown	White	High Risk	80	Death	1:DECEASED	649.0	22.0	2009.0	10	80/20			
TARGET-30-PASUCU	ANBL00B1, ANBL0531, AEPI07N1	C38.2		 Posterior mediastinum	227	1	2009	Stage 4	Favorable	Neuroblastoma			1959.0		Male	Not Hispanic or Latino	White	Intermediate Risk	75	Censored	0:LIVING	1959.0	65.0	2014.0					
TARGET-30-PALYLZ	ANBL00B1, P9641	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	488	2	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	3083.0	2205.0	Male	Not Hispanic or Latino	White	Low Risk	95	Censored	0:LIVING	3083.0	102.0	2011.0	5	80/20			
TARGET-30-PATNRK	ANBL00B1, ANBL0532, ANBL0032, ALTE05N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1372	4	2010	Stage 4	Unfavorable	Neuroblastoma			1903.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1903.0	63.0	2015.0					
TARGET-30-PANBCI	ANBL00B1, ADVL0524	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	753	3	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	607.0	1039.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1049.0	35.0	2007.0					
TARGET-30-PATWTW	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1601	5	2010	Stage 4	Unfavorable	Neuroblastoma			506.0		Female	Hispanic or Latino	White	High Risk	90	Event	1:DECEASED	550.0	19.0	2012.0					
TARGET-30-PAUBYW	ANBL00B1, ANBL0531	C38.2		 Posterior mediastinum	337	1	2011	Stage 4	Favorable	Neuroblastoma			19.0		Female	Not Hispanic or Latino	White	Intermediate Risk	95	Event	0:LIVING	1513.0	50.0	2015.0					
TARGET-30-PAKYZS	ANBL00B1	C74.1	999	Medulla of adrenal gland	659	2	2001	Stage 4	Unknown	Unknown	1.0	0.0	238.0	2753.0	Male	Not Hispanic or Latino	White	High Risk		Progression	0:LIVING	3587.0	118.0	2011.0					
TARGET-30-PAUMUC	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1726	5	2011	Stage 3	Unfavorable	Neuroblastoma			780.0		Female	Not Hispanic or Latino	Asian	High Risk	95	Censored	0:LIVING	780.0	26.0	2013.0					
TARGET-30-PARASL	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1606	5	2007	Stage 4	Unknown	Unknown	1.0	1.0	199.0	193.0	Female	Not Hispanic or Latino	White	High Risk	60-70	Death	1:DECEASED	199.0	7.0	2007.0	10	60-70/30-40			
TARGET-30-PATLNM	ANBL00B1, ACCL05C1, ANBL0931	C48.2		Peritoneum, NOS Peritoneal cavity	5068	14	2010	Stage 3	Unfavorable	Neuroblastoma			1886.0		Male	Not Hispanic or Latino	Asian	High Risk	70	Censored	0:LIVING	1886.0	63.0	2015.0					
TARGET-30-PANWRR	ANBL00B1, A3973	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2937	9	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	267.0	339.0	Male	Not Hispanic or Latino	White	High Risk		Progression	1:DECEASED	345.0	12.0	2006.0					
TARGET-30-PATRJG	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1103	4	2010	Stage 4	Unfavorable	Neuroblastoma			274.0		Female	Hispanic or Latino	White	High Risk	70	Event	1:DECEASED	646.0	22.0	2012.0					
TARGET-30-PASZGB	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	457	2	2009	Stage 4	Unfavorable	Neuroblastoma			145.0		Female	Not Hispanic or Latino	White	High Risk	90	Progression	1:DECEASED	164.0	6.0	2010.0					
TARGET-30-PASZYY	ANBL00B1, ANBL0532, ANBL0931, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	493	2	2009	Stage 4	Unfavorable	Neuroblastoma			394.0		Female	Not Hispanic or Latino	White	High Risk	70	Event	1:DECEASED	449.0	15.0	2010.0					
TARGET-30-PARVME	ANBL00B1	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	1495	5	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1086.0	371.0	Male	Not Hispanic or Latino	White	High Risk	70	Relapse	0:LIVING	2573.0	85.0	2015.0	10	70/30			
TARGET-30-PAUPRN	ANBL00B1, ANBL0532, ADVL0912	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	941	3	2011	Stage 4	Unfavorable	Neuroblastoma			325.0		Female	Hispanic or Latino	White	High Risk	70	Progression	1:DECEASED	490.0	17.0	2013.0					
TARGET-30-PARXZR	ANBL00B1, ANBL0532, ACCL05C1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1126	4	2008	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	201.0	231.0	Female	Unknown	Unknown	High Risk	5	Progression	1:DECEASED	1076.0	36.0	2011.0	10				
TARGET-30-PAITZV	9047	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	1689	5	1999	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2147.0	2142.0	Male	Unknown	White	High Risk	95	Censored	0:LIVING	2147.0	71.0	2004.0	5	85/15			
TARGET-30-PASLYF	ANBL00B1	C76.0		Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Ce	283	1	2009	Stage 2a	Favorable	Neuroblastoma			1823.0		Male	Not Hispanic or Latino	White	Low Risk	70	Censored	0:LIVING	1823.0	60.0	2014.0					
TARGET-30-PALRSD	B947, ANBL00B1, A3973, ALTE05N1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2726	8	2002	Stage 4	Unknown	Unknown	0.0	0.0	4683.0	3184.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4683.0	154.0	2015.0					
TARGET-30-PARHAM	ANBL00B1	C76.3	999	Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa P	341	1	2007	Stage 4	Favorable	Neuroblastoma			38.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Progression	1:DECEASED	2466.0	82.0	2014.0	10	90/10	95	3.0	
TARGET-30-PAUHSJ	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	932	3	2011	Stage 3	Unfavorable	Neuroblastoma			1364.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1364.0	45.0	2015.0					
TARGET-30-PAVCHH	ANBL00B1, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1242	4	2012	Stage 4	Unfavorable	Neuroblastoma			1132.0		Female	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	1132.0	38.0	2015.0					
TARGET-30-PAUAKT	ANBL00B1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1163	4	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1554.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1554.0	52.0	2015.0					
TARGET-30-PAMUTD	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	825	3	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	667.0	653.0	Male	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	High Risk		Death	1:DECEASED	667.0	22.0	2005.0					
TARGET-30-PARABN	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	974	3	2007	Stage 4	Unknown	Neuroblastoma	1.0	1.0	607.0	457.0	Male	Not Hispanic or Latino	White	High Risk	10	Relapse	1:DECEASED	827.0	28.0	2009.0	10	10/90			
TARGET-30-PASTXV	ANBL00B1	C49.5		Connective, Subcutaneous and other Soft tissues of pelvis C	23	1	2009	Stage 1	Favorable	Neuroblastoma			2272.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2272.0	75.0	2015.0					
TARGET-30-PAMKBM	ANBL00B1, P9641	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	41	1	2003	Stage 1	Favorable	Neuroblastoma			1232.0		Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	1232.0	41.0	2006.0					
TARGET-30-PATHJU	ANBL00B1, ACCL05C1, ANBL0931, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	997	3	2010	Stage 4	Unfavorable	Neuroblastoma			1921.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1921.0	64.0	2015.0					
TARGET-30-PARPGU	ANBL00B1	C80.9	999	Unknown primary site	1145	4	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	686.0	1160.0	Female	Not Hispanic or Latino	White	High Risk	15-10	Relapse	1:DECEASED	1381.0	46.0	2011.0	10	10-15/90-85			
TARGET-30-PASZFX	ANBL00B1	C38.2		 Posterior mediastinum	1661	5	2009	Stage 2a	Favorable	Ganglioneuroblastoma, intermixed			2176.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2176.0	72.0	2015.0					
TARGET-30-PANRRN	ANBL00B1, A3973, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	848	3	2005	Stage 4	Unfavorable	Neuroblastoma			3479.0		Female	Hispanic or Latino	White	High Risk		Censored	0:LIVING	3479.0	115.0	2014.0					
TARGET-30-PALVDR	ANBL00B1, P9641	C74.1		Medulla of adrenal gland	20	1	2002	Stage 1	Favorable	Neuroblastoma			1114.0		Male	Not Hispanic or Latino	Black or African American	Low Risk		Censored	0:LIVING	1114.0	37.0	2005.0					
TARGET-30-PAPVXS	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1366	4	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	224.0	222.0	Male	Not Hispanic or Latino	Black or African American	High Risk	80	Death	1:DECEASED	224.0	8.0	2007.0	10	80/20			
TARGET-30-PAPZYZ	ANBL00B1, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	550	2	2007	Stage 4	Unknown	Neuroblastoma	0.0	0.0	1209.0	1209.0	Female	Not Hispanic or Latino	Black or African American	High Risk	60	Censored	0:LIVING	1209.0	40.0	2010.0		60/40			
TARGET-30-PATLKI	ANBL00B1, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1153	4	2010	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1851.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1851.0	61.0	2015.0					
TARGET-30-PASUML	ANBL00B1, ANBL0531	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	4	1	2009	Stage 4s	Favorable	Neuroblastoma			12.0		Male	Not Hispanic or Latino	Black or African American	Intermediate Risk	90	Event	1:DECEASED	20.0	1.0	2009.0					
TARGET-30-PATPPU	ANBL00B1, ANBL0532	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1048	3	2010	Stage 4	Unfavorable	Neuroblastoma			281.0		Female	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	343.0	12.0	2011.0					
TARGET-30-PASFNY	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	945	3	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1996.0	940.0	Female	Not Hispanic or Latino	White	High Risk	75	Censored	0:LIVING	1996.0	66.0	2014.0	10	75/25			
TARGET-30-PARMPP	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1370	4	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2674.0	774.0	Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	2674.0	88.0	2015.0	25	70/30			
TARGET-30-PAUDFR	ANBL00B1, ANBL0032, AEPI07N1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	1119	4	2011	Stage 4	Unfavorable	Neuroblastoma			1581.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1581.0	52.0	2015.0					
TARGET-30-PALEVG	ANBL00B1, A3973, ANBL0032, ALTE05N1, ALTE03N1	C74.1	999	Medulla of adrenal gland	666	2	2001	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4948.0	2832.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4948.0	163.0	2015.0					
TARGET-30-PADHWC	3891, B003, B954, R9702	C74.0	999	Cortex of adrenal gland	1152	4	1992	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	541.0	1116.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Event	1:DECEASED	1122.0	37.0	1995.0					
TARGET-30-PANSBN	ANBL00B1	C38.3	999	Mediastinum, NOS	2329	7	2005	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	505.0	824.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	836.0	28.0	2007.0					
TARGET-30-PASFGG	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1037	3	2008	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	700.0	700.0	Female	Not Hispanic or Latino	White	High Risk	60	Death	1:DECEASED	700.0	24.0	2010.0	10	60/40			
TARGET-30-PATPPK	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	577	2	2010	Stage 4	Unfavorable	Neuroblastoma			845.0		Male	Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	1759.0	58.0	2015.0					
TARGET-30-PALIIN	ANBL00B1, A3973	C80.9	999	Unknown primary site	1279	4	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	684.0	1393.0	Male	Not Hispanic or Latino	White	High Risk	95	Relapse	1:DECEASED	1395.0	46.0	2005.0	5	90/10			
TARGET-30-PASCTR	ANBL00B1, ANBL0531	C74.0	999	Cortex of adrenal gland	60	1	2008	Stage 4s	Favorable	Neuroblastoma	0.0	0.0	2325.0	1142.0	Male	Not Hispanic or Latino	White	Intermediate Risk	40	Censored	0:LIVING	2325.0	77.0	2014.0					
TARGET-30-PAKGMY	B947, B973	C49.4	999	Connective, Subcutaneous and other Soft tissues of abdomen Connective, Subcutaneous and other Soft tissues of (see list under C49): . Abdomen . abdominal wall . Umbilicus Abdominal aorta Abdominal vena cava Abdominal wall muscle Celiac artery Ilio	673	2	2000	Stage 4	Unknown	Neuroblastoma	0.0	0.0	2.0	3.0	Male	Not Hispanic or Latino	Black or African American	High Risk	60	Censored	0:LIVING	2.0	1.0	2000.0	40	85/15			
TARGET-30-PAPBGH	ANBL00B1, A3973, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1074	3	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	470.0	718.0	Female	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	High Risk		Relapse	1:DECEASED	723.0	24.0	2007.0					
TARGET-30-PASSJK	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	244	1	2009	Stage 1	Favorable	Neuroblastoma			244.0		Female	Hispanic or Latino	Not Reported	Low Risk	98	Relapse	0:LIVING	2091.0	69.0	2015.0					
TARGET-30-PARTYI	ANBL00B1, ANBL0531	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	119	1	2008	Stage 4	Favorable	Neuroblastoma			2304.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	2304.0	76.0	2014.0					
TARGET-30-PASDZJ	ANBL00B1, ANBL0532	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	902	3	2008	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	282.0	330.0	Female	Hispanic or Latino	White	High Risk	75	Progression	1:DECEASED	330.0	11.0	2009.0	10	75/25			
TARGET-30-PASBEN	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1543	5	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	1297.0	346.0	Male	Not Hispanic or Latino	White	High Risk	60	Death	1:DECEASED	1297.0	43.0	2012.0	10	60/40			
TARGET-30-PASWLY	ANBL00B1, ANBL0532, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	979	3	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	537.0	620.0	Male	Hispanic or Latino	White	High Risk	60-70	Relapse	0:LIVING	2037.0	67.0	2015.0	10	60-70/30-40			
TARGET-30-PASTIJ	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2	1	2009	Stage 4	Favorable	Neuroblastoma			1955.0		Male	Not Hispanic or Latino	Black or African American	Intermediate Risk	90	Censored	0:LIVING	1955.0	65.0	2014.0					
TARGET-30-PAUDPP	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	977	3	2011	Stage 1	Unfavorable	Neuroblastoma			130.0		Male	Not Hispanic or Latino	White	Low Risk	90	Progression	0:LIVING	1466.0	49.0	2015.0					
TARGET-30-PARXMH	ANBL00B1, ANBL0531	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	247	1	2008	Stage 4	Favorable	Neuroblastoma			2727.0		Female	Unknown	Unknown	Intermediate Risk	60	Censored	0:LIVING	2727.0	90.0	2015.0					
TARGET-30-PADLTD	3891, B003, B954	Unknown	999	Left side abdominal adrenal tumor with no intraspinal ext. Size: 7.2cm x 6.5cm x 6.8cm. METS: BM, bone	950	3	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	454.0	472.0	Female	Hispanic or Latino	Unknown	High Risk		Event	1:DECEASED	477.0	16.0	1994.0					
TARGET-30-PASLSS	ANBL00B1, ANBL0531	C77.3		Lymph nodes of axilla or arm Axillary lymph node Brachial	136	1	2009	Stage 4	Favorable	Neuroblastoma			1195.0		Female	Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	1195.0	40.0	2012.0					
TARGET-30-PADSMF	3891, B003, B954	Unknown	999	Thoracoabdominal mass crossing midline-no intraspinal extension. SIZE: 2.5cm x 7.5 cm x 7.5cm Mets: BM, Bone	1222	4	1994	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	2998.0	2998.0	Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	2998.0	99.0	2002.0					
TARGET-30-PARCET	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	43	1	2007	Stage 4s	Favorable	Neuroblastoma			2810.0		Female	Not Hispanic or Latino	White	Low Risk	10	Censored	0:LIVING	2810.0	93.0	2014.0	50	10/90			
TARGET-30-PAMYXR	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	713	2	2004	Stage 4	Unknown	Unknown			374.0		Female	Not Hispanic or Latino	Black or African American	High Risk		Progression	1:DECEASED	421.0	14.0	2005.0					
TARGET-30-PATJPI	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	136	1	2010	Stage 1	Favorable	Neuroblastoma			152.0		Male	Not Hispanic or Latino	White	Low Risk	80	Relapse	0:LIVING	1888.0	63.0	2015.0					
TARGET-30-PASYPX	ANBL00B1, ANBL0532	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1514	5	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	296.0	491.0	Female	Hispanic or Latino	White	High Risk	97-98	Progression	0:LIVING	2215.0	73.0	2015.0	15				
TARGET-30-PAUNWR	ANBL00B1, ACCL05C1, ACCL0431, ANBL0032, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	958	3	2011	Stage 4	Unfavorable	Neuroblastoma			1202.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1202.0	40.0	2015.0					
TARGET-30-PADWEN	3891, B003	Unknown	999	Pelvic masses METS: bone, BM, LN, Shimada classification: stroma poor, undifferentiated NBL with high mitosis/karyorrhexis index	2042	6	1995	Stage 4	Unfavorable	Unknown	1.0	1.0	359.0	396.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Event	1:DECEASED	411.0	14.0	1997.0					
TARGET-30-PALVKK	ANBL00B1, A3973, AADM01P1	C74.1	999	Medulla of adrenal gland	1810	5	2002	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	217.0	1027.0	Female	Not Hispanic or Latino	White	High Risk	80	Event	1:DECEASED	1033.0	34.0	2005.0	0-20	95/5			
TARGET-30-PADNFT	3891, B003, B954	Unknown	999	Abdominal adrenal crossing midline encircling celiac artery and superior mesenteric artery.-no intraspinal ext. Mets; BM, LN	1494	5	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	447.0	728.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	729.0	24.0	1995.0					
TARGET-30-PATMAW	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	11	1	2010	Stage 4s	Favorable	Neuroblastoma			1783.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1783.0	59.0	2015.0					
TARGET-30-PAUNTY	ANBL00B1, ANBL0532, AEPI07N1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	582	2	2011	Stage 4	Unfavorable	Neuroblastoma			491.0		Male	Not Hispanic or Latino	Asian	High Risk	90	Relapse	1:DECEASED	840.0	28.0	2014.0					
TARGET-30-PAUTLP	ANBL00B1, ANBL0532, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	468	2	2012	Stage 4	Unfavorable	Neuroblastoma			54.0		Male	Not Hispanic or Latino	White	High Risk	90	Death	1:DECEASED	54.0	2.0	2012.0					
TARGET-30-PAIXLY	9047	Unknown		ABDOMEN/PERITONEUM OR RETROPERITONEUM	1241	4	2000	Stage 4	Unknown	Unknown			150.0		Male	Unknown	White	High Risk		Death	1:DECEASED	150.0	5.0	2000.0					
TARGET-30-PAIDJS	9047	Unknown	Y2	THORAX/MEDIASTINUM OR DIAPHRAGM	298	1	1995	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4191.0	4188.0	Male	Unknown	White	Low Risk	100	Censored	0:LIVING	4191.0	138.0	2006.0	0	80/20			
TARGET-30-PAPUWY	ANBL00B1, ANBL0621	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1955	6	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	765.0	1089.0	Female	Not Hispanic or Latino	White	High Risk	40	Relapse	1:DECEASED	1102.0	37.0	2009.0	10	40/60			
TARGET-30-PAMUFZ	ANBL00B1, A3973	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1489	5	2003	Stage 4	Unfavorable	Neuroblastoma			699.0		Male	Not Hispanic or Latino	White	High Risk		Progression	1:DECEASED	1166.0	39.0	2007.0					
TARGET-30-PASTXR	ANBL00B1, ANBL0532, ANBL0032	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	1100	4	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2276.0	643.0	Male	Not Hispanic or Latino	Unknown	High Risk	90	Censored	0:LIVING	2276.0	75.0	2015.0	10-20	90/10			
TARGET-30-PASLGM	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	44	1	2009	Stage 3	Favorable	Neuroblastoma			2319.0		Male	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2319.0	77.0	2015.0					
TARGET-30-PAUFVW	ANBL00B1, ANBL0532, ANBL0032, ALTE05N1	C49.4		 Connective, Subcutaneous and other Soft tissues of abdomen C	2488	7	2011	Stage 3	Unfavorable	Neuroblastoma			1379.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1379.0	46.0	2015.0					
TARGET-30-PASEWX	ANBL00B1, ANBL0531	C47.9		Autonomic nervous system, NOS Ganglia, NOS Nerve, NOS Par	180	1	2008	Stage 2b	Favorable	Neuroblastoma			350.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Event	0:LIVING	2183.0	72.0	2014.0					
TARGET-30-PASMPT	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	448	2	2009	Stage 4	Unfavorable	Neuroblastoma			2081.0		Male	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	2081.0	69.0	2014.0					
TARGET-30-PASKKZ	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	855	3	2009	Stage 4	Unfavorable	Neuroblastoma			400.0		Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	515.0	17.0	2010.0					
TARGET-30-PASSRS	ANBL00B1, ANBL0532, ANBL0032, ADVL0912, ANBL1021	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2492	7	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	861.0	622.0	Male	Not Hispanic or Latino	Unknown	High Risk	65	Relapse	1:DECEASED	1319.0	44.0	2012.0	15	65/35			
TARGET-30-PAVDBS	ANBL00B1, ANBL0032, ADVL0912	C47.4		Peripheral nerves and Autonomic nervous system of abdomen P	1211	4	2012	Stage 4	Unfavorable	Neuroblastoma			475.0		Female	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	863.0	29.0	2014.0					
TARGET-30-PADNNX	3891, B003, B903, B954	Unknown	999	Abdominal adrenal left side-no intraspinal ext. Size: 7cm x 6cm x 5cm METS: bone	1087	3	1993	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	228.0	495.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	499.0	17.0	1995.0					
TARGET-30-PASJWG	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	905	3	2009	Stage 1	Unfavorable	Neuroblastoma			2206.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2206.0	73.0	2015.0					
TARGET-30-PATUZF	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	678	2	2010	Stage 3	Unfavorable	Neuroblastoma			672.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	672.0	23.0	2012.0					
TARGET-30-PAPZYP	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1010	3	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2386.0	751.0	Female	Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2386.0	79.0	2013.0	10	90/10			
TARGET-30-PACPJG	323P, B954	Unknown	999	Unknown	760	3	1987	Unknown	Unknown	Unknown					Female	Not Hispanic or Latino	White	Unknown		Unknown									
TARGET-30-PARJMX	ANBL00B1, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	903	3	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2874.0	1295.0	Female	Hispanic or Latino	Unknown	High Risk	10	Censored	0:LIVING	2874.0	95.0	2015.0	10	10/90			
TARGET-30-PATPXF	ANBL00B1, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	0	0	2010	Stage 4s	Favorable	Neuroblastoma			1870.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1870.0	62.0	2015.0					
TARGET-30-PAURCG	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	226	1	2011	Stage 4	Unfavorable	Neuroblastoma			400.0		Female	Hispanic or Latino	Not Reported	High Risk	60	Relapse	1:DECEASED	580.0	20.0	2013.0					
TARGET-30-PATGLU	ANBL00B1, ANBL0931, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1037	3	2010	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	715.0	440.0	Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	1330.0	44.0	2013.0	40	80/20			
TARGET-30-PANBSP	ANBL00B1, A3973	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	1064	3	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	470.0	647.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	659.0	22.0	2006.0					
TARGET-30-PALNVP	ANBL00B1, A3973	C76.3	999	Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa Pelvic wall, NOS Perineum, NOS Rectovaginal septum Rectovesical septum Gluteal region, NOS Inguinal region, NOS Perirectal region, NOS Presacral region, NOS Sacrococcygeal region, NOS	1155	4	2002	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4665.0	2465.0	Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	4665.0	154.0	2015.0	5				
TARGET-30-PASAJY	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	148	1	2008	Stage 1	Favorable	Neuroblastoma			2423.0		Male	Not Hispanic or Latino	White	Low Risk	70	Censored	0:LIVING	2423.0	80.0	2015.0					
TARGET-30-PAPZWS	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	557	2	2007	Stage 4	Unfavorable	Neuroblastoma			237.0		Female	Hispanic or Latino	White	High Risk	40	Death	1:DECEASED	237.0	8.0	2007.0	10	40/60			
TARGET-30-PATMAJ	ANBL00B1, ANBL0532, ANBL0931	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	599	2	2010	Stage 3	Unfavorable	Neuroblastoma			1888.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1888.0	63.0	2015.0					
TARGET-30-PASNWH	ANBL00B1, ANBL0531, ALTE05N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	615	2	2009	Stage 2b	Unfavorable	Neuroblastoma			2056.0		Male	Not Hispanic or Latino	White	Intermediate Risk	95	Censored	0:LIVING	2056.0	68.0	2014.0					
TARGET-30-PAUPGV	ANBL00B1, ANBL0532	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1275	4	2011	Stage 4	Unfavorable	Neuroblastoma			1143.0		Male	Not Hispanic or Latino	White	High Risk	90	Relapse	0:LIVING	1282.0	43.0	2015.0					
TARGET-30-PASBGV	ANBL00B1, ANBL0532, ADVL0921	C80.9		Unknown primary site	1304	4	2008	Stage 4	Unknown	Unknown			2486.0		Female	Not Hispanic or Latino	White	High Risk	75	Censored	0:LIVING	2486.0	82.0	2015.0	0	75/25			
TARGET-30-PASVYV	ANBL00B1, ANBL0531, AEPI07N1	C75.5		Aortic body and other paraganglia Coccygeal body Coccygeal	306	1	2009	Stage 4	Favorable	Neuroblastoma			1861.0		Male	Not Hispanic or Latino	White	Intermediate Risk	60	Censored	0:LIVING	1861.0	62.0	2014.0					
TARGET-30-PARYSR	ANBL00B1, ANBL0532	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	512	2	2008	Stage 4	Unfavorable	Neuroblastoma			2462.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2462.0	81.0	2015.0					
TARGET-30-PATGWU	ANBL00B1, ANBL0531	C49.3		Connective, Subcutaneous and other Soft tissues of thorax	387	2	2010	Stage 3	Favorable	Ganglioneuroblastoma, nodular			2011.0		Male	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2011.0	67.0	2015.0					
TARGET-30-PARYUK	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	336	1	2008	Stage 2a	Unfavorable	Neuroblastoma			2664.0		Male	Not Hispanic or Latino	White	Low Risk	70	Censored	0:LIVING	2664.0	88.0	2015.0					
TARGET-30-PATVJX	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	575	2	2010	Stage 4	Unfavorable	Neuroblastoma			1720.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1720.0	57.0	2015.0					
TARGET-30-PAUEZU	ANBL00B1, ANBL0532, ANBL1021, ADVL0918	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	957	3	2011	Stage 4	Unfavorable	Neuroblastoma			934.0		Male	Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	934.0	31.0	2013.0					
TARGET-30-PAMBDH	ANBL00B1, A3973	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	797	3	2002	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4430.0	2038.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4430.0	146.0	2015.0					
TARGET-30-PATMTX	ANBL00B1, ANBL0531, ALTE05N1	C47.9		Autonomic nervous system, NOS Ganglia, NOS Nerve, NOS Par	291	1	2010	Stage 3	Favorable	Neuroblastoma			864.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	864.0	29.0	2012.0					
TARGET-30-PALBUY	ANBL00B1, A3973, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1053	3	2001	Stage 4	Unfavorable	Neuroblastoma			5019.0		Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	5019.0	166.0	2015.0					
TARGET-30-PAUAZA	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C38.2		 Posterior mediastinum	698	2	2011	Stage 4	Unfavorable	Neuroblastoma			1575.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1575.0	52.0	2015.0					
TARGET-30-PAPZFW	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1342	4	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	3153.0	1296.0	Male	Not Hispanic or Latino	White	High Risk	30	Censored	0:LIVING	3153.0	104.0	2015.0	10	30/70			
TARGET-30-PASCLP	ANBL00B1, ANBL0532, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	644	2	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	964.0	393.0	Male	Not Hispanic or Latino	White	High Risk	90	Relapse	0:LIVING	2268.0	75.0	2014.0	20-30	90/10			
TARGET-30-PAPEAV	ANBL00B1, A3973, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	696	2	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3462.0	1276.0	Female	Not Hispanic or Latino	White	High Risk	85-90	Censored	0:LIVING	3462.0	114.0	2015.0	30				
TARGET-30-PADLDT	3891, B003, B954, E18	Unknown	999	Abdominal Left adrenal primary-no intraspinal ext. Size: 10x12x9cm-Mets: Paravertebral mass, LN/Liver/BM/Bones	805	3	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	9.0	11.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	13.0	1.0	1993.0					
TARGET-30-PAPSEI	ANBL00B1, ADVL0912	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	573	2	2006	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1710.0	721.0	Female	Not Hispanic or Latino	White	High Risk	40	Relapse	1:DECEASED	2056.0	68.0	2012.0	5	40/60			
TARGET-30-PASGKP	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	3095	9	2008	Stage 4	Unfavorable	Neuroblastoma			625.0		Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	843.0	28.0	2011.0					
TARGET-30-PAUGJI	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	326	1	2011	Stage 4	Unfavorable	Neuroblastoma			427.0		Female	Hispanic or Latino	Not Reported	High Risk	90	Relapse	1:DECEASED	475.0	16.0	2012.0					
TARGET-30-PAHXZM	9047	Unknown		ADRENAL GLAND	1079	3	1993	Stage 4	Unknown	Unknown			671.0		Male	Unknown	White	High Risk	95	Death	1:DECEASED	671.0	23.0	1995.0	5	90/10			
TARGET-30-PASTTX	ANBL00B1	C74.1		  Medulla of adrenal gland	213	1	2009	Stage 1	Favorable	Neuroblastoma			2065.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2065.0	68.0	2015.0					
TARGET-30-PASMRC	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	50	1	2009	Stage 4	Favorable	Neuroblastoma			1485.0		Female	Not Hispanic or Latino	Unknown	Intermediate Risk	85	Censored	0:LIVING	1485.0	49.0	2013.0					
TARGET-30-PAVCGD	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1197	4	2012	Stage 4	Unfavorable	Neuroblastoma			527.0		Female	Hispanic or Latino	White	High Risk	70	Death	1:DECEASED	527.0	18.0	2014.0					
TARGET-30-PARJVP	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	56	1	2007	Stage 4s	Favorable	Neuroblastoma			2064.0		Male	Not Hispanic or Latino	Unknown	Low Risk	90	Censored	0:LIVING	2064.0	68.0	2013.0	10	90/10			
TARGET-30-PAJZWL	3891, B003, N891, E18	Unknown	999	Unknown	547	2	1992	Stage 4	Unknown	Unknown	1.0	1.0	377.0	409.0	Female	Unknown	Unknown	High Risk		Event	1:DECEASED	415.0	14.0	1993.0					
TARGET-30-PATXXI	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	3728	11	2010	Stage 4	Unfavorable	Neuroblastoma			1113.0		Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	1572.0	52.0	2015.0					
TARGET-30-PAIWHU	9047, P9641	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	242	1	1999	Stage 1	Favorable	Neuroblastoma	0.0	0.0	3678.0	3350.0	Male	Unknown	White	Low Risk	95	Censored	0:LIVING	3678.0	121.0	2009.0	5	80/20			
TARGET-30-PATYWM	ANBL00B1	C47.4		Peripheral nerves and Autonomic nervous system of abdomen P	328	1	2011	Stage 4	Unfavorable	Neuroblastoma			183.0		Female	Not Hispanic or Latino	White	High Risk	80	Death	1:DECEASED	183.0	7.0	2011.0					
TARGET-30-PARZBH	ANBL00B1, ANBL0531, AEPI07N1	C48.8		Overlapping lesion of retroperitoneum and peritoneum (See n	262	1	2008	Stage 3	Favorable	Neuroblastoma			2611.0		Male	Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2611.0	86.0	2015.0					
TARGET-30-PADWVR	3891, B003, 0935	Unknown	999	Abdominal left adrenal-no intraspinal ext. SIZE: 7.8cm x 6.1cm x 7.5cmMETS: BM, bone. Stroma Poor, High MKI	2158	6	1996	Stage 4	Unfavorable	Unknown	0.0	0.0	2776.0	2774.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2776.0	92.0	2003.0					
TARGET-30-PATRXC	ANBL00B1, ANBL0531, ANBL0532	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	153	1	2010	Stage 4	Unfavorable	Neuroblastoma			205.0		Female	Not Hispanic or Latino	White	High Risk	95	Progression	1:DECEASED	234.0	8.0	2011.0					
TARGET-30-PATWIL	ANBL00B1, ANBL00P3, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	577	2	2010	Stage 1	Unfavorable	Neuroblastoma			1492.0		Male	Unknown	Unknown	Low Risk	65	Censored	0:LIVING	1492.0	50.0	2014.0					
TARGET-30-PAJZUU	3891, B003, E18	Unknown	999	Unknown	3231	9	1992	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	476.0	782.0	Male	Unknown	Unknown	High Risk		Event	1:DECEASED	790.0	26.0	1994.0					
TARGET-30-PAUZTF	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	57	1	2012	Stage 4	Favorable	Neuroblastoma			903.0		Female	Not Hispanic or Latino	Unknown	Intermediate Risk	60	Censored	0:LIVING	903.0	30.0	2014.0					
TARGET-30-PAITRM	9047	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	1499	5	1998	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	1836.0	1832.0	Female	Unknown	Not Reported	High Risk	80	Death	1:DECEASED	1836.0	61.0	2003.0	20	80/20			
TARGET-30-PAUELT	ANBL00B1, ANBL0532	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	1632	5	2011	Stage 4	Unfavorable	Neuroblastoma			29.0		Female	Not Hispanic or Latino	Black or African American	High Risk	70	Death	1:DECEASED	29.0	1.0	2011.0					
TARGET-30-PADLNM	3891, B003	Unknown	999	Primary tumor=abdominal adrenal Left with no intraspinal ext. Size 4.5 cm x 4cm x 2.5 cm. Mets to LN, liver, BM, Bones	948	3	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	439.0	436.0	Male	Hispanic or Latino	Unknown	High Risk		Event	1:DECEASED	455.0	15.0	1994.0					
TARGET-30-PADINC	3891, B003, B954, E18	Unknown	999	Left retroperitoneal mass-no intraspinal ext-7x5x5cm-Bone/BM mets	1004	3	1992	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	252.0	403.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Event	1:DECEASED	409.0	14.0	1993.0					
TARGET-30-PAUDDZ	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2584	8	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1488.0		Male	Not Hispanic or Latino	Asian	High Risk	90	Censored	0:LIVING	1488.0	49.0	2015.0					
TARGET-30-PASPVZ	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2042	6	2009	Stage 4	Unfavorable	Neuroblastoma			2230.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	2230.0	74.0	2015.0					
TARGET-30-PATRJK	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	936	3	2010	Stage 3	Unfavorable	Ganglioneuroblastoma, nodular			1823.0		Female	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1823.0	60.0	2015.0					
TARGET-30-PATWZB	ANBL00B1	C38.2		 Posterior mediastinum	233	1	2010	Stage 2a	Favorable	Neuroblastoma			162.0		Female	Not Hispanic or Latino	Black or African American	Low Risk	90	Progression	0:LIVING	1652.0	55.0	2015.0					
TARGET-30-PASPER	ANBL00B1, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	753	3	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	638.0	632.0	Female	Hispanic or Latino	White	High Risk	90	Progression	0:LIVING	2087.0	69.0	2014.0	10	90/10			
TARGET-30-PADLPZ	3891, B003, B903, B954, E18	Unknown	999	Pelvic tumor originating from the Organ of zuckerkandl crossing midline displacing all pelvic viscer anteriorly and cephalad. Mass encroachign and displacing ureters, bladder and rectosigmoid. Sacral disection revealed the tumor invading a large foramen	2577	8	1993	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	1022.0	1398.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1409.0	47.0	1997.0					
TARGET-30-PASCFD	ANBL00B1, ANBL0531	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	183	1	2008	Stage 4	Favorable	Neuroblastoma			1812.0		Female	Not Hispanic or Latino	White	Intermediate Risk	50	Censored	0:LIVING	1812.0	60.0	2013.0					
TARGET-30-PAIXNG	9047, 4941	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	1221	4	2000	Stage 4	Unknown	Unknown	0.0	0.0	629.0	623.0	Male	Not Hispanic or Latino	White	High Risk	100	Censored	0:LIVING	629.0	21.0	2002.0	0	90/10			
TARGET-30-PALZBH	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	1390	4	2002	Stage 4	Unfavorable	Neuroblastoma			824.0		Male	Not Hispanic or Latino	White	High Risk	75	Death	1:DECEASED	824.0	28.0	2005.0	25	70/30			
TARGET-30-PAKFVB	9047	C44.5		Skin of trunk Skin of: . Abdomen . abdominal wall . Anus . Axilla . Back . Breast . Buttock . Chest . chest wall . Flank . Groin . Perineum . thoracic wall . Thorax . Trunk . Umbilicus . gluteal region . infraclavicular region . inguin	1098	4	2000	Stage 4	Unfavorable	Neuroblastoma			536.0		Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1049.0	35.0	2003.0					
TARGET-30-PAMMYR	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1548	5	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	659.0	1167.0	Male	Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1169.0	39.0	2006.0					
TARGET-30-PAUHHW	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2762	8	2011	Stage 4	Unfavorable	Neuroblastoma			1372.0		Male	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	1372.0	46.0	2015.0					
TARGET-30-PAKPNF	ANBL00B1, P9641, B947	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	79	1	2001	Stage 1	Favorable	Neuroblastoma			4454.0		Male	Hispanic or Latino	Not Reported	Low Risk		Censored	0:LIVING	4454.0	147.0	2013.0					
TARGET-30-PATBKX	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	259	1	2009	Stage 2a	Favorable	Ganglioneuroblastoma, nodular			262.0		Female	Not Hispanic or Latino	White	Intermediate Risk	60	Progression	0:LIVING	1794.0	59.0	2014.0					
TARGET-30-PASEWZ	ANBL00B1, AEPI07N1	C75.5		Aortic body and other paraganglia Coccygeal body Coccygeal	423	2	2008	Stage 2b	Favorable	Neuroblastoma			2524.0		Male	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2524.0	83.0	2015.0					
TARGET-30-PANLSG	ANBL00B1, A3973, ANBL0322	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1073	3	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	715.0	890.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	891.0	30.0	2007.0					
TARGET-30-PADSEC	3891, B003, B954	Unknown	999	Abdominal adrenal right side retroperitoneal--no intraspinal ext. Size: 25cm x 18cm x 12.5cm Mets: LN, BM, bone	1476	5	1994	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	428.0	651.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	665.0	22.0	1996.0					
TARGET-30-PASRFS	ANBL00B1, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1328	4	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	1675.0	752.0	Female	Not Hispanic or Latino	White	High Risk	70	Relapse	0:LIVING	2075.0	69.0	2014.0	10	70/30			
TARGET-30-PASEJZ	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	563	2	2008	Stage 3	Unfavorable	Neuroblastoma			218.0		Male	Not Hispanic or Latino	White	High Risk	60	Relapse	1:DECEASED	633.0	21.0	2010.0					
TARGET-30-PAKVUY	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1482	5	2001	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4855.0	3349.0	Male	Not Hispanic or Latino	Asian	High Risk		Censored	0:LIVING	4855.0	160.0	2014.0					
TARGET-30-PANAKY	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	924	3	2004	Stage 4	Unfavorable	Neuroblastoma			3896.0		Male	Hispanic or Latino	Not Reported	High Risk		Censored	0:LIVING	3896.0	129.0	2015.0					
TARGET-30-PAJXLE	I03, 323P, 8605, B954	Unknown	999	Unknown	720	2	1986	Unknown	Unknown	Unknown					Male	Unknown	Unknown	Unknown		Unknown									
TARGET-30-PAPRMJ		C74.1	999	Medulla of adrenal gland	1339	4	2006	Stage 4	Unknown	Unknown					Male	Hispanic or Latino	White	High Risk	10	Unknown					0	10/90			
TARGET-30-PAMDAL	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1222	4	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	147.0	138.0	Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	147.0	5.0	2003.0					
TARGET-30-PATWED	ANBL00B1, ANBL0531, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	48	1	2010	Stage 4s	Unfavorable	Neuroblastoma			100.0		Male	Not Hispanic or Latino	Asian	High Risk	95	Death	1:DECEASED	100.0	4.0	2011.0					
TARGET-30-PASKYH	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	98	1	2009	Stage 4s	Favorable	Neuroblastoma			2199.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2199.0	73.0	2015.0					
TARGET-30-PADKRU	3891, B003, B954, E18	Unknown	999	Retroperitoneal abdominal celiac mass crossing the midline-no intraspinal ext-8x8x7cm-Mets: LN/BM	1426	4	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	78.0	620.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	621.0	21.0	1994.0					
TARGET-30-PASKSR	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	398	2	2009	Stage 4	Unfavorable	Neuroblastoma			348.0		Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	621.0	21.0	2010.0					
TARGET-30-PARJTB	ANBL00B1, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	656	2	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1002.0	732.0	Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	1912.0	63.0	2012.0	10	90/10			
TARGET-30-PASSEC	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	777	3	2009	Stage 3	Unfavorable	Neuroblastoma			1957.0		Male	Not Hispanic or Latino	White	High Risk	95	Censored	0:LIVING	1957.0	65.0	2014.0					
TARGET-30-PATMSI	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	6217	18	2010	Stage 2b	Unfavorable	Neuroblastoma			747.0		Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	747.0	25.0	2012.0					
TARGET-30-PANYGR	ANBL00B1	C48.8	999	Overlapping lesion of retroperitoneum and peritoneum (See note page 1)	993	3	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	281.0	270.0	Male	Not Hispanic or Latino	Unknown	High Risk		Progression	1:DECEASED	283.0	10.0	2006.0					
TARGET-30-PALYPW	ANBL00B1	C74.1	999	Medulla of adrenal gland	858	3	2002	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	0.0	887.0	2117.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	2543.0	84.0	2009.0					
TARGET-30-PALGGL	ANBL00B1	C80.9		Unknown primary site	791	3	2001	Stage 4	Unfavorable	Neuroblastoma			4267.0		Female	Not Hispanic or Latino	Black or African American	High Risk	100	Censored	0:LIVING	4267.0	141.0	2013.0	0	95/5			
TARGET-30-PAKWWF	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1312	4	2001	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			3920.0		Male	Not Hispanic or Latino	Asian	High Risk		Censored	0:LIVING	3920.0	129.0	2012.0					
TARGET-30-PARLTG	ANBL00B1	C74.0	999	Cortex of adrenal gland	2436	7	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	1193.0	1180.0	Male	Not Hispanic or Latino	American Indian or Alaska Native	High Risk	90	Death	1:DECEASED	1193.0	40.0	2010.0	10	90/10			
TARGET-30-PACRYY	321P3, I03, S31	Unknown	999	Lge Right retroperitoneal mass extending thru into the lesser sac beneath the porta hepatis. Was encapsulated in RUQ with periaortic nodes	1314	4	1987	Stage 4	Unfavorable	Unknown	0.0	0.0	5296.0	5286.0	Male	Hispanic or Latino	Unknown	High Risk		Censored	0:LIVING	5296.0	175.0	2002.0					
TARGET-30-PAUBGW	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1777	5	2011	Stage 4	Unfavorable	Neuroblastoma			1592.0		Male	Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1592.0	53.0	2015.0					
TARGET-30-PASTKC	ANBL00B1, ANBL0532, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	3035	9	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1952.0	586.0	Male	Not Hispanic or Latino	White	High Risk	30-40	Censored	0:LIVING	1952.0	65.0	2014.0	10	30-40/60-70			
TARGET-30-PARHDE	ANBL00B1, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	842	3	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	288.0	473.0	Male	Hispanic or Latino	Not Reported	High Risk	40	Progression	1:DECEASED	487.0	17.0	2008.0	20	40/60			
TARGET-30-PARLMK	ANBL00B1, ACCL05C1, ANBL0032, ANBL0421	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1597	5	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			263.0		Female	Not Hispanic or Latino	White	High Risk	85	Relapse	1:DECEASED	376.0	13.0	2008.0	0	85/15			
TARGET-30-PASZKE	ANBL00B1, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	31	1	2009	Stage 4s	Unknown	Neuroblastoma			8.0		Male	Not Hispanic or Latino	White	Intermediate Risk	85	Death	1:DECEASED	8.0	1.0	2009.0					
TARGET-30-PAREGK	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	568	2	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3045.0	568.0	Male	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	3045.0	101.0	2015.0	10	50/50			
TARGET-30-PAIXIF	9047	Unknown	93	ADRENAL GLAND	1315	4	2000	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2228.0	2220.0	Male	Unknown	Unknown	High Risk		Censored	0:LIVING	2228.0	74.0	2006.0					
TARGET-30-PACSSR	321P3, B003	Unknown	999	Unknown	565	2	1988	Stage 4	Unfavorable	Unknown	1.0	1.0	47.0	201.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	203.0	7.0	1988.0					
TARGET-30-PARXMM	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	640	2	2008	Stage 3	Unfavorable	Neuroblastoma			2436.0		Male	Not Hispanic or Latino	Black or African American	High Risk	75	Censored	0:LIVING	2436.0	81.0	2014.0					
TARGET-30-PADUYJ	3891, B003	Unknown	999	Abdominal left retroperitoneal adrenal extending up from near spleen across midline down twds sacrum no intraspinal ext. METS: BM, bone	3115	9	1995	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	246.0	413.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	416.0	14.0	1996.0					
TARGET-30-PATXWY	ANBL00B1, ANBL0532, ADVL1115	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	953	3	2010	Stage 4	Unknown	Neuroblastoma			1025.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1025.0	34.0	2013.0					
TARGET-30-PAUZRC	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	194	1	2012	Stage 4	Favorable	Neuroblastoma			997.0		Female	Not Hispanic or Latino	White	Intermediate Risk	50	Censored	0:LIVING	997.0	33.0	2015.0					
TARGET-30-PAUKRF	ANBL00B1, ANBL0532, ANBL0032	C48.8		Overlapping lesion of retroperitoneum and peritoneum (See n	758	3	2011	Stage 4	Unfavorable	Neuroblastoma			1444.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1444.0	48.0	2015.0					
TARGET-30-PASYLD	ANBL00B1, ANBL0532	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2015	6	2009	Stage 4	Unknown	Unknown	1.0	1.0	188.0	276.0	Male	Not Hispanic or Latino	Black or African American	High Risk	60	Progression	1:DECEASED	276.0	10.0	2010.0	10	60/40			
TARGET-30-PAUBEC	ANBL00B1, ANBL1021, ADVL1213	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	4390	13	2011	Stage 4	Unfavorable	Neuroblastoma			413.0		Female	Not Hispanic or Latino	White	High Risk	70	Progression	0:LIVING	1112.0	37.0	2014.0					
TARGET-30-PANYBL	ANBL00B1, AADM01P1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1216	4	2005	Stage 4	Unknown	Unknown	1.0	1.0	495.0	491.0	Male	Not Hispanic or Latino	Asian	High Risk		Death	1:DECEASED	495.0	17.0	2007.0					
TARGET-30-PASAVJ	ANBL00B1, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	10	1	2008	Stage 1	Favorable	Neuroblastoma			2290.0		Male	Not Hispanic or Latino	Black or African American	Low Risk	90	Censored	0:LIVING	2290.0	76.0	2014.0					
TARGET-30-PATYMZ	ANBL00B1, ANBL0531, ANBL0532, ANBL0032	C38.2		 Posterior mediastinum	2347	7	2011	Stage 3	Unfavorable	Neuroblastoma			1231.0		Female	Not Hispanic or Latino	White	High Risk	80	Progression	0:LIVING	1608.0	53.0	2015.0					
TARGET-30-PATXHT	ANBL00B1, ANBL0532, ANBL0032	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	1181	4	2010	Stage 4	Unfavorable	Neuroblastoma			1637.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1637.0	54.0	2015.0					
TARGET-30-PAPREJ	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	3806	11	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	930.0	1280.0	Female	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	1281.0	43.0	2010.0					
TARGET-30-PAPTLA	ANBL0032, ANBL0421, ADVL0911, ADVL1011, ADVL1111	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1089	3	2006	Stage 4	Unfavorable	Unknown	1.0	0.0	334.0	1188.0	Female	Not Hispanic or Latino	White	High Risk	10	Event	1:DECEASED	2220.0	73.0	2013.0	10	10/90			
TARGET-30-PATINJ	ANBL00B1, AEPI07N1, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1037	3	2010	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	736.0	366.0	Male	Not Hispanic or Latino	White	High Risk	75	Relapse	1:DECEASED	822.0	28.0	2012.0	10	75/25			
TARGET-30-PAUSXH	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	474	2	2012	Stage 4	Unfavorable	Neuroblastoma			1248.0		Female	Not Hispanic or Latino	Black or African American	High Risk	99	Censored	0:LIVING	1248.0	42.0	2015.0					
TARGET-30-PASTSI	ANBL00B1, ANBL0531	C41.2		Vertebral column (excludes Sacrum and Coccyx C41.4) Atlas	540	2	2009	Stage 2a	Favorable	Neuroblastoma			175.0		Female	Not Hispanic or Latino	White	Intermediate Risk	60	Event	0:LIVING	1966.0	65.0	2014.0					
TARGET-30-PATCDJ	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	348	1	2009	Stage 4	Unfavorable	Neuroblastoma			333.0		Female	Not Hispanic or Latino	White	High Risk	50	Death	1:DECEASED	333.0	11.0	2010.0					
TARGET-30-PATIHB	ANBL00B1, ANBL0531, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	372	2	2010	Stage 4	Unfavorable	Neuroblastoma			1654.0		Male	Not Hispanic or Latino	White	High Risk	75	Censored	0:LIVING	1654.0	55.0	2014.0					
TARGET-30-PASBDN	ANBL00B1, ANBL0531, AEPI07N1	C76.0		Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Ce	46	1	2008	Stage 3	Favorable	Neuroblastoma			643.0		Male	Not Hispanic or Latino	White	Intermediate Risk	80	Event	0:LIVING	2343.0	78.0	2014.0					
TARGET-30-PANCYF	ANBL00B1, A3973	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1646	5	2004	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1696.0	1692.0	Female	Hispanic or Latino	White	High Risk		Censored	0:LIVING	1696.0	56.0	2009.0					
TARGET-30-PASGPY	ANBL00B1, ANBL0532	C38.3	999	Mediastinum, NOS	1972	6	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	438.0	184.0	Female	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	1438.0	48.0	2012.0	10	80/20			
TARGET-30-PATAFE	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	66	1	2009	Stage 4s	Favorable	Neuroblastoma			1577.0		Female	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	1577.0	52.0	2014.0					
TARGET-30-PAUKVC	ANBL00B1, ANBL0532, ANBL0032	C38.3		 Mediastinum, NOS	662	2	2011	Stage 4	Unfavorable	Neuroblastoma			1340.0		Female	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1340.0	45.0	2015.0					
TARGET-30-PALNFE	ANBL00B1, P9641	C76.3	999	Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa Pelvic wall, NOS Perineum, NOS Rectovaginal septum Rectovesical septum Gluteal region, NOS Inguinal region, NOS Perirectal region, NOS Presacral region, NOS Sacrococcygeal region, NOS	551	2	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4622.0	2432.0	Female	Not Hispanic or Latino	White	Low Risk	95	Censored	0:LIVING	4622.0	152.0	2014.0	5	95/5			
TARGET-30-PAUBHV	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	7612	21	2011	Stage 4	Unfavorable	Neuroblastoma			583.0		Male	Not Hispanic or Latino	White	High Risk	50	Progression	1:DECEASED	1168.0	39.0	2014.0					
TARGET-30-PAJYLA	321P2, B003	Unknown	999	Unknown	562	2	1989	Stage 4	Unfavorable	Unknown	1.0	1.0	266.0	364.0	Male	Unknown	Unknown	High Risk		Event	1:DECEASED	368.0	13.0	1990.0					
TARGET-30-PASSRN	ANBL00B1, ANBL0532, ANBL0931	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	5345	15	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2227.0	672.0	Male	Not Hispanic or Latino	White	High Risk	35	Censored	0:LIVING	2227.0	74.0	2015.0	5	35/65			
TARGET-30-PATBAC	ANBL00B1, ANBL0531	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	401	2	2009	Stage 3	Favorable	Neuroblastoma			1895.0		Female	Hispanic or Latino	Not Reported	Intermediate Risk	70	Censored	0:LIVING	1895.0	63.0	2015.0					
TARGET-30-PALKXJ	P9641, ANBL00B1	C74.1	999	Right Super Renal Mass with lessions	10	1	2002	Stage 4s	Favorable	Neuroblastoma	0.0	0.0	637.0	630.0	Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	637.0	21.0	2003.0					
TARGET-30-PAMCXF	ANBL00B1, A3973	Unknown	999	Right adrenal (this was added from text description)	765	3	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	376.0	712.0	Male	Hispanic or Latino	White	High Risk		Progression	1:DECEASED	718.0	24.0	2005.0					
TARGET-30-PAPUJU	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	954	3	2006	Stage 4	Unknown	Unknown	0.0	0.0	3193.0	1402.0	Male	Not Hispanic or Latino	Black or African American	High Risk	60	Censored	0:LIVING	3193.0	105.0	2015.0	10	60/40			
TARGET-30-PAIWRB	9047	Unknown	93	ADRENAL GLAND	1065	3	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	637.0	637.0	Female	Unknown	White	High Risk	98	Death	1:DECEASED	637.0	21.0	2001.0	2	80/20			
TARGET-30-PASESX	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	448	2	2008	Stage 4	Unfavorable	Neuroblastoma			2272.0		Female	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	2272.0	75.0	2014.0					
TARGET-30-PASLXS	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	858	3	2009	Stage 4	Unfavorable	Neuroblastoma			122.0		Female	Not Hispanic or Latino	White	High Risk	80	Death	1:DECEASED	122.0	5.0	2009.0					
TARGET-30-PAMEZH	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	746	3	2003	Stage 4	Unknown	Unknown	1.0	1.0	330.0	324.0	Female	Not Hispanic or Latino	Black or African American	High Risk	85	Death	1:DECEASED	330.0	11.0	2004.0	15	75/25			
TARGET-30-PANZVU	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1713	5	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	934.0	932.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	934.0	31.0	2008.0					
TARGET-30-PARSBI	ANBL00B1, ADVL0921, ANBL1021	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2390	7	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1377.0	760.0	Female	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	1743.0	58.0	2012.0	90	90/10			
TARGET-30-PAKACY	3891, B003, B903, E18	Unknown	999	Unknown	1114	4	1994	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	680.0	1362.0	Male	Unknown	Unknown	High Risk		Event	1:DECEASED	1366.0	45.0	1997.0					
TARGET-30-PATNPW	ANBL00B1, ANBL0532, ANBL0032, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	571	2	2010	Stage 4	Unfavorable	Neuroblastoma			1849.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1849.0	61.0	2015.0					
TARGET-30-PAUEYW	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2165	6	2011	Stage 4	Unfavorable	Neuroblastoma			1143.0		Female	Not Hispanic or Latino	White	High Risk	55	Relapse	0:LIVING	1350.0	45.0	2015.0					
TARGET-30-PAKGGW	B947, B973, P9641	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	30	1	2000	Stage 1	Favorable	Neuroblastoma			1227.0		Female	Not Hispanic or Latino	Black or African American	Low Risk		Censored	0:LIVING	1227.0	41.0	2003.0					
TARGET-30-PASLRM	ANBL00B1	C38.2		 Posterior mediastinum	590	2	2009	Stage 4	Unfavorable	Neuroblastoma			2304.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	2304.0	76.0	2015.0					
TARGET-30-PAILNI	9047	Unknown		ADRENAL GLAND	1142	4	1997	Stage 4	Unknown	Unknown			2874.0		Female	Unknown	White	High Risk	80	Censored	0:LIVING	2874.0	95.0	2005.0	20	90/10			
TARGET-30-PARVRR	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	705	2	2008	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	478.0	478.0	Male	Not Hispanic or Latino	White	High Risk	60	Relapse	1:DECEASED	572.0	19.0	2009.0	10	60/40			
TARGET-30-PAUNST	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	138	1	2011	Stage 4s	Favorable	Neuroblastoma			1060.0		Female	Not Hispanic or Latino	White	Low Risk	95	Censored	0:LIVING	1060.0	35.0	2014.0					
TARGET-30-PASNPG	ANBL00B1, ANBL0531	C76.7	999	Other ill-defined sites Back, NOS Flank, NOS Trunk, NOS	318	1	2009	Stage 3	Favorable	Neuroblastoma			302.0		Female	Not Hispanic or Latino	Black or African American	Intermediate Risk	90	Event	0:LIVING	2274.0	75.0	2015.0	10	90/10	75-90	10.0	
TARGET-30-PAUCFI	ANBL00B1, ANBL0532, ANBL0032	C38.3		 Mediastinum, NOS	1056	3	2011	Stage 4	Unfavorable	Neuroblastoma			1625.0		Female	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1625.0	54.0	2015.0					
TARGET-30-PARIKF	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	832	3	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2810.0	357.0	Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	2810.0	93.0	2015.0	10	80/20			
TARGET-30-PATVSU	ANBL00B1, ANBL0532, ANBL0032	C77.0		Lymph nodes of head, face and neck Auricular lymph node Ce	1266	4	2010	Stage 4	Unfavorable	Neuroblastoma			464.0		Male	Not Hispanic or Latino	Black or African American	High Risk	60	Censored	0:LIVING	464.0	16.0	2012.0					
TARGET-30-PAPVEB	ANBL00B1, ANBL0621	C74.9	999	Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS	1720	5	2006	Stage 2b	Unfavorable	Neuroblastoma			263.0		Male	Not Hispanic or Latino	White	Low Risk	60	Relapse	1:DECEASED	1211.0	40.0	2010.0	10	60/40	90		
TARGET-30-PARNEE	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1071	3	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	318.0	318.0	Female	Not Hispanic or Latino	White	High Risk	40	Death	1:DECEASED	318.0	11.0	2008.0	10	40/60			
TARGET-30-PAJYHP	321P2, B003	Unknown	999	Unknown	1409	4	1989	Stage 4	Unknown	Unknown	1.0	1.0	190.0	189.0	Female	Unknown	Unknown	High Risk		Death	1:DECEASED	190.0	7.0	1989.0					
TARGET-30-PASTKW	ANBL00B1, ANBL0532, ANBL0032	C47.3	999	Peripheral nerves and Autonomic nervous system of thorax Peripheral nerves and Autonomic nervous system of (see list under C47): . Axilla . Chest . chest wall . thoracic wall . infraclavicular region . scapular region Intercostal nerve	716	2	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2071.0	716.0	Female	Hispanic or Latino	Unknown	High Risk	40	Censored	0:LIVING	2071.0	69.0	2015.0	10	40/60			
TARGET-30-PASXMI	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1446	4	2009	Stage 4	Unfavorable	Neuroblastoma			173.0		Female	Hispanic or Latino	White	High Risk	90	Progression	1:DECEASED	203.0	7.0	2010.0					
TARGET-30-PARIRD	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	733	3	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	108.0	89.0	Male	Hispanic or Latino	White	High Risk	90	Death	1:DECEASED	108.0	4.0	2007.0	10	90/10			
TARGET-30-PATFTY	ANBL00B1, ANBL0531	C22.0		Liver Hepatic, NOS	163	1	2010	Stage 4s	Favorable	Neuroblastoma			1877.0		Female	Not Hispanic or Latino	Black or African American	Intermediate Risk	80	Censored	0:LIVING	1877.0	62.0	2015.0					
TARGET-30-PALFSE	ANBL00B1, P9641	C76.1	999	Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intrathoracic site, NOS Thoracic wall, NOS Infraclavicular region, NOS Scapular region, NOS	200	1	2001	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2873.0	2296.0	Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	2873.0	95.0	2009.0					
TARGET-30-PAUBPW	ANBL00B1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1246	4	2011	Stage 4	Unfavorable	Neuroblastoma			1534.0		Male	Not Hispanic or Latino	Not Reported	High Risk	90	Censored	0:LIVING	1534.0	51.0	2015.0					
TARGET-30-PAMACS	ANBL00B1, A3973	C74.1	999	Medulla of adrenal gland	1352	4	2002	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	233.0	235.0	Male	Not Hispanic or Latino	White	High Risk	100	Progression	1:DECEASED	243.0	8.0	2003.0	0	70/30			
TARGET-30-PATCJP	ANBL00B1, ANBL0032, ADVL0918	C42.1		 Bone marrow	1560	5	2009	Stage 4	Unknown	Unknown			841.0		Male	Not Hispanic or Latino	Not Reported	High Risk	50	Relapse	0:LIVING	1077.0	36.0	2012.0					
TARGET-30-PAUMXC	ANBL00B1, ANBL0532, ANBL0032	C49.4		 Connective, Subcutaneous and other Soft tissues of abdomen C	1277	4	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			830.0		Female	Unknown	White	High Risk	85	Death	1:DECEASED	830.0	28.0	2014.0					
TARGET-30-PARMLF	ANBL00B1, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	2512	7	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1993.0	1241.0	Male	Hispanic or Latino	Not Reported	High Risk	10	Progression	0:LIVING	2041.0	68.0	2013.0	60	10/90			
TARGET-30-PALURF	ANBL00B1, A3973	C80.9		Unknown primary site	1002	3	2002	Stage 4	Unfavorable	Neuroblastoma			4803.0		Male	Not Hispanic or Latino	Unknown	High Risk		Censored	0:LIVING	4803.0	158.0	2015.0					
TARGET-30-PAUSJB	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	548	2	2012	Stage 4	Unfavorable	Neuroblastoma			1084.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1084.0	36.0	2014.0					
TARGET-30-PADKFU	3891, B003, E18	Unknown	999	Para-aortic abdominal tumor crossing midline; 16x12x8cm-Mets: LN. Mid abdominal mass from level of superior mesenteric artery down to aortic bifucation with involvement of mid-gut mesentery and Iliac LN invlvmt of right & left chains	1778	5	1992	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	3866.0	3859.0	Male	Not Hispanic or Latino	Not Reported	High Risk		Censored	0:LIVING	3866.0	128.0	2003.0					
TARGET-30-PAPHGF	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	890	3	2006	Stage 4	Unfavorable	Neuroblastoma			24.0		Female	Not Hispanic or Latino	Black or African American	High Risk		Death	1:DECEASED	24.0	1.0	2006.0					
TARGET-30-PASWCY	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	538	2	2009	Stage 4	Unfavorable	Neuroblastoma			446.0		Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	501.0	17.0	2010.0					
TARGET-30-PARURB	ANBL00B1, ACCL05C1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2178	6	2008	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	365.0	720.0	Male	Not Hispanic or Latino	Black or African American	High Risk	0	Progression	1:DECEASED	724.0	24.0	2010.0					
TARGET-30-PASGCD	ANBL00B1	C76.3		Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa P	389	2	2008	Stage 1	Favorable	Neuroblastoma			2505.0		Female	Hispanic or Latino	Not Reported	Low Risk	70	Censored	0:LIVING	2505.0	83.0	2015.0					
TARGET-30-PAMVLG	ANBL00B1, A3973, AADM01P1, ANBL0032, ANBL0621	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1978	6	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	678.0	1539.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1540.0	51.0	2008.0					
TARGET-30-PALFDZ	ANBL00B1, A3973, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1080	3	2001	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			4620.0		Female	Not Hispanic or Latino	White	High Risk	95	Censored	0:LIVING	4620.0	152.0	2014.0	5	80/20			
TARGET-30-PAPICY	ANBL00B1	C44.7	999	Skin of lower limb and hip  Skin of:  . Ankle  . Calf  . Foo	58	1	2006	Stage 4s	Favorable	Neuroblastoma			205.0		Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	205.0	7.0	2006.0					
TARGET-30-PASCDX	ANBL00B1, ANBL0532, AEPI07N1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	652	2	2008	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	157.0	192.0	Female	Not Hispanic or Latino	White	High Risk	60	Relapse	1:DECEASED	192.0	7.0	2009.0	10	60/40			
TARGET-30-PAKHCF	9047	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	839	3	2000	Stage 4	Favorable	Neuroblastoma	1.0	1.0	915.0	903.0	Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	915.0	31.0	2003.0					
TARGET-30-PASRSG	ANBL00B1, ANBL0531, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1360	4	2009	Stage 3	Unfavorable	Neuroblastoma			2010.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2010.0	67.0	2014.0					
TARGET-30-PAPBJE	AADM01P1, ANBL00B1, A3973, ALTE05N1	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	1860	6	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3467.0	1972.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3467.0	114.0	2015.0					
TARGET-30-PATHJZ	ANBL00B1, AEPI07N1, ADVL1412	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	339	1	2010	Stage 4	Favorable	Neuroblastoma			722.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Progression	0:LIVING	2031.0	67.0	2015.0					
TARGET-30-PARKAG	ANBL00B1, ANBL0421, ADVL0821	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1363	4	2007	Stage 4	Unknown	Neuroblastoma	1.0	1.0	864.0	848.0	Female	Unknown	Unknown	High Risk	70	Death	1:DECEASED	864.0	29.0	2009.0	10	70/30			
TARGET-30-PARFBW	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	759	3	2007	Stage 4	Unknown	Neuroblastoma	0.0	0.0	3001.0	708.0	Male	Not Hispanic or Latino	Black or African American	High Risk	80	Censored	0:LIVING	3001.0	99.0	2015.0	10	80/20			
TARGET-30-PALXTB	ANBL00B1, A3973, ALTE05N1	C74.1	999	Medulla of adrenal gland	635	2	2002	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4621.0	2186.0	Male	Not Hispanic or Latino	White	High Risk	80-90	Censored	0:LIVING	4621.0	152.0	2015.0	10				
TARGET-30-PASMDG	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	148	1	2009	Stage 2a	Favorable	Neuroblastoma			134.0		Female	Unknown	White	Low Risk	60	Relapse	0:LIVING	2277.0	75.0	2015.0					
TARGET-30-PASAZZ	ACCL05C1, ANBL00B1, ANBL0532	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1914	6	2008	Stage 4	Unfavorable	Neuroblastoma			795.0		Female	Not Hispanic or Latino	White	High Risk	90	Relapse	0:LIVING	2444.0	81.0	2015.0					
TARGET-30-PAKIAP	9047	C47.9		Autonomic nervous system, NOS Ganglia, NOS Nerve, NOS Parasympathetic nervous system, NOS Peripheral nerve, NOS Spinal nerve, NOS Sympathetic nervous system, NOS	1742	5	2000	Stage 4	Unfavorable	Neuroblastoma			826.0		Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	826.0	28.0	2002.0					
TARGET-30-PARMDD	ANBL00B1, ACCL05C1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1180	4	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	1260.0	1264.0	Female	Not Hispanic or Latino	Black or African American	High Risk	0	Relapse	0:LIVING	2654.0	88.0	2015.0					
TARGET-30-PASYMX	ANBL00B1, ANBL0532, ADVL0918	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2894	8	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	822.0	637.0	Female	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	822.0	28.0	2011.0	10	70/30			
TARGET-30-PAKUAW	ANBL00B1, P9641	C76.7		Other ill-defined sites Back, NOS Flank, NOS Trunk, NOS	416	2	2001	Stage 1	Favorable	Ganglioneuroblastoma, intermixed			61.0		Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	61.0	3.0	2001.0					
TARGET-30-PASLCD	ANBL00B1, ANBL0531, ANBL0532, ANBL0032, D9902, ALTE03N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	505	2	2009	Stage 3	Unfavorable	Neuroblastoma			661.0		Male	Not Hispanic or Latino	White	High Risk	60	Second Malignant Neoplasm	0:LIVING	2369.0	78.0	2015.0					
TARGET-30-PASKJX	ANBL00B1, ANBL0532, ANBL1021	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	7446	21	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	595.0	174.0	Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	1682.0	56.0	2013.0	10	90/10			
TARGET-30-PADPCI	3891, B003, B954	Unknown	999	Abdominal adrenal left side-no intraspinal ext. Size: 12cm x 9.5cm x 7cm METS: LN, Bone, Neck	1996	6	1994	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	113.0	238.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	240.0	8.0	1994.0					
TARGET-30-PAKHAE	9047, P9641	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	359	1	2000	Stage 1	Favorable	Neuroblastoma			4907.0		Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	4907.0	162.0	2014.0					
TARGET-30-PASTGH	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	6799	19	2009	Stage 4	Unknown	Unknown			817.0		Male	Not Hispanic or Latino	White	High Risk	50	Relapse	1:DECEASED	1766.0	59.0	2014.0					
TARGET-30-PADFLI	3891, B003, B954	Unknown	999	Shimada: unfavorable; NMYC: < 10 copies; Serum ferritin ND; Abd adrenal- 13 cm-Right sided retroperitoneal mass-crossing the midline; no intraspinal extn.	557	2	1991	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2872.0	2870.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2872.0	95.0	1999.0					
TARGET-30-PARTZW	ANBL00B1	C38.3		 Mediastinum, NOS	341	1	2008	Stage 4	Favorable	Neuroblastoma			37.0		Female	Not Hispanic or Latino	White	Intermediate Risk	80	Death	1:DECEASED	37.0	2.0	2008.0					
TARGET-30-PALWBT	ANBL00B1, P9641	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	399	2	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2637.0	2256.0	Male	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	2637.0	87.0	2009.0	0	80/20			
TARGET-30-PAIXHH	9047, P9641	Unknown		ADRENAL GLAND	38	1	2000	Stage 1	Favorable	Neuroblastoma			4011.0		Male	Unknown	White	Low Risk		Censored	0:LIVING	4011.0	132.0	2011.0					
TARGET-30-PARZNV	ANBL00B1	C38.3		 Mediastinum, NOS	473	2	2008	Stage 2a	Favorable	Neuroblastoma			2631.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	2631.0	87.0	2015.0					
TARGET-30-PARWEH	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	407	2	2008	Stage 3	Favorable	Neuroblastoma			2601.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	2601.0	86.0	2015.0					
TARGET-30-PATIYD	ANBL00B1, AEPI07N1, ANBL0931	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	537	2	2010	Stage 4	Favorable	Neuroblastoma			1724.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1724.0	57.0	2014.0					
TARGET-30-PARHYL	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1394	4	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2739.0	688.0	Female	Not Hispanic or Latino	Black or African American	High Risk	20	Censored	0:LIVING	2739.0	91.0	2015.0	10	20/80			
TARGET-30-PALCBW	ANBL00B1	C74.1	999	Medulla of adrenal gland	679	2	2001	Stage 4	Favorable	Neuroblastoma	0.0	0.0	4565.0	2544.0	Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	4565.0	151.0	2014.0	1				
TARGET-30-PATFIN	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	631	2	2010	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1192.0	352.0	Female	Not Hispanic or Latino	White	High Risk	90	Event	1:DECEASED	1363.0	45.0	2013.0	10	90/10			
TARGET-30-PASTMW	ANBL00B1, ANBL0532, ANBL0032, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	268	1	2009	Stage 4	Unknown	Neuroblastoma			1919.0		Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1919.0	64.0	2014.0					
TARGET-30-PATVMF	ANBL00B1, ANBL0531, AEPI07N1	C76.3		Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa P	291	1	2010	Stage 3	Favorable	Neuroblastoma			460.0		Male	Hispanic or Latino	White	Intermediate Risk	90	Event	0:LIVING	1593.0	53.0	2015.0					
TARGET-30-PARJAR	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1459	4	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	0.0	721.0	715.0	Male	Not Hispanic or Latino	White	High Risk	40	Relapse	0:LIVING	2913.0	96.0	2015.0	0	40/60			
TARGET-30-PARYRJ	ANBL00B1, ANBL0531, AEPI07N1	C77.0		Lymph nodes of head, face and neck Auricular lymph node Ce	400	2	2008	Stage 3	Favorable	Neuroblastoma			369.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Event	0:LIVING	2406.0	80.0	2014.0					
TARGET-30-PATAAV	ANBL00B1, ANBL0532, ANBL0931, AEPI07N1, ADVL0912	C48.8		Overlapping lesion of retroperitoneum and peritoneum (See n	1894	6	2009	Stage 3	Unfavorable	Neuroblastoma			636.0		Female	Unknown	White	High Risk	70	Event	1:DECEASED	817.0	27.0	2011.0					
TARGET-30-PANWBG	ANBL00B1	C76.7		Other ill-defined sites Back, NOS Flank, NOS Trunk, NOS	948	3	2005	Stage 4	Unfavorable	Neuroblastoma			3523.0		Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3523.0	116.0	2015.0		1/99			
TARGET-30-PAIFXV	9047, 9340, 9341, 9342, P9462	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	2004	6	1995	Stage 4	Unfavorable	Unknown	1.0	1.0	630.0	1111.0	Female	Unknown	White	High Risk		Event	1:DECEASED	1114.0	37.0	1998.0					
TARGET-30-PARDVT	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1338	4	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	732.0	721.0	Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	732.0	25.0	2009.0	70	90/10			
TARGET-30-PARXXC	ANBL00B1, ANBL0532	C22.0		Liver Hepatic, NOS	1725	5	2008	Stage 4	Unfavorable	Neuroblastoma			427.0		Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	679.0	23.0	2010.0					
TARGET-30-PASUEZ	ANBL00B1, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	20	1	2009	Stage 2a	Favorable	Neuroblastoma			211.0		Male	Not Hispanic or Latino	White	Low Risk	90	Progression	0:LIVING	1725.0	57.0	2014.0					
TARGET-30-PATNGD	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1065	3	2010	Stage 4	Unfavorable	Neuroblastoma			1798.0		Male	Not Hispanic or Latino	White	High Risk	85	Censored	0:LIVING	1798.0	60.0	2015.0					
TARGET-30-PASTGD	ANBL00B1, ANBL0532, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	925	3	2009	Stage 4	Unfavorable	Neuroblastoma			375.0		Male	Not Hispanic or Latino	White	High Risk	80	Progression	1:DECEASED	565.0	19.0	2010.0					
TARGET-30-PALXRL	ANBL00B1, A3973, AAML00P2, B947, AADM01P1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1530	5	2002	Stage 4	Unfavorable	Neuroblastoma			822.0		Male	Not Hispanic or Latino	Black or African American	High Risk		Second Malignant Neoplasm	0:LIVING	1607.0	53.0	2007.0					
TARGET-30-PAUZZI	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	725	2	2012	Stage 4	Unfavorable	Neuroblastoma			1016.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1016.0	34.0	2015.0					
TARGET-30-PAUATG	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	3641	10	2011	Stage 4	Unfavorable	Neuroblastoma			1512.0		Female	Not Hispanic or Latino	White	High Risk	80	Relapse	0:LIVING	1512.0	50.0	2015.0					
TARGET-30-PAUBFU	ANBL00B1, ANBL0532, ANBL1021	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	1519	5	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			418.0		Male	Hispanic or Latino	Not Reported	High Risk	90	Event	0:LIVING	1308.0	44.0	2014.0					
TARGET-30-PADVSN	3891, B003	Unknown	999	Thoracoabdominal paraspinous T9-T12 crossing midline no intraspinal ext. Size: 1.5cm x 2.5cm x 5.5 cm Mets: BM, Bone	834	3	1995	Stage 4	Unfavorable	Unknown	0.0	0.0	2565.0	2562.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2565.0	85.0	2002.0					
TARGET-30-PASUCB	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1008	3	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1976.0	742.0	Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1976.0	65.0	2014.0	10	90/10			
TARGET-30-PAPRTD	ANBL00B1, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1568	5	2006	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	1030.0	777.0	Male	Not Hispanic or Latino	White	High Risk	100	Censored	0:LIVING	1030.0	34.0	2009.0	0	100/0			
TARGET-30-PALGFF	ANBL00B1, P9641	C38.2	999	Posterior mediastinum	117	1	2001	Stage 1	Favorable	Neuroblastoma	0.0	0.0	1446.0	1442.0	Female	Not Hispanic or Latino	American Indian or Alaska Native	Low Risk	95	Censored	0:LIVING	1446.0	48.0	2005.0	5	90/10			
TARGET-30-PATCJF	ANBL00B1, ANBL0531	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	132	1	2009	Stage 4	Favorable	Neuroblastoma			1668.0		Male	Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	1668.0	55.0	2014.0					
TARGET-30-PADNXC	3891, B003, B903, E18	Unknown	999	Abdominal adrenal-right side, no intraspinal ext. SIZE: 5cm x 7cm x 5cm Mets: BM, bone	561	2	1994	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1375.0	1375.0	Female	Hispanic or Latino	Unknown	High Risk		Censored	0:LIVING	1375.0	46.0	1997.0					
TARGET-30-PARPUF	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	95	1	2007	Stage 4	Favorable	Neuroblastoma			2812.0		Male	Hispanic or Latino	White	Intermediate Risk	60	Censored	0:LIVING	2812.0	93.0	2015.0					
TARGET-30-PATFES	ANBL00B1	C41.0		 Bones of skull and face and associated joints (excludes Mand	639	2	2010	Stage 4	Unfavorable	Neuroblastoma			420.0		Male	Not Hispanic or Latino	White	High Risk	70	Relapse	1:DECEASED	847.0	28.0	2012.0					
TARGET-30-PASBYW	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	770	3	2008	Stage 3	Favorable	Ganglioneuroma, maturing subtype OR Ganglioneuroblastoma, well differentiated			2583.0		Male	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	Intermediate Risk	90	Censored	0:LIVING	2583.0	85.0	2015.0					
TARGET-30-PASFNF	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	46	1	2008	Stage 1	Favorable	Neuroblastoma			163.0		Male	Not Hispanic or Latino	White	Low Risk	80	Progression	0:LIVING	2499.0	83.0	2015.0					
TARGET-30-PASKNK	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	481	2	2009	Stage 1	Favorable	Neuroblastoma			2189.0		Female	Not Hispanic or Latino	White	Low Risk	85	Censored	0:LIVING	2189.0	72.0	2015.0					
TARGET-30-PATDVF	ANBL00B1, ANBL0531, ADVL0912	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	198	1	2009	Stage 4	Unknown	Neuroblastoma			505.0		Female	Unknown	White	Intermediate Risk	70	Event	0:LIVING	906.0	30.0	2012.0					
TARGET-30-PATLXP	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	662	2	2010	Stage 4	Unknown	Unknown			489.0		Male	Not Hispanic or Latino	White	High Risk	70	Relapse	1:DECEASED	697.0	23.0	2012.0					
TARGET-30-PATLLI	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	558	2	2010	Stage 4	Unfavorable	Neuroblastoma			351.0		Male	Not Hispanic or Latino	White	High Risk	50	Relapse	1:DECEASED	357.0	12.0	2011.0					
TARGET-30-PASLDM	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1896	6	2009	Stage 2b	Unfavorable	Neuroblastoma			2192.0		Female	Unknown	White	High Risk	90	Censored	0:LIVING	2192.0	73.0	2015.0					
TARGET-30-PARZZC	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	754	3	2008	Stage 3	Unfavorable	Ganglioneuroblastoma, nodular			171.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	171.0	6.0	2008.0					
TARGET-30-PAKANZ	3891, B003, B947, P9462, S921	Unknown	999	Unknown, to be determined later	1975	6	1996	Stage 4	Unfavorable	Unknown	1.0	1.0	795.0	1235.0	Male	Unknown	White	High Risk		Event	1:DECEASED	1235.0	41.0	1999.0					
TARGET-30-PAPBFP	ANBL00B1, AADM01P1, ANBL0621	C38.1		Anterior mediastinum	1800	5	2005	Stage 4	Unfavorable	Neuroblastoma			552.0		Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	586.0	20.0	2007.0					
TARGET-30-PAUDVA	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1530	5	2011	Stage 4	Unfavorable	Neuroblastoma			1572.0		Male	Not Hispanic or Latino	White	High Risk	85	Relapse	0:LIVING	1572.0	52.0	2015.0					
TARGET-30-PASBMW	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1645	5	2008	Stage 3	Unfavorable	Neuroblastoma			2388.0		Male	Not Hispanic or Latino	Asian	High Risk	80	Censored	0:LIVING	2388.0	79.0	2015.0					
TARGET-30-PAUXSZ	ANBL00B1, ANBL0032, ANUR1131	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	5786	16	2012	Stage 4	Unfavorable	Neuroblastoma			1203.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1203.0	40.0	2015.0					
TARGET-30-PATRUX	ANBL00B1, ANBL0532, ANBL0931	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	404	2	2010	Stage 4	Unfavorable	Neuroblastoma			312.0		Female	Not Hispanic or Latino	White	High Risk	70	Event	1:DECEASED	597.0	20.0	2012.0					
TARGET-30-PASCRK	ANBL00B1, ANBL0531	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	159	1	2008	Stage 3	Favorable	Neuroblastoma			1905.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	1905.0	63.0	2013.0					
TARGET-30-PADMGA	3891, B003, E18	Unknown	999	Left side abdominal adrenal tumor with no intraspinal ext. Size: 3.4cm x 3.0cm x 2cm. METs:BM, Bone, LN.	1827	6	1993	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	0.0	932.0	4283.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Event	0:LIVING	4287.0	141.0	2005.0					
TARGET-30-PASWSZ	ANBL00B1, ANBL0531, ANBL0532	C72.0		Spinal cord Cervical cord Conus medullaris Filum terminal	613	2	2009	Stage 3	Unfavorable	Neuroblastoma			1957.0		Female	Not Hispanic or Latino	Not Reported	High Risk	90	Censored	0:LIVING	1957.0	65.0	2014.0					
TARGET-30-PALRFJ	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	709	2	2002	Stage 4	Unfavorable	Neuroblastoma			2536.0		Female	Not Hispanic or Latino	Black or African American	High Risk		Censored	0:LIVING	2536.0	84.0	2009.0					
TARGET-30-PAMTZV	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	902	3	2003	Stage 4	Unfavorable	Neuroblastoma			389.0		Female	Not Hispanic or Latino	White	High Risk		Progression	1:DECEASED	437.0	15.0	2005.0					
TARGET-30-PASFXS	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	381	2	2008	Stage 2a	Unknown	Neuroblastoma			2214.0		Male	Not Hispanic or Latino	Asian	Low Risk	70	Censored	0:LIVING	2214.0	73.0	2014.0					
TARGET-30-PARVIH	ANBL00B1	C76.0		Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Ce	180	1	2008	Stage 1	Favorable	Neuroblastoma			2408.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2408.0	80.0	2014.0					
TARGET-30-PASVRU	ANBL00B1, ANBL0532	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	631	2	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	254.0	436.0	Male	Hispanic or Latino	White	High Risk	80	Event	1:DECEASED	440.0	15.0	2010.0	10	80/20			
TARGET-30-PARKZF	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	730	2	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2589.0	1078.0	Male	Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2589.0	86.0	2014.0	10	90/10			
TARGET-30-PAMSXU	ANBL00B1, ANBL00P1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1663	5	2003	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			2959.0		Female	Not Hispanic or Latino	Black or African American	High Risk		Censored	0:LIVING	2959.0	98.0	2011.0					
TARGET-30-PALAKE	ANBL00B1	C74.1	999	Medulla of adrenal gland	860	3	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	246.0	403.0	Male	Not Hispanic or Latino	Unknown	High Risk		Relapse	1:DECEASED	406.0	14.0	2002.0					
TARGET-30-PASJWU	ANBL00B1, ANBL0531, AEPI07N1	C38.2		 Posterior mediastinum	262	1	2009	Stage 4	Favorable	Neuroblastoma			2376.0		Male	Not Hispanic or Latino	White	Intermediate Risk	65	Censored	0:LIVING	2376.0	79.0	2015.0					
TARGET-30-PASXIE	ANBL00B1, ANBL0532, AEPI07N1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	837	3	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2123.0	650.0	Male	Not Hispanic or Latino	White	High Risk	30-40	Censored	0:LIVING	2123.0	70.0	2015.0	10	30-40/60-70			
TARGET-30-PAUXFZ	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	158	1	2012	Stage 2b	Favorable	Neuroblastoma			1095.0		Male	Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1095.0	36.0	2015.0					
TARGET-30-PAUFFP	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	758	3	2011	Stage 4	Unfavorable	Neuroblastoma			402.0		Female	Unknown	White	High Risk	80	Relapse	1:DECEASED	533.0	18.0	2012.0					
TARGET-30-PATNKP	ANBL00B1, ANBL0532, ANBL0931, ADVL0912	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Per	3446	10	2010	Stage 4	Unfavorable	Neuroblastoma			616.0		Male	Not Hispanic or Latino	White	High Risk	90	Event	1:DECEASED	1549.0	51.0	2014.0			98	1.0	
TARGET-30-PARNNC	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Per	41	1	2007	Stage 4s	Favorable	Neuroblastoma			735.0		Female	Not Hispanic or Latino	White	Low Risk	10-20	Relapse	0:LIVING	2611.0	86.0	2014.0	10	10-20/80-90			
TARGET-30-PASANE	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1640	5	2008	Stage 1	Favorable	Ganglioneuroblastoma, intermixed			2620.0		Female	Hispanic or Latino	Unknown	Low Risk	90	Censored	0:LIVING	2620.0	87.0	2015.0					
TARGET-30-PATBJI	ANBL00B1	C49.6		 Connective, Subcutaneous and other Soft tissues of trunk, NO	87	1	2009	Stage 2a	Favorable	Neuroblastoma			90.0		Female	Not Hispanic or Latino	Not Reported	Low Risk	60	Progression	0:LIVING	2058.0	68.0	2015.0					
TARGET-30-PANUKV	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1486	5	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	356.0	402.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	404.0	14.0	2006.0					
TARGET-30-PARVVM	ANBL00B1, AEPI07N1	C42.1		 Bone marrow	339	1	2008	Stage 4	Unknown	Neuroblastoma			182.0		Male	Not Hispanic or Latino	White	High Risk	80	Progression	1:DECEASED	313.0	11.0	2009.0					
TARGET-30-PAPTMM	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	559	2	2006	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3186.0	765.0	Female	Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	3186.0	105.0	2015.0	0	80/20			
TARGET-30-PAUITU	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	351	1	2011	Stage 4	Unfavorable	Neuroblastoma			421.0		Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	478.0	16.0	2012.0					
TARGET-30-PASAAB	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	272	1	2008	Stage 1	Favorable	Neuroblastoma			2659.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2659.0	88.0	2015.0					
TARGET-30-PASCFA	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	33	1	2008	Stage 4s	Favorable	Neuroblastoma			2437.0		Male	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2437.0	81.0	2015.0					
TARGET-30-PAIMDS	9047, P9462	Unknown	93	ADRENAL GLAND	1332	4	1997	Stage 4	Unknown	Unknown	1.0	1.0	454.0	1013.0	Female	Unknown	White	High Risk	95	Event	1:DECEASED	1013.0	34.0	2000.0	5	85/15			
TARGET-30-PALZHF	ANBL00B1, P9641	C74.1		Medulla of adrenal gland	16	1	2002	Stage 1	Favorable	Neuroblastoma			126.0		Male	Hispanic or Latino	Not Reported	Low Risk		Event	0:LIVING	4318.0	142.0	2014.0					
TARGET-30-PACVNB	321P2, B003, B954	Unknown	999	Unknown	1610	5	1989	Stage 4	Unfavorable	Unknown	1.0	1.0	245.0	243.0	Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	245.0	9.0	1989.0					
TARGET-30-PARGZK	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1583	5	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	162.0	148.0	Male	Not Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	162.0	6.0	2007.0	20	70/30			
TARGET-30-PATUPR	ANBL00B1, ANBL0531, ANBL0532	C48.8		Overlapping lesion of retroperitoneum and peritoneum (See n	270	1	2010	Stage 4	Unfavorable	Neuroblastoma			183.0		Male	Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	257.0	9.0	2011.0					
TARGET-30-PAUJTY	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C77.0		Lymph nodes of head, face and neck Auricular lymph node Ce	596	2	2011	Stage 4	Unfavorable	Neuroblastoma			1353.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1353.0	45.0	2015.0					
TARGET-30-PAUIWS	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	924	3	2011	Stage 4	Unfavorable	Neuroblastoma			1385.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1385.0	46.0	2015.0					
TARGET-30-PAVDYS	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	23	1	2012	Stage 2b	Favorable	Neuroblastoma			1063.0		Male	Not Hispanic or Latino	Black or African American	Low Risk	80	Censored	0:LIVING	1063.0	35.0	2015.0					
TARGET-30-PAUKAW	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	505	2	2011	Stage 4	Favorable	Neuroblastoma			1444.0		Female	Not Hispanic or Latino	Not Reported	High Risk	80	Censored	0:LIVING	1444.0	48.0	2015.0					
TARGET-30-PATMJV	ANBL00B1, ANBL0532, ANBL0032, ANBL1221	C42.1		 Bone marrow	4349	12	2010	Stage 4	Unfavorable	Neuroblastoma			1245.0		Female	Not Hispanic or Latino	White	High Risk	90	Progression	0:LIVING	1812.0	60.0	2015.0					
TARGET-30-PATNXK	ANBL00B1, ANBL0531, AEPI07N1, ALTE05N1	C38.3		 Mediastinum, NOS	211	1	2010	Stage 4	Favorable	Neuroblastoma			511.0		Male	Not Hispanic or Latino	White	Intermediate Risk	85	Event	0:LIVING	1706.0	57.0	2015.0					
TARGET-30-PAUWXY	ANBL00B1	C38.3		 Mediastinum, NOS	145	1	2012	Stage 4	Favorable	Neuroblastoma			959.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	959.0	32.0	2014.0					
TARGET-30-PAHYWC	9047, 9340	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	704	2	1993	Stage 4	Unknown	Unknown	1.0	1.0	324.0	429.0	Male	Unknown	White	High Risk	85	Event	1:DECEASED	437.0	15.0	1994.0	15	95/5			
TARGET-30-PAMNYX	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1923	6	2003	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	850.0	1101.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Relapse	1:DECEASED	1107.0	37.0	2006.0					
TARGET-30-PAPUNH	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	3425	10	2006	Stage 3	Unfavorable	Neuroblastoma	0.0	0.0	2958.0	707.0	Female	Not Hispanic or Latino	White	High Risk	30	Censored	0:LIVING	2958.0	98.0	2014.0	5	30/70			
TARGET-30-PATTEF	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	224	1	2010	Stage 2b	Favorable	Neuroblastoma			141.0		Female	Hispanic or Latino	White	Low Risk	90	Relapse	0:LIVING	1549.0	51.0	2014.0					
TARGET-30-PATZRF	ANBL00B1, ANBL0531, ANBL0532, ANBL0032, AEPI07N1	C22.0		Liver Hepatic, NOS	188	1	2011	Stage 4s	Unfavorable	Neuroblastoma			481.0		Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	885.0	30.0	2013.0					
TARGET-30-PATBMM	ANBL00B1, ANBL0032, AEPI07N1, ADVL0912	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1112	4	2009	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	709.0	476.0	Male	Not Hispanic or Latino	White	High Risk	90	Relapse	0:LIVING	768.0	26.0	2011.0	10	90/10			
TARGET-30-PASXCG	ANBL00B1, ANBL0531	C49.4		 Connective, Subcutaneous and other Soft tissues of abdomen C	246	1	2009	Stage 3	Favorable	Neuroblastoma			1871.0		Male	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	1871.0	62.0	2014.0					
TARGET-30-PATKPD	ANBL00B1, ANBL0532, AEPI07N1, ANBL0931	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	575	2	2010	Stage 4	Unfavorable	Neuroblastoma			1931.0		Male	Unknown	White	High Risk	60	Censored	0:LIVING	1931.0	64.0	2015.0					
TARGET-30-PATTFB	ANBL00B1, ANBL0531, ANBL0532, ANBL0032	C49.5		Connective, Subcutaneous and other Soft tissues of pelvis C	548	2	2010	Stage 3	Unfavorable	Neuroblastoma			1214.0		Female	Not Hispanic or Latino	White	High Risk	80	Progression	0:LIVING	1736.0	58.0	2015.0					
TARGET-30-PAUBWP	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	925	3	2011	Stage 4	Unfavorable	Neuroblastoma			203.0		Male	Not Hispanic or Latino	White	High Risk	95	Death	1:DECEASED	203.0	7.0	2011.0					
TARGET-30-PATAKH	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	181	1	2009	Stage 4	Favorable	Neuroblastoma			1977.0		Female	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	Intermediate Risk	70	Censored	0:LIVING	1977.0	65.0	2015.0					
TARGET-30-PALXHW	ANBL00B1, A3973, ANBL0321	C74.1	999	Medulla of adrenal gland	1131	4	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	569.0	1404.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1408.0	47.0	2006.0					
TARGET-30-PAPRPR	ANBL00B1	C41.0	999	Bones of skull and face and associated joints (excludes Mandible C41.1) Calvarium Cranial bone Ethmoid bone Facial bone Frontal bone Hyoid bone Maxilla Upper jaw bone Nasal bone Occipital bone Orbital bone Parietal bone Skull, NOS Sphenoid b	614	2	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	1207.0	1577.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1585.0	53.0	2010.0					
TARGET-30-PASKSX	ANBL00B1, ANBL0531	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	335	1	2009	Stage 4	Favorable	Neuroblastoma			2207.0		Female	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2207.0	73.0	2015.0					
TARGET-30-PACZPX	321P2, B003, 321P3	Unknown	999	Unknown	1046	3	1990	Stage 4	Unknown	Unknown	0.0	0.0	5564.0	5562.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Censored	0:LIVING	5564.0	183.0	2005.0					
TARGET-30-PASVWG	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1469	5	2009	Stage 4	Unknown	Neuroblastoma			2162.0		Male	Not Hispanic or Latino	Black or African American	High Risk	60	Censored	0:LIVING	2162.0	72.0	2015.0					
TARGET-30-PATTHA	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1512	5	2010	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			466.0		Male	Not Hispanic or Latino	Asian	High Risk	90	Progression	1:DECEASED	830.0	28.0	2012.0					
TARGET-30-PADIHC	3891, B003, 0914, E18	Unknown	999	Retroperitoneal abdominal adrenal Right side extends across midline-no intraspinal ext.-10x12x8cm. Mets to BM/Bone/LN	1916	6	1992	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	165.0	4592.0	Male	Not Hispanic or Latino	White	High Risk		Event	0:LIVING	4596.0	152.0	2005.0					
TARGET-30-PAPUEB	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1595	5	2006	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2772.0	848.0	Female	Not Hispanic or Latino	White	High Risk	40	Censored	0:LIVING	2772.0	92.0	2014.0	5	40/60			
TARGET-30-PAPTDH	ANBL00B1	C74.9	999	Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS	11	1	2006	Stage 4s	Favorable	Neuroblastoma			193.0		Female	Not Hispanic or Latino	White	Low Risk	40	Second Malignant Neoplasm	0:LIVING	3264.0	108.0	2015.0	30	40/60			
TARGET-30-PAKINP	9047, P9641	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	813	3	2000	Stage 1	Favorable	Neuroblastoma	0.0	0.0	3672.0	2899.0	Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	3672.0	121.0	2010.0	10	90/10			
TARGET-30-PARYWX	ANBL00B1, ANBL0531	C76.3		Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa P	411	2	2008	Stage 3	Favorable	Neuroblastoma			2266.0		Male	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2266.0	75.0	2014.0					
TARGET-30-PATNRI	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2387	7	2010	Stage 4	Unfavorable	Neuroblastoma			637.0		Female	Unknown	Unknown	High Risk	90	Relapse	1:DECEASED	1378.0	46.0	2014.0					
TARGET-30-PARIKT	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1031	3	2007	Stage 4	Unknown	Unknown	0.0	0.0	1707.0	489.0	Female	Unknown	Unknown	High Risk	10	Death	1:DECEASED	1707.0	57.0	2012.0	10	10/90			
TARGET-30-PASCUF	ANBL00B1, ANBL0532, ACCL05C1, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1622	5	2008	Stage 4	Unknown	Neuroblastoma	0.0	0.0	610.0	373.0	Male	Not Hispanic or Latino	Black or African American	High Risk	60	Relapse	1:DECEASED	833.0	28.0	2010.0	10	60/40			
TARGET-30-PARUXY	ANBL00B1, ANBL0421	C72.0	999	Spinal cord Cervical cord Conus medullaris Filum terminale Lumbar cord Sacral cord Thoracic cord	1767	5	2008	Stage 4	Unknown	Unknown	0.0	0.0	2523.0	409.0	Male	Not Hispanic or Latino	White	High Risk	30	Death	1:DECEASED	2523.0	83.0	2015.0		30/70			
TARGET-30-PANEYN	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	551	2	2004	Stage 4	Unfavorable	Neuroblastoma			61.0		Female	Hispanic or Latino	White	High Risk		Death	1:DECEASED	61.0	3.0	2004.0					
TARGET-30-PADKNE	3891, B003, 0925, B954, R9702, E18	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1748	5	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	387.0	583.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	588.0	20.0	1994.0					
TARGET-30-PAPHPE	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	806	3	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	453.0	461.0	Male	Not Hispanic or Latino	Black or African American	High Risk	90	Relapse	1:DECEASED	470.0	16.0	2007.0	10	98/2			
TARGET-30-PALZSL	ANBL00B1, A3973, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1564	5	2002	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2606.0	2269.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2606.0	86.0	2010.0					
TARGET-30-PAPBZI	ANBL00B1, A3973	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1710	5	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	172.0	427.0	Male	Not Hispanic or Latino	White	High Risk		Progression	1:DECEASED	430.0	15.0	2007.0					
TARGET-30-PARSZV	ANBL00B1	C38.3		 Mediastinum, NOS	286	1	2008	Stage 2a	Favorable	Neuroblastoma			2675.0		Male	Not Hispanic or Latino	White	Low Risk	80	Relapse	0:LIVING	2711.0	90.0	2015.0					
TARGET-30-PALAKM	ANBL00B1	C74.1	999	Medulla of adrenal gland	1758	5	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	2820.0	2843.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	2846.0	94.0	2009.0			90	10.0	>90/<10
TARGET-30-PATFPS	ANBL00B1, ANBL0931, ALTE05N1	C80.9		 Unknown primary site	1120	4	2010	Stage 4	Unfavorable	Neuroblastoma			1900.0		Female	Not Hispanic or Latino	White	High Risk	75	Censored	0:LIVING	1900.0	63.0	2015.0					
TARGET-30-PASSNN	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1024	3	2009	Stage 3	Unfavorable	Neuroblastoma			833.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	833.0	28.0	2011.0					
TARGET-30-PACRZM	321P2	Unknown	999	Unknown	3686	11	1987	Stage 4	Unfavorable	Unknown	1.0	1.0	922.0	922.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	922.0	31.0	1990.0					
TARGET-30-PARWTY	ANBL00B1	C38.3		 Mediastinum, NOS	116	1	2008	Stage 2a	Favorable	Neuroblastoma			2604.0		Male	Not Hispanic or Latino	White	Low Risk	75	Censored	0:LIVING	2604.0	86.0	2015.0					
TARGET-30-PAUPWX	ANBL00B1, ANBL00P3	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	486	2	2011	Stage 2b	Favorable	Ganglioneuroblastoma, nodular			1184.0		Male	Not Hispanic or Latino	Black or African American	Low Risk	80	Censored	0:LIVING	1184.0	39.0	2015.0					
TARGET-30-PATXHW	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	926	3	2010	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1598.0		Female	Not Hispanic or Latino	White	High Risk	75	Censored	0:LIVING	1598.0	53.0	2015.0					
TARGET-30-PASMNU	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	371	2	2009	Stage 4	Favorable	Neuroblastoma			1953.0		Male	Not Hispanic or Latino	Unknown	Intermediate Risk	80	Censored	0:LIVING	1953.0	65.0	2014.0					
TARGET-30-PAMBYG	ANBL00B1	C74.1	999	Medulla of adrenal gland	614	2	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	332.0	328.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	332.0	11.0	2003.0					
TARGET-30-PATACA	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	547	2	2009	Stage 2b	Favorable	Neuroblastoma			1821.0		Male	Not Hispanic or Latino	White	Low Risk	65	Censored	0:LIVING	1821.0	60.0	2014.0					
TARGET-30-PAICGF	9047, 9340, 9341, 9342, 9343	Unknown	93	ADRENAL GLAND	1278	4	1994	Stage 4	Unknown	Neuroblastoma	1.0	1.0	772.0	1307.0	Female	Unknown	White	High Risk	90	Event	1:DECEASED	1314.0	44.0	1998.0	10	80/20			
TARGET-30-PARUPT	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	993	3	2008	Stage 3	Unfavorable	Neuroblastoma			178.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	178.0	6.0	2008.0					
TARGET-30-PADKGF	3891, B003, B954, E18	Unknown	999	Retroperitoneal abdominal celiac mass crossing the midline involvement of mesentery-no intraspinal ext.-8x9x12cm-Mets; LN/BM	554	2	1992	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2644.0	2638.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2644.0	87.0	2000.0					
TARGET-30-PARGKK	ANBL00B1, ADVL0812	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2241	7	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	1075.0	1312.0	Male	Not Hispanic or Latino	Black or African American	High Risk	40	Progression	1:DECEASED	1321.0	44.0	2011.0	10	40/60			
TARGET-30-PASSUU	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	94	1	2009	Stage 4s	Favorable	Neuroblastoma			2226.0		Male	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2226.0	74.0	2015.0					
TARGET-30-PAKJBA	B947, 9047	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	802	3	2000	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1964.0	1964.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	1964.0	65.0	2006.0					
TARGET-30-PALYEC	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1240	4	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	74.0	149.0	Male	Hispanic or Latino	White	High Risk	70	Progression	1:DECEASED	159.0	6.0	2003.0	30	50/50			
TARGET-30-PALXMM	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1475	5	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	1924.0	2375.0	Male	Not Hispanic or Latino	White	High Risk		Second Malignant Neoplasm	1:DECEASED	2434.0	81.0	2009.0					
TARGET-30-PASALE	ANBL00B1, ANBL0531, ALTE03N1	C38.2		 Posterior mediastinum	1682	5	2008	Stage 2b	Favorable	Neuroblastoma			2415.0		Female	Not Hispanic or Latino	Black or African American	Intermediate Risk	70	Censored	0:LIVING	2415.0	80.0	2015.0					
TARGET-30-PALXUM	ANBL00B1, P9641	C74.1	999	Medulla of adrenal gland	20	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	1638.0	1625.0	Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1638.0	54.0	2007.0	10	80/20			
TARGET-30-PAMNAL	ANBL00B1, A3973	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1235	4	2003	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4165.0	2006.0	Female	Not Hispanic or Latino	Black or African American	High Risk	50	Censored	0:LIVING	4165.0	137.0	2015.0	50	2/98			
TARGET-30-PASATF	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	135	1	2008	Stage 2b	Favorable	Neuroblastoma			2394.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2394.0	79.0	2015.0					
TARGET-30-PALEBK	ANBL00B1	C47.6	999	Peripheral nerves and Autonomic nervous system of trunk, NOS Peripheral nerves and Autonomic nervous system of (see list under C47): . Back . Flank . Trunk Lumbar nerve	19	1	2001	Stage 1	Favorable	Neuroblastoma	0.0	0.0	3792.0	2696.0	Male	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	3792.0	125.0	2012.0	0	80/20			
TARGET-30-PAKWMT	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1359	4	2001	Stage 4	Unfavorable	Neuroblastoma			922.0		Female	Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1548.0	51.0	2005.0					
TARGET-30-PALWXP	ANBL00B1, P9641	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	70	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2510.0	2188.0	Male	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	2510.0	83.0	2009.0	0	80/20			
TARGET-30-PASPTF	ANBL00B1	C47.3		Peripheral nerves and Autonomic nervous system of thorax Pe	132	1	2009	Stage 1	Favorable	Neuroblastoma			2191.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2191.0	73.0	2015.0					
TARGET-30-PATDSY	ANBL00B1, ANBL0032	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	721	2	2009	Stage 2b	Unfavorable	Neuroblastoma			1878.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1878.0	62.0	2015.0					
TARGET-30-PADPHP	3891, B003, E18	Unknown	999	Abdominal adrenal left side-no intraspinal ext. Size: 6xm x 4.4xm x 4cm METS: Liver	1128	4	1994	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	148.0	215.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Event	1:DECEASED	219.0	8.0	1994.0					
TARGET-30-PANDHZ	ANBL00B1, ANBL02P1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1129	4	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	303.0	819.0	Male	Unknown	Unknown	High Risk		Progression	1:DECEASED	821.0	27.0	2006.0					
TARGET-30-PAVCKK	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2507	7	2012	Stage 4	Unfavorable	Neuroblastoma			1111.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1111.0	37.0	2015.0					
TARGET-30-PASNMJ	ANBL00B1, ANBL0531	C47.5		Peripheral nerves and Autonomic nervous system of pelvis Pe	58	1	2009	Stage 3	Favorable	Neuroblastoma			2291.0		Male	Not Hispanic or Latino	Asian	Intermediate Risk	90	Censored	0:LIVING	2291.0	76.0	2015.0					
TARGET-30-PALBFW	ANBL00B1, A3973, ANBL0032	C74.1	999	Medulla of adrenal gland	804	3	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	611.0	1060.0	Male	Not Hispanic or Latino	White	High Risk	85	Relapse	1:DECEASED	1073.0	36.0	2004.0	15	80/20			
TARGET-30-PATLCM	ANBL00B1, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	2044	6	2010	Stage 4	Unfavorable	Neuroblastoma			1945.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1945.0	64.0	2015.0					
TARGET-30-PANNIJ	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1084	3	2005	Stage 4	Unknown	Neuroblastoma	1.0	1.0	603.0	937.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	944.0	32.0	2007.0					
TARGET-30-PAUCKF	ANBL00B1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1914	6	2011	Stage 4	Unfavorable	Neuroblastoma			1596.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1596.0	53.0	2015.0					
TARGET-30-PARACR	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1191	4	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2953.0	1256.0	Male	Not Hispanic or Latino	White	High Risk	0	Censored	0:LIVING	2953.0	98.0	2015.0		0/100			
TARGET-30-PARRBU	ANBL00B1, ANBL0532, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1448	4	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	415.0	503.0	Male	Not Hispanic or Latino	White	High Risk	80	Progression	1:DECEASED	907.0	30.0	2010.0	0	80/20			
TARGET-30-PAMYCK	ANBL00B1, A3973, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	958	3	2004	Stage 4	Unfavorable	Neuroblastoma			4109.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4109.0	136.0	2015.0					
TARGET-30-PATXUG	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1303	4	2010	Stage 4	Favorable	Neuroblastoma			282.0		Female	Not Hispanic or Latino	White	High Risk	90	Event	0:LIVING	1647.0	55.0	2015.0					
TARGET-30-PARMTT	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	945	3	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	291.0	415.0	Female	Not Hispanic or Latino	White	High Risk		Progression	1:DECEASED	1722.0	57.0	2012.0					
TARGET-30-PAUDBX	ANBL00B1, ANBL0532, ANBL0032	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	583	2	2011	Stage 3	Unfavorable	Neuroblastoma			1587.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1587.0	53.0	2015.0					
TARGET-30-PAUKIJ	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1129	4	2011	Stage 4	Unfavorable	Neuroblastoma			1287.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1287.0	43.0	2015.0					
TARGET-30-PAUUHD	ANBL00B1, ANBL0032, ANBL1221	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1856	6	2012	Stage 4	Unfavorable	Neuroblastoma			1108.0		Female	Not Hispanic or Latino	Black or African American	High Risk	95	Relapse	0:LIVING	1168.0	39.0	2015.0					
TARGET-30-PARDUJ	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1052	3	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	523.0	729.0	Female	Not Hispanic or Latino	Black or African American	High Risk	30-40	Progression	0:LIVING	2757.0	91.0	2014.0	10	30-40/60-70			
TARGET-30-PATCFL	ANBL00B1, ANBL0032, AEPI07N1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1041	3	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2125.0	411.0	Male	Not Hispanic or Latino	White	High Risk	20-30	Censored	0:LIVING	2125.0	70.0	2015.0	10	20-30/80-70			
TARGET-30-PATRHD	ANBL00B1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2533	7	2010	Stage 4	Unfavorable	Neuroblastoma			1739.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1739.0	58.0	2015.0					
TARGET-30-PASWVE	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	95	1	2009	Stage 4s	Favorable	Neuroblastoma			83.0		Male	Not Hispanic or Latino	White	Low Risk	85	Progression	0:LIVING	2031.0	67.0	2015.0					
TARGET-30-PADPEY	3891, B003	Unknown	999	Abdominal adrenal left adrenalcrossing midline-no intraspinal ext. Size: 6cm x 4cm x 6cm. METS: LN	1435	4	1994	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3788.0	3780.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3788.0	125.0	2004.0					
TARGET-30-PASBJY	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	71	1	2008	Stage 4	Favorable	Neuroblastoma			2283.0		Female	Unknown	Not Reported	Intermediate Risk	90	Censored	0:LIVING	2283.0	76.0	2014.0					
TARGET-30-PAVAGS	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1093	3	2012	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			626.0		Female	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	951.0	32.0	2015.0					
TARGET-30-PASAFG	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2304	7	2008	Stage 2b	Unfavorable	Ganglioneuroblastoma, nodular			259.0		Male	Not Hispanic or Latino	White	Low Risk	80	Relapse	0:LIVING	2558.0	85.0	2015.0					
TARGET-30-PASPGU	ANBL00B1	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	1124	4	2009	Stage 1	Unfavorable	Neuroblastoma			1293.0		Male	Not Hispanic or Latino	Black or African American	Low Risk	90	Censored	0:LIVING	1293.0	43.0	2012.0					
TARGET-30-PAUMMZ	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1506	5	2011	Stage 4	Unfavorable	Neuroblastoma			1166.0		Female	Not Hispanic or Latino	White	High Risk	95	Relapse	0:LIVING	1368.0	45.0	2015.0					
TARGET-30-PAPTLV	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	641	2	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	366.0	566.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	575.0	19.0	2008.0					
TARGET-30-PASAHC	ANBL00B1, ANBL00P3, ANBL0531, AEPI07N1	C77.0		Lymph nodes of head, face and neck Auricular lymph node Ce	517	2	2008	Stage 2b	Favorable	Neuroblastoma			332.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Event	0:LIVING	2625.0	87.0	2015.0					
TARGET-30-PAVEZM	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2516	7	2012	Stage 4	Unfavorable	Neuroblastoma			1013.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1013.0	34.0	2015.0					
TARGET-30-PASKTB	ANBL00B1, ANBL0032, AEPI07N1	C42.1	999	Bone marrow	1425	4	2009	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2353.0	803.0	Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2353.0	78.0	2015.0	10	90/10			
TARGET-30-PAPTFZ	ANBL00B1, ANBL0421, ANBL0621	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	564	2	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	516.0	769.0	Male	Not Hispanic or Latino	Black or African American	High Risk	5	Relapse	1:DECEASED	779.0	26.0	2008.0	0	5/95			
TARGET-30-PARSXI	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	537	2	2007	Stage 4	Favorable	Neuroblastoma			2456.0		Female	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	2456.0	81.0	2014.0					
TARGET-30-PADSXU	3891, B003, 0914, B954	Unknown	999	Abdominal left adrenal crossing midline no intraspinal ext. Size: 10.5cm x 10.1cm x 10.5cm Mets: LN, BM	654	2	1994	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	68.0	327.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	331.0	11.0	1995.0					
TARGET-30-PASBKP	ANBL00B1, ANBL0531	C72.9		Nervous system, NOS Epidural Central nervous system Extra	380	2	2008	Stage 3	Favorable	Neuroblastoma			2323.0		Female	Not Hispanic or Latino	Black or African American	Intermediate Risk	80	Censored	0:LIVING	2323.0	77.0	2014.0					
TARGET-30-PARFWB	ANBL00B1, ADVL0921, ANBL1021	C47.3	999	Peripheral nerves and Autonomic nervous system of thorax Peripheral nerves and Autonomic nervous system of (see list under C47): . Axilla . Chest . chest wall . thoracic wall . infraclavicular region . scapular region Intercostal nerve	1555	5	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	1105.0	1472.0	Male	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	1836.0	61.0	2012.0	40	90/10			
TARGET-30-PARSHT	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	752	3	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2711.0	441.0	Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2711.0	90.0	2015.0	10	90/10			
TARGET-30-PARETE	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	686	2	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	241.0	255.0	Male	Not Hispanic or Latino	White	High Risk	40	Progression	1:DECEASED	261.0	9.0	2008.0	30	40/60			
TARGET-30-PATVDP	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2595	8	2010	Stage 4	Unfavorable	Neuroblastoma			711.0		Male	Not Hispanic or Latino	White	High Risk	50	Relapse	1:DECEASED	1160.0	39.0	2014.0					
TARGET-30-PASCIX	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1659	5	2008	Stage 4	Unknown	Unknown			326.0		Male	Not Hispanic or Latino	White	High Risk	50	Progression	0:LIVING	2459.0	81.0	2015.0					
TARGET-30-PAUKNU	ANBL00B1, ANBL00P3, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	728	2	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1448.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1448.0	48.0	2015.0					
TARGET-30-PAUHFW	ANBL00B1, ANBL0032, ALTE05N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	788	3	2011	Stage 4	Unfavorable	Neuroblastoma			1435.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1435.0	48.0	2015.0					
TARGET-30-PAIVHE	9047, P9462, ANBL0321	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1123	4	1999	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	672.0	1602.0	Male	Not Hispanic or Latino	White	High Risk	90	Event	1:DECEASED	1605.0	53.0	2003.0	10	70/30			
TARGET-30-PAAPFA	I03, 321P2, E04, 321P3, B954	Unknown	999	Unknown	1762	5	1986	Stage 4	Unfavorable	Unknown	1.0	1.0	444.0	459.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	487.0	17.0	1988.0					
TARGET-30-PASJUU	ANBL00B1, ANBL0531, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2	1	2008	Stage 4	Unfavorable	Neuroblastoma			2437.0		Male	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2437.0	81.0	2015.0					
TARGET-30-PATXXF	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	787	3	2010	Stage 4	Unfavorable	Neuroblastoma			1599.0		Male	Not Hispanic or Latino	Black or African American	High Risk	60	Censored	0:LIVING	1599.0	53.0	2015.0					
TARGET-30-PATDXG	ANBL00B1, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	688	2	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2052.0	552.0	Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2052.0	68.0	2015.0	10	90/10			
TARGET-30-PASGUT	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1259	4	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	401.0	401.0	Male	Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	401.0	14.0	2009.0	10	90/10			
TARGET-30-PARSEA	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1779	5	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2642.0	373.0	Male	Not Hispanic or Latino	White	High Risk	40	Censored	0:LIVING	2642.0	87.0	2015.0	70	40/60			
TARGET-30-PAURZH	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1514	5	2012	Stage 4	Unfavorable	Neuroblastoma			170.0		Female	Not Hispanic or Latino	White	High Risk	95	Relapse	1:DECEASED	364.0	12.0	2013.0					
TARGET-30-PAKHHB	9047	C49.4	999	Connective, Subcutaneous and other Soft tissues of abdomen Connective, Subcutaneous and other Soft tissues of (see list under C49): . Abdomen . abdominal wall . Umbilicus Abdominal aorta Abdominal vena cava Abdominal wall muscle Celiac artery Ilio	687	2	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	462.0	458.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	462.0	16.0	2001.0					
TARGET-30-PARVNT	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2487	7	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2758.0	747.0	Male	Hispanic or Latino	White	High Risk	10	Censored	0:LIVING	2758.0	91.0	2015.0	10	10/90			
TARGET-30-PAUXUP	ANBL00B1, ANBL0032	C48.2		Peritoneum, NOS Peritoneal cavity	1684	5	2012	Stage 4	Unfavorable	Neuroblastoma			1087.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1087.0	36.0	2015.0					
TARGET-30-PAITCI	9047, 9082	Unknown	93	ADRENAL GLAND	728	2	1998	Stage 4	Favorable	Neuroblastoma	1.0	1.0	232.0	317.0	Male	Unknown	White	High Risk	90	Event	1:DECEASED	324.0	11.0	1999.0	10	90/10			
TARGET-30-PANXFT	ANBL00B1, A3973	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1706	5	2005	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			490.0		Female	Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	593.0	20.0	2007.0			40		
TARGET-30-PATDBR	ANBL00B1, ANBL0531	C38.2		 Posterior mediastinum	822	3	2009	Stage 2b	Favorable	Neuroblastoma			1932.0		Male	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	1932.0	64.0	2015.0					
TARGET-30-PASGEE	ANBL00B1, ANBL0532	C38.3		 Mediastinum, NOS	1824	5	2008	Stage 4	Unfavorable	Neuroblastoma			2484.0		Male	Not Hispanic or Latino	Asian	High Risk	50	Censored	0:LIVING	2484.0	82.0	2015.0					
TARGET-30-PASZTV	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	29	1	2009	Stage 4s	Favorable	Neuroblastoma			1921.0		Male	Hispanic or Latino	Unknown	Intermediate Risk	60	Censored	0:LIVING	1921.0	64.0	2015.0					
TARGET-30-PAMTUV	ANBL00B1	C47.9		Autonomic nervous system, NOS Ganglia, NOS Nerve, NOS Parasympathetic nervous system, NOS Peripheral nerve, NOS Spinal nerve, NOS Sympathetic nervous system, NOS	4795	14	2003	Stage 4	Unfavorable	Neuroblastoma			1223.0		Male	Hispanic or Latino	Not Reported	High Risk		Death	1:DECEASED	1223.0	41.0	2007.0					
TARGET-30-PATJEY	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	923	3	2010	Stage 3	Unfavorable	Ganglioneuroblastoma, nodular			1938.0		Female	Not Hispanic or Latino	Not Reported	High Risk	80	Censored	0:LIVING	1938.0	64.0	2015.0					
TARGET-30-PASPBZ	ANBL00B1, ANBL0531	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	62	1	2009	Stage 4s	Unfavorable	Neuroblastoma			2347.0		Male	Not Hispanic or Latino	Black or African American	Intermediate Risk	80	Censored	0:LIVING	2347.0	78.0	2015.0					
TARGET-30-PAIXFZ	9047	Unknown	93	Seminal vesicles	60	1	2000	Stage 4s	Favorable	Neuroblastoma	0.0	0.0	1955.0	1941.0	Female	Unknown	White	Intermediate Risk		Censored	0:LIVING	1955.0	65.0	2005.0					
TARGET-30-PAMLMY	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	952	3	2003	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2593.0	1826.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	2593.0	86.0	2010.0					
TARGET-30-PANJLH	ANBL00B1, A3973	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1010	3	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	500.0	495.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	500.0	17.0	2006.0					
TARGET-30-PAUWYM	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	620	2	2012	Stage 4	Unfavorable	Neuroblastoma			1025.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1025.0	34.0	2015.0					
TARGET-30-PASWXG	ANBL00B1, ANBL0532, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	740	3	2009	Stage 3	Unfavorable	Neuroblastoma			171.0		Male	Unknown	Not Reported	High Risk	80	Progression	1:DECEASED	190.0	7.0	2010.0					
TARGET-30-PARACM	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1442	4	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2994.0	773.0	Female	Not Hispanic or Latino	Black or African American	High Risk	10-20	Censored	0:LIVING	2994.0	99.0	2015.0	10	10-20/80-90			
TARGET-30-PASMJG	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1765	5	2009	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	1162.0	716.0	Female	Not Hispanic or Latino	Not Reported	High Risk	90	Progression	1:DECEASED	1544.0	51.0	2013.0	10	90/10			
TARGET-30-PACYGY	321P2, B003, 0901, B954	Unknown	999	Unknown	1509	5	1989	Stage 4	Unknown	Unknown	1.0	1.0	263.0	539.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	542.0	18.0	1991.0					
TARGET-30-PATJXV	ANBL00B1, AEPI07N1	C76.0		Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Ce	7	1	2010	Stage 4s	Favorable	Neuroblastoma			1740.0		Female	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	1740.0	58.0	2015.0					
TARGET-30-PAPVFD	ANBL00B1	C74.1	999	Medulla of adrenal gland	1961	6	2006	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1765.0	1588.0	Male	Not Hispanic or Latino	White	High Risk	90	Death	1:DECEASED	1765.0	59.0	2011.0	10	90/10			
TARGET-30-PATEKG	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1275	4	2009	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	1988.0	521.0	Female	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1988.0	66.0	2015.0	10	90/10			
TARGET-30-PASUFL	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1444	4	2009	Stage 2a	Favorable	Ganglioneuroblastoma, intermixed			2017.0		Female	Unknown	White	Low Risk	90	Censored	0:LIVING	2017.0	67.0	2014.0					
TARGET-30-PASSII	ANBL00B1, ANBL0531	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	272	1	2009	Stage 3	Favorable	Neuroblastoma			2278.0		Male	Hispanic or Latino	Not Reported	Intermediate Risk	90	Censored	0:LIVING	2278.0	75.0	2015.0					
TARGET-30-PAKXDZ	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	828	3	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	614.0	1105.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1115.0	37.0	2004.0					
TARGET-30-PATTMM	ANBL00B1, ANBL0531, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	275	1	2010	Stage 4	Unfavorable	Neuroblastoma			1628.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1628.0	54.0	2015.0					
TARGET-30-PATESI	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	752	3	2010	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	622.0	263.0	Male	Not Hispanic or Latino	Black or African American	High Risk	75	Relapse	1:DECEASED	958.0	32.0	2012.0	25	75/25			
TARGET-30-PAMAFV	ANBL00B1, P9641	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	303	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4067.0	2256.0	Male	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	4067.0	134.0	2014.0	0	85/15			
TARGET-30-PALRIA	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	685	2	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4080.0	2555.0	Male	Not Hispanic or Latino	Asian	Low Risk		Censored	0:LIVING	4080.0	135.0	2013.0					
TARGET-30-PASDYT	ANBL00B1, ANBL00P3, AEPI07N1	C38.2		 Posterior mediastinum	675	2	2008	Stage 1	Unfavorable	Neuroblastoma			2427.0		Male	Not Hispanic or Latino	Not Reported	Low Risk	90	Censored	0:LIVING	2427.0	80.0	2015.0					
TARGET-30-PALNLU	ANBL00B1, A3973, ANBL0032, ANBL0321	C76.0	999	Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Cervical region, NOS Supraclavicular region, NOS	1439	4	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	538.0	953.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	954.0	32.0	2004.0					
TARGET-30-PARYNK	ANBL00B1, ANBL0532	C77.2	999	Intra-abdominal lymph nodes Abdominal lymph node Aortic lymph node Celiac lymph node Colic lymph node Common duct lymph node Gastric lymph node Hepatic lymph node Ileocolic lymph node Inferior mesenteric lymph node Intestinal lymph node Lumbar lymph node	2279	7	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2351.0	962.0	Female	Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2351.0	78.0	2014.0	15-10	90/10			
TARGET-30-PAIXNV	9047	Unknown	93	ADRENAL GLAND	644	2	2000	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2133.0	2129.0	Female	Unknown	Black or African American	High Risk		Censored	0:LIVING	2133.0	71.0	2006.0					
TARGET-30-PARBAJ	ANBL00B1	C48.0	999	Retroperitoneum  Periadrenal tissue  Perinephric tissue  Per	35	1	2007	Stage 3	Favorable	Neuroblastoma			302.0		Male	Not Hispanic or Latino	White	Intermediate Risk		Relapse	0:LIVING	3122.0	103.0	2015.0			40-85	0.0	
TARGET-30-PASKZT	ANBL00B1, AEPI07N1	C38.2		 Posterior mediastinum	1075	3	2009	Stage 2a	Favorable	Neuroblastoma			466.0		Female	Not Hispanic or Latino	White	Low Risk	90	Progression	0:LIVING	2400.0	79.0	2015.0					
TARGET-30-PADMTD	3891, B003, E18	Unknown	999	Unknown	1040	3	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	148.0	3232.0	Male	Not Hispanic or Latino	White	High Risk		Event	0:LIVING	3235.0	107.0	2002.0					
TARGET-30-PAKFUY	9047	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1194	4	2000	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	864.0	859.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	864.0	29.0	2002.0					
TARGET-30-PASDRV	ANBL00B1	C38.2		 Posterior mediastinum	434	2	2008	Stage 2a	Favorable	Neuroblastoma			395.0		Female	Not Hispanic or Latino	White	Low Risk	95	Second Malignant Neoplasm	0:LIVING	2339.0	77.0	2015.0					
TARGET-30-PATXTF	ANBL00B1, ANBL0531, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	2	1	2010	Stage 4s	Favorable	Neuroblastoma			1446.0		Male	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	1446.0	48.0	2014.0					
TARGET-30-PAKZRE	ANBL00B1	C74.1	999	Medulla of adrenal gland	1083	3	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	456.0	461.0	Female	Hispanic or Latino	White	High Risk		Progression	1:DECEASED	463.0	16.0	2002.0					
TARGET-30-PALJPF	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1502	5	2002	Stage 4	Unfavorable	Neuroblastoma			565.0		Male	Not Hispanic or Latino	White	High Risk		Relapse	0:LIVING	4153.0	137.0	2013.0					
TARGET-30-PAPJLD	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1309	4	2006	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2007.0	1016.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	2679.0	89.0	2013.0					
TARGET-30-PAPCTS	ANBL00B1	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	2008	6	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2236.0	1737.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Relapse	1:DECEASED	2636.0	87.0	2013.0					
TARGET-30-PAPSKM	ANBL00B1, ANBL0421	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1330	4	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	573.0	1006.0	Male	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	High Risk	100	Relapse	1:DECEASED	1019.0	34.0	2009.0	0	100/0			
TARGET-30-PARYXW	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2208	7	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	427.0	426.0	Male	Not Hispanic or Latino	White	High Risk	90	Death	1:DECEASED	427.0	15.0	2009.0	10	90/10			
TARGET-30-PAVALS	ANBL00B1, AEPI07N1, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	553	2	2012	Stage 3	Unfavorable	Neuroblastoma			1020.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1020.0	34.0	2015.0					
TARGET-30-PANHUA	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1430	4	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	206.0	198.0	Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	206.0	7.0	2005.0					
TARGET-30-PATTNA	ANBL00B1, ANBL0532	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1411	4	2010	Stage 4	Favorable	Ganglioneuroblastoma, intermixed			153.0		Female	Unknown	Asian	High Risk	90	Progression	0:LIVING	1675.0	56.0	2015.0					
TARGET-30-PASZJB	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	130	1	2009	Stage 4s	Favorable	Neuroblastoma			2084.0		Female	Not Hispanic or Latino	White	Low Risk	85	Censored	0:LIVING	2084.0	69.0	2015.0					
TARGET-30-PASFGD	ANBL00B1, ANBL0531, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	342	1	2008	Stage 4	Favorable	Neuroblastoma			2526.0		Female	Not Hispanic or Latino	Black or African American	Intermediate Risk	70	Censored	0:LIVING	2526.0	84.0	2015.0					
TARGET-30-PAUCGP	ANBL00B1, ANBL0032	C38.2		 Posterior mediastinum	700	2	2011	Stage 4	Unfavorable	Neuroblastoma			1417.0		Female	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	1417.0	47.0	2015.0					
TARGET-30-PAMPFJ	ANBL00B1, A3973	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	596	2	2003	Stage 4	Unfavorable	Neuroblastoma			292.0		Female	Not Hispanic or Latino	White	High Risk	35	Progression	1:DECEASED	345.0	12.0	2004.0	65	85/15			
TARGET-30-PAPEVV	ANBL00B1, A3973, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1050	3	2006	Stage 4	Unfavorable	Neuroblastoma			3130.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3130.0	103.0	2014.0					
TARGET-30-PALFIT	ANBL00B1, ANBL0321	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1428	4	2001	Stage 4	Unfavorable	Neuroblastoma			636.0		Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	944.0	32.0	2004.0					
TARGET-30-PAIPUD	9047	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	659	2	1998	Stage 4	Favorable	Neuroblastoma	0.0	0.0	1843.0	1841.0	Male	Unknown	Black or African American	High Risk	85	Censored	0:LIVING	1843.0	61.0	2003.0	15	80/20			
TARGET-30-PATWMX	ANBL00B1, ANBL0531	C74.1		  Medulla of adrenal gland	461	2	2010	Stage 4	Favorable	Neuroblastoma			52.0		Female	Not Hispanic or Latino	Black or African American	Intermediate Risk	80	Event	0:LIVING	1556.0	52.0	2015.0					
TARGET-30-PAMXYU	ANBL00B1, P9641	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	185	1	2004	Stage 1	Favorable	Neuroblastoma			2552.0		Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	2552.0	84.0	2011.0					
TARGET-30-PASZST	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	922	3	2009	Stage 4	Unfavorable	Neuroblastoma			423.0		Male	Not Hispanic or Latino	White	High Risk	50	Progression	0:LIVING	2079.0	69.0	2015.0					
TARGET-30-PAUJRW	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	943	3	2011	Stage 3	Unfavorable	Neuroblastoma			402.0		Female	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	473.0	16.0	2012.0					
TARGET-30-PAKZRH	B947, ANBL00B1, A3961	C74.1	999	Bilateral adrenal	21	1	2001	Stage 4s	Favorable	Unknown	0.0	0.0	3341.0	3333.0	Male	Hispanic or Latino	White	Intermediate Risk		Censored	0:LIVING	3341.0	110.0	2010.0					
TARGET-30-PASCWD	ANBL00B1, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	132	1	2008	Stage 4	Unfavorable	Neuroblastoma			672.0		Male	Not Hispanic or Latino	White	High Risk	90	Relapse	0:LIVING	2336.0	77.0	2014.0					
TARGET-30-PATJZC	ANBL00B1, ANBL0531	C38.2		 Posterior mediastinum	324	1	2010	Stage 4	Favorable	Neuroblastoma			207.0		Male	Not Hispanic or Latino	American Indian or Alaska Native	Intermediate Risk	70	Event	1:DECEASED	282.0	10.0	2011.0					
TARGET-30-PARVZT	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	781	3	2008	Stage 1	Unfavorable	Neuroblastoma			2537.0		Female	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2537.0	84.0	2015.0					
TARGET-30-PAURPL	ANBL00B1, ANBL0532, ANBL1221	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	3455	10	2011	Stage 4	Unfavorable	Neuroblastoma			1081.0		Female	Unknown	Unknown	High Risk	90	Event	0:LIVING	1337.0	44.0	2015.0					
TARGET-30-PAKUXT	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	971	3	2001	Stage 4	Favorable	Neuroblastoma	1.0	1.0	491.0	726.0	Male	Not Hispanic or Latino	White	High Risk	75	Relapse	1:DECEASED	731.0	25.0	2003.0	25	50/50			
TARGET-30-PATXHC	ANBL00B1, ANBL0532, ALTE05N1, ADVL1115	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1599	5	2010	Stage 4	Unfavorable	Neuroblastoma			542.0		Male	Hispanic or Latino	White	High Risk	80	Progression	1:DECEASED	1131.0	38.0	2014.0					
TARGET-30-PARHUX	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	698	2	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	513.0	505.0	Female	Not Hispanic or Latino	White	High Risk	80	Death	1:DECEASED	513.0	17.0	2008.0	10	80/20			
TARGET-30-PASSGT	ANBL00B1, ANBL0032	C38.2		 Posterior mediastinum	942	3	2009	Stage 2b	Unfavorable	Ganglioneuroblastoma, nodular			217.0		Male	Not Hispanic or Latino	White	Low Risk	80	Progression	0:LIVING	2329.0	77.0	2015.0					
TARGET-30-PAVAYF	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	2996	9	2012	Stage 4	Unfavorable	Neuroblastoma			1140.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1140.0	38.0	2015.0					
TARGET-30-PADKFS	3891, B003, N891, E18	Unknown	999	Unknown	1567	5	1992	Stage 4	Unknown	Unknown	1.0	1.0	603.0	1220.0	Male	Hispanic or Latino	Unknown	High Risk		Event	1:DECEASED	1230.0	41.0	1996.0					
TARGET-30-PAIGRH	9047	Unknown		ADRENAL GLAND	744	3	1995	Stage 4	Unknown	Unknown			569.0		Female	Unknown	White	High Risk	100	Death	1:DECEASED	569.0	19.0	1997.0	0	1/99			
TARGET-30-PAKMVJ	B973	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1490	5	2000	Stage 4	Unfavorable	Neuroblastoma			6.0		Female	Hispanic or Latino	Not Reported	High Risk		Censored	0:LIVING	6.0	1.0	2000.0					
TARGET-30-PARTPF	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	233	1	2008	Stage 4	Favorable	Neuroblastoma			2394.0		Female	Not Hispanic or Latino	Not Reported	Intermediate Risk	90	Censored	0:LIVING	2394.0	79.0	2014.0					
TARGET-30-PASSWB	ANBL00B1, ANBL0532, ANBL0032	C74.0	999	Cortex of adrenal gland	910	3	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2102.0	630.0	Male	Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	2102.0	70.0	2015.0	30	70/30			
TARGET-30-PAUGIP	ANBL00B1, ANBL0532, ANBL0032, ALTE05N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1360	4	2011	Stage 4	Unfavorable	Neuroblastoma			1419.0		Female	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1419.0	47.0	2015.0					
TARGET-30-PATSKE	ANBL00B1, ANBL0532, ANBL0032	C70.1		Spinal meninges Spinal arachnoid Spinal dura mater Spinal pi	4284	12	2010	Stage 4	Unfavorable	Neuroblastoma			839.0		Male	Not Hispanic or Latino	Black or African American	High Risk	70	Relapse	0:LIVING	1811.0	60.0	2015.0					
TARGET-30-PARACS	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1180	4	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1328.0	1319.0	Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1328.0	44.0	2010.0	10	80/20			
TARGET-30-PALTYB	ANBL00B1	C74.1	999	Medulla of adrenal gland	1536	5	2002	Stage 4	Favorable	Neuroblastoma	1.0	1.0	232.0	229.0	Female	Unknown	Unknown	High Risk		Death	1:DECEASED	232.0	8.0	2003.0					
TARGET-30-PATEWM	ANBL00B1, ANBL0531	C76.0		Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Ce	202	1	2010	Stage 3	Favorable	Neuroblastoma			1732.0		Male	Hispanic or Latino	White	Intermediate Risk	50	Censored	0:LIVING	1732.0	57.0	2014.0					
TARGET-30-PAMZRP	B947, ANBL00B1, P9641	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	120	1	2004	Stage 1	Favorable	Neuroblastoma			653.0		Female	Not Hispanic or Latino	White	Low Risk		Event	0:LIVING	1414.0	47.0	2008.0			100	0.0	100/0
TARGET-30-PASLFG	ANBL00B1, ANBL0531	C38.2		 Posterior mediastinum	471	2	2009	Stage 4	Favorable	Neuroblastoma			2283.0		Male	Not Hispanic or Latino	White	Intermediate Risk	65	Censored	0:LIVING	2283.0	76.0	2015.0					
TARGET-30-PAUIFL	ANBL00B1, ANBL0532, ANBL1021	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2602	8	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1365.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1365.0	45.0	2015.0					
TARGET-30-PARNCW	ANBL00B1	C49.0	999	Connective, Subcutaneous and other Soft tissues of head, face, and neck (excludes Connective tissue of orbit C69.6 and Nasal cartilage C30.0) Connective, Subcutaneous and other Soft tissues of (see list under C49): . Cheek . Chin . Face . Forehead .	1639	5	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	606.0	603.0	Female	Not Hispanic or Latino	Not Reported	High Risk	90	Progression	1:DECEASED	972.0	32.0	2010.0	5	90/10			
TARGET-30-PATZRU	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	832	3	2011	Stage 4	Unfavorable	Neuroblastoma			1655.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1655.0	55.0	2015.0					
TARGET-30-PAMFBR	ANBL00B1	C80.9		Unknown primary site	1626	5	2003	Stage 4	Unfavorable	Neuroblastoma			3824.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3824.0	126.0	2013.0					
TARGET-30-PATVWA	ANBL00B1, ANBL0532, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1532	5	2010	Stage 4	Unfavorable	Neuroblastoma			603.0		Male	Not Hispanic or Latino	White	High Risk	95	Death	1:DECEASED	603.0	20.0	2012.0					
TARGET-30-PATNWL	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1793	5	2010	Stage 4	Unfavorable	Neuroblastoma			680.0		Female	Hispanic or Latino	Not Reported	High Risk	90	Relapse	1:DECEASED	1079.0	36.0	2013.0					
TARGET-30-PAPKWN	ANBL00B1	C76.0	999	Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Cervical region, NOS Supraclavicular region, NOS	710	2	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	260.0	462.0	Female	Unknown	White	High Risk		Relapse	1:DECEASED	465.0	16.0	2007.0					
TARGET-30-PASEAR	ANBL00B1, ANBL0531	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	86	1	2008	Stage 3	Favorable	Neuroblastoma			2306.0		Male	Unknown	Unknown	Intermediate Risk	80	Censored	0:LIVING	2306.0	76.0	2014.0					
TARGET-30-PAKGAB	9047	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	1108	4	2000	Stage 4	Unfavorable	Neuroblastoma			1821.0		Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	1821.0	60.0	2005.0					
TARGET-30-PALVVH	ANBL00B1, P9641, AADM01P1	C74.1	999	Medulla of adrenal gland	219	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2183.0	2171.0	Male	Not Hispanic or Latino	White	Low Risk	40	Censored	0:LIVING	2183.0	72.0	2008.0	60	90/10			
TARGET-30-PANPVI	ANBL00B1, A3973, ANBL0621, ADVL0525, ADVL0714	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1289	4	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	520.0	1246.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1706.0	57.0	2009.0					
TARGET-30-PAMVRA	ANBL00B1, A3973, AADM01P1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1554	5	2004	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2433.0	1721.0	Female	Not Hispanic or Latino	White	High Risk	75-85	Death	1:DECEASED	2433.0	80.0	2010.0	10				
TARGET-30-PATTPC	ANBL00B1, ANBL0532, AEPI07N1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	413	2	2010	Stage 4	Unfavorable	Neuroblastoma			1648.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1648.0	55.0	2015.0					
TARGET-30-PASSZI	ANBL00B1, ANBL0531, ALTE03N1, AEPI07N1	C76.0		Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Ce	227	1	2009	Stage 4s	Unknown	Neuroblastoma			2200.0		Female	Not Hispanic or Latino	White	Intermediate Risk	70	Censored	0:LIVING	2200.0	73.0	2015.0					
TARGET-30-PATCKU	ANBL00B1, ANBL0931	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2037	6	2009	Stage 3	Unfavorable	Neuroblastoma			1857.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1857.0	62.0	2014.0					
TARGET-30-PASKPC	ANBL00B1, ANBL0032	C80.9		 Unknown primary site	963	3	2009	Stage 3	Unfavorable	Neuroblastoma			2210.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	2210.0	73.0	2015.0					
TARGET-30-PADUKP	3891, B003	Unknown	999	Abdominal Right adrenal no intraspinal extension Size: 10cm x 9.5cm x 5cm Mets: LN, bone	1659	5	1995	Stage 4	Favorable	Neuroblastoma	1.0	1.0	104.0	612.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	618.0	21.0	1996.0					
TARGET-30-PADXBB	3891, B003	Unknown	999	Abdominal Left adrenal- no intraspinal ext. SIZE: 4.5cm x 5cm x 6cmMets: BM , bone, LN. Shimada unfavorable, stroma poor, differentiating, high MKI	1992	6	1996	Stage 4	Unfavorable	Unknown	1.0	1.0	632.0	1558.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1561.0	52.0	2000.0					
TARGET-30-PAVDGG	ANBL00B1, ACCL0934	C38.2		 Posterior mediastinum	660	2	2012	Stage 4	Unfavorable	Neuroblastoma			181.0		Male	Not Hispanic or Latino	Asian	High Risk	90	Death	1:DECEASED	181.0	6.0	2013.0					
TARGET-30-PALKUC	ANBL00B1	C74.1	999	Medulla of adrenal gland	823	3	2002	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4399.0	2430.0	Female	Not Hispanic or Latino	Black or African American	High Risk	100	Censored	0:LIVING	4399.0	145.0	2014.0	0				
TARGET-30-PAIBIW	9047, 9340, 9082, 9341, 9342	Unknown		ABDOMEN/PERITONEUM OR RETROPERITONEUM	1124	4	1994	Stage 4	Unfavorable	Unknown			4447.0		Female	Unknown	White	High Risk	95	Censored	0:LIVING	4447.0	147.0	2006.0	5	80/20			
TARGET-30-PAUBRR	ANBL00B1, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	161	1	2011	Stage 4s	Favorable	Neuroblastoma			1517.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1517.0	50.0	2015.0					
TARGET-30-PASMCP	ANBL00B1, ANBL0531	C76.7		Other ill-defined sites Back, NOS Flank, NOS Trunk, NOS	446	2	2009	Stage 3	Favorable	Neuroblastoma			2076.0		Female	Unknown	Unknown	Intermediate Risk	70	Censored	0:LIVING	2076.0	69.0	2014.0					
TARGET-30-PAIWZA	9047, P9641	Unknown		THORAX/MEDIASTINUM OR DIAPHRAGM	292	1	2000	Stage 1	Favorable	Neuroblastoma			5216.0		Male	Unknown	White	Low Risk		Censored	0:LIVING	5216.0	172.0	2014.0					
TARGET-30-PASGHN	ANBL00B1, ANBL00P3	C49.3		Connective, Subcutaneous and other Soft tissues of thorax	690	2	2008	Stage 1	Favorable	Neuroblastoma			2224.0		Female	Not Hispanic or Latino	White	Low Risk	50	Censored	0:LIVING	2224.0	74.0	2014.0					
TARGET-30-PAVDNK	ANBL00B1	C48.2		Peritoneum, NOS Peritoneal cavity	756	3	2012	Stage 3	Unfavorable	Neuroblastoma			957.0		Male	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	High Risk	80	Censored	0:LIVING	957.0	32.0	2015.0					
TARGET-30-PAVCLI	ANBL00B1, ANBL09P1, ACCL1031, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	4111	12	2012	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1008.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1008.0	34.0	2015.0					
TARGET-30-PAUDDK	ANBL00B1, ANBL0531	C76.3	999	Pelvis, NOS Buttock, NOS Groin, NOS Ischiorectal fossa P	361	1	2011	Stage 3	Favorable	Neuroblastoma			344.0		Male	Not Hispanic or Latino	Black or African American	Intermediate Risk	70	Event	0:LIVING	1528.0	51.0	2015.0			90-95	5.0	
TARGET-30-PAPPKJ	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1731	5	2006	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	617.0	609.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	617.0	21.0	2008.0					
TARGET-30-PASVKL	ANBL00B1, ANBL0532, ANBL0032	C38.2		 Posterior mediastinum	1299	4	2009	Stage 4	Unknown	Unknown			2135.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2135.0	71.0	2015.0					
TARGET-30-PASREY	ANBL00B1, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	78	1	2009	Stage 4s	Favorable	Neuroblastoma			2332.0		Female	Not Hispanic or Latino	White	Low Risk	60	Censored	0:LIVING	2332.0	77.0	2015.0					
TARGET-30-PAUFUS	ANBL00B1, ANBL0532	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	863	3	2011	Stage 4	Unfavorable	Neuroblastoma			519.0		Female	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	539.0	18.0	2012.0					
TARGET-30-PAIDSV	9047, 9341	Unknown		THORAX/MEDIASTINUM OR DIAPHRAGM	1255	4	1995	Stage 4	Unfavorable	Unknown			4112.0		Male	Unknown	Not Reported	High Risk	100	Censored	0:LIVING	4112.0	136.0	2006.0	0	90/10			
TARGET-30-PATHVK	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2109	6	2010	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	171.0	387.0	Female	Not Hispanic or Latino	White	High Risk	90	Progression	0:LIVING	1807.0	60.0	2015.0	50	90/10			
TARGET-30-PATECM	ANBL00B1	C47.4		Peripheral nerves and Autonomic nervous system of abdomen P	624	2	2009	Stage 1	Unfavorable	Neuroblastoma			2013.0		Male	Not Hispanic or Latino	Black or African American	Low Risk	75	Censored	0:LIVING	2013.0	67.0	2015.0					
TARGET-30-PATEUC	ANBL00B1, ANBL0032	C41.3		Rib, Sternum, Clavicle and associated joints Costal cartila	1587	5	2010	Stage 4	Unfavorable	Neuroblastoma			443.0		Female	Unknown	White	High Risk	75	Relapse	1:DECEASED	650.0	22.0	2011.0					
TARGET-30-PAREAG	ANBL00B1, ALTE03N1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2091	6	2007	Stage 4	Unfavorable	Unknown	0.0	0.0	2962.0	1164.0	Male	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	2962.0	98.0	2015.0	40	90/10			
TARGET-30-PARUCL	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1971	6	2008	Stage 4	Unfavorable	Neuroblastoma			2586.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	2586.0	86.0	2015.0					
TARGET-30-PATGWT	ANBL00B1, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	591	2	2010	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	727.0	455.0	Male	Not Hispanic or Latino	Black or African American	High Risk	50	Relapse	1:DECEASED	928.0	31.0	2012.0	10	50/50			
TARGET-30-PATBPG	ANBL00B1, ANBL0531	C38.2		 Posterior mediastinum	520	2	2009	Stage 2b	Favorable	Neuroblastoma			1613.0		Male	Hispanic or Latino	White	Intermediate Risk	100	Censored	0:LIVING	1613.0	54.0	2014.0					
TARGET-30-PASGAP	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1330	4	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1285.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Progression	1:DECEASED	1543.0	51.0	2013.0	10	90/10	65-96	1.0	71-100/0-29
TARGET-30-PAITEG	9047	Unknown	93	ADRENAL GLAND	1034	3	1998	Stage 4	Unknown	Neuroblastoma	1.0	1.0	692.0	804.0	Male	Unknown	White	High Risk	95	Event	1:DECEASED	812.0	27.0	2001.0	5	70/30			
TARGET-30-PASYTP	ANBL00B1, ANBL0931	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1291	4	2009	Stage 2b	Unfavorable	Neuroblastoma			1877.0		Male	Not Hispanic or Latino	White	High Risk	95	Censored	0:LIVING	1877.0	62.0	2014.0					
TARGET-30-PAKADI	3891, B003, E18	Unknown	999	Unknown	1456	4	1994	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	1456.0	2318.0	Male	Unknown	Unknown	High Risk		Event	1:DECEASED	2325.0	77.0	2000.0					
TARGET-30-PALKKV	ANBL00B1, P9641, AADM01P1	C74.1	999	Medulla of adrenal gland	283	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2613.0	2600.0	Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	2613.0	86.0	2009.0					
TARGET-30-PAUHBZ	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	959	3	2011	Stage 4	Favorable	Neuroblastoma			1362.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1362.0	45.0	2015.0					
TARGET-30-PATYDC	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1918	6	2011	Stage 4	Unfavorable	Neuroblastoma			1138.0		Male	Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	1570.0	52.0	2015.0					
TARGET-30-PAKPJE	9047	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	999	3	2001	Stage 4	Unfavorable	Neuroblastoma			1640.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	1640.0	54.0	2005.0					
TARGET-30-PAMHPN	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1075	3	2003	Stage 4	Unfavorable	Neuroblastoma			3864.0		Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3864.0	128.0	2013.0					
TARGET-30-PASGNT	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	156	1	2008	Stage 2a	Favorable	Neuroblastoma			2187.0		Female	Not Hispanic or Latino	Asian	Intermediate Risk	75	Censored	0:LIVING	2187.0	72.0	2014.0					
TARGET-30-PASFIC	ANBL00B1, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	51	1	2008	Stage 4s	Favorable	Neuroblastoma			2152.0		Male	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2152.0	71.0	2014.0					
TARGET-30-PATYIL	ANBL00B1, ANBL0531	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	328	1	2011	Stage 4	Favorable	Neuroblastoma			239.0		Female	Not Hispanic or Latino	White	Intermediate Risk	70	Relapse	1:DECEASED	481.0	16.0	2012.0	20-30	70/30	80	5.0	
TARGET-30-PARSVF	ANBL00B1, ADVL0921	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	963	3	2007	Stage 4	Unfavorable	Neuroblastoma			997.0		Male	Not Hispanic or Latino	White	High Risk	50	Relapse	1:DECEASED	1516.0	50.0	2012.0					
TARGET-30-PANRVJ	ANBL00B1, ANBL0032, ALTE03N1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	4781	14	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3722.0	2074.0	Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3722.0	123.0	2015.0					
TARGET-30-PARXPD	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	290	1	2008	Stage 1	Favorable	Neuroblastoma			2616.0		Male	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2616.0	87.0	2015.0					
TARGET-30-PARGUX	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1704	5	2007	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2744.0	365.0	Female	Not Hispanic or Latino	Black or African American	High Risk	70	Censored	0:LIVING	2744.0	91.0	2014.0	20	70/30			
TARGET-30-PAMHDM	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	960	3	2003	Stage 4	Unfavorable	Neuroblastoma			301.0		Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	424.0	14.0	2004.0					
TARGET-30-PATNEA	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1233	4	2010	Stage 4	Unfavorable	Neuroblastoma			324.0		Female	Not Hispanic or Latino	White	High Risk	50	Death	1:DECEASED	324.0	11.0	2011.0					
TARGET-30-PAMYVA	ANBL00B1, A3973, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	988	3	2004	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	4019.0	1928.0	Male	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	High Risk		Censored	0:LIVING	4019.0	133.0	2015.0					
TARGET-30-PATDFU	ANBL00B1	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	543	2	2009	Stage 4	Unfavorable	Neuroblastoma			521.0		Male	Hispanic or Latino	White	High Risk	90	Event	1:DECEASED	529.0	18.0	2011.0					
TARGET-30-PASPBY	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	96	1	2009	Stage 4s	Favorable	Neuroblastoma			2222.0		Female	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2222.0	74.0	2015.0					
TARGET-30-PARTRP	ANBL00B1, ANBL0032, AEPI07N1	C47.0		 Peripheral nerves and Autonomic nervous system of head, face	938	3	2008	Stage 3	Unfavorable	Neuroblastoma			2672.0		Female	Not Hispanic or Latino	White	High Risk	85	Censored	0:LIVING	2672.0	88.0	2015.0					
TARGET-30-PANRRW	ANBL00B1, A3973, ANBL0032, ANBL0322	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1730	5	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	408.0	1470.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	0:LIVING	2178.0	72.0	2011.0					
TARGET-30-PAIWEH	9047	Unknown		ADRENAL GLAND	1078	3	1999	Stage 4	Unfavorable	Neuroblastoma			2213.0		Male	Unknown	White	High Risk		Censored	0:LIVING	2213.0	73.0	2005.0					
TARGET-30-PATWZZ	ANBL00B1, ANBL1021	C49.5		Connective, Subcutaneous and other Soft tissues of pelvis C	1070	3	2010	Stage 4	Unfavorable	Neuroblastoma			577.0		Male	Not Hispanic or Latino	White	High Risk	75	Progression	1:DECEASED	845.0	28.0	2013.0					
TARGET-30-PADTCU	3891, B003	Unknown	999	Abdominal retroperitoneal Right adrenal no intraspinal ext Size: 6.5cm x 5.5cm x 8cm. METS: BM, bone, LN	1294	4	1994	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	425.0	1053.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1059.0	35.0	1997.0					
TARGET-30-PAUTKP	ANBL00B1, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	608	2	2012	Stage 4	Unfavorable	Neuroblastoma			1077.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1077.0	36.0	2015.0					
TARGET-30-PAKSFV	ANBL00B1, A3973, ANBL0032, ALTE05N1	C80.9		Unknown primary site	796	3	2001	Stage 4	Unfavorable	Neuroblastoma			5055.0		Male	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	5055.0	167.0	2015.0	50	50/50			
TARGET-30-PANNMS	ANBL00B1, A3973, ANBL0032	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1080	3	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	3509.0	1450.0	Female	Not Hispanic or Latino	White	High Risk	90-95	Censored	0:LIVING	3509.0	116.0	2014.0	5				
TARGET-30-PATWNB	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	557	2	2010	Stage 3	Unfavorable	Neuroblastoma			1730.0		Female	Hispanic or Latino	Not Reported	High Risk	90	Censored	0:LIVING	1730.0	57.0	2015.0					
TARGET-30-PARDYU	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1942	6	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	1116.0	1097.0	Male	Not Hispanic or Latino	White	High Risk	90	Death	1:DECEASED	1116.0	37.0	2010.0	10	90/10			
TARGET-30-PARUTJ	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	690	2	2008	Stage 3	Unfavorable	Neuroblastoma			169.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	169.0	6.0	2008.0					
TARGET-30-PAPNEP	ANBL00B1	C64.9	999	Kidney, NOS Renal, NOS Kidney parenchyma	720	2	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	203.0	199.0	Male	Not Hispanic or Latino	White	High Risk	70	Death	1:DECEASED	203.0	7.0	2007.0	25	70/30			
TARGET-30-PATVNW	ANBL00B1, ANBL0531, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	467	2	2010	Stage 4	Favorable	Ganglioneuroblastoma, nodular			1585.0		Male	Not Hispanic or Latino	Black or African American	High Risk	80	Censored	0:LIVING	1585.0	53.0	2015.0					
TARGET-30-PARBGP	ANBL00B1, ADVL0912	C76.0	999	Head, face or neck, NOS Cheek, NOS Jaw, NOS Nose, NOS Cervical region, NOS Supraclavicular region, NOS	3625	10	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	1524.0	1564.0	Female	Not Hispanic or Latino	Black or African American	High Risk	70-80	Relapse	1:DECEASED	2039.0	68.0	2012.0	10	70-80/20-30			
TARGET-30-PAMZGT	ANBL00B1, A3973	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	602	2	2004	Stage 4	Unknown	Neuroblastoma	1.0	0.0	603.0	1729.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	0:LIVING	3823.0	126.0	2014.0					
TARGET-30-PASPXU	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	5253	15	2009	Stage 4	Unfavorable	Neuroblastoma			607.0		Female	Not Hispanic or Latino	White	High Risk	70	Progression	1:DECEASED	1306.0	43.0	2012.0					
TARGET-30-PATILE	ANBL00B1	C70.1	999	Spinal meninges Spinal arachnoid Spinal dura mater Spinal pia mater	824	3	2010	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	306.0	303.0	Male	Not Hispanic or Latino	White	High Risk	75	Death	1:DECEASED	306.0	11.0	2011.0	90	75/25			
TARGET-30-PAINLN	9047	Unknown	Y2	THORAX/MEDIASTINUM OR DIAPHRAGM	1404	4	1997	Stage 4	Unknown	Unknown	1.0	1.0	599.0	596.0	Male	Unknown	White	High Risk	95	Death	1:DECEASED	599.0	20.0	1999.0	5	65/35			
TARGET-30-PALNHZ	A3973, ANBL00B1, ANBL0032	C74.1	999	Medulla of adrenal gland	622	2	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	298.0	310.0	Male	Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	314.0	11.0	2003.0					
TARGET-30-PAPUTN	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1223	4	2006	Stage 4	Unknown	Unknown	1.0	1.0	284.0	281.0	Male	Not Hispanic or Latino	White	High Risk	0	Relapse	1:DECEASED	284.0	10.0	2007.0		0/100			
TARGET-30-PATSRD	ANBL00B1, ANBL0532, ANBL0931, ALTE05N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1223	4	2010	Stage 4	Unfavorable	Neuroblastoma			1550.0		Male	Not Hispanic or Latino	Black or African American	High Risk	60	Censored	0:LIVING	1550.0	51.0	2014.0					
TARGET-30-PATBHY	ANBL00B1, AEPI07N1	C38.2		 Posterior mediastinum	318	1	2009	Stage 1	Favorable	Neuroblastoma			2067.0		Female	Not Hispanic or Latino	White	Low Risk	60	Censored	0:LIVING	2067.0	68.0	2015.0					
TARGET-30-PAUKLK	ANBL00B1, ANBL0532, AEPI07N1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	978	3	2011	Stage 4	Unfavorable	Neuroblastoma			1355.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1355.0	45.0	2015.0					
TARGET-30-PATUWG	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1447	4	2010	Stage 4	Unfavorable	Neuroblastoma			765.0		Female	Not Hispanic or Latino	White	High Risk	75	Relapse	1:DECEASED	1281.0	43.0	2014.0					
TARGET-30-PANZHT	ANBL00B1, A3973, ADVL0921	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1454	4	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2528.0	1261.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	2528.0	84.0	2012.0					
TARGET-30-PADLJN	3881, B003, 3891, B954, E18	Unknown	999	Left chest with intraspinal ext. Size: 2.8x2.6x6cm-Mets: LN/BM Tumor extended from Apex of L chest along the esophagus at the thoracic inlet down on top of the veterbral bodies to level of t-6	1041	3	1993	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	802.0	1125.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1175.0	39.0	1996.0					
TARGET-30-PASNUI	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1125	4	2009	Stage 2b	Unfavorable	Neuroblastoma			2380.0		Female	Not Hispanic or Latino	White	High Risk	85	Censored	0:LIVING	2380.0	79.0	2015.0					
TARGET-30-PAPLSD	ANBL00B1, ANBL0421	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	710	2	2006	Stage 4	Unknown	Neuroblastoma	1.0	1.0	583.0	1381.0	Male	Not Hispanic or Latino	White	High Risk	20	Relapse	1:DECEASED	1383.0	46.0	2010.0	75	20/80			
TARGET-30-PAKHAV	B973, P9641	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	150	1	2000	Stage 1	Favorable	Neuroblastoma	0.0	0.0	1659.0	1656.0	Male	Hispanic or Latino	Not Reported	Low Risk		Censored	0:LIVING	1659.0	55.0	2005.0					
TARGET-30-PASLIH	ANBL00B1, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1566	5	2009	Stage 2b	Unfavorable	Neuroblastoma			1628.0		Male	Not Hispanic or Latino	Black or African American	Low Risk	90	Censored	0:LIVING	1628.0	54.0	2013.0					
TARGET-30-PADTRV	3891, B003	Unknown	999	Abdominal retroperitoneal right adrenal crossing midline no intraspinal extension-Size: 7cm x 6.5cm x 3.8cm Mets: BM + Chest	562	2	1995	Stage 4	Unknown	Unknown	0.0	0.0	3742.0	3739.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3742.0	124.0	2005.0					
TARGET-30-PALWIP	ANBL00B1, A3973	C74.1	999	Medulla of adrenal gland	1232	4	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	748.0	804.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	809.0	27.0	2004.0					
TARGET-30-PALJPX	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	860	3	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	38.0	25.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	38.0	2.0	2002.0					
TARGET-30-PAULNF	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1060	3	2011	Stage 4	Unfavorable	Neuroblastoma			437.0		Female	Not Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	906.0	30.0	2014.0					
TARGET-30-PAUZAE	ANBL00B1, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1275	4	2012	Stage 4	Unfavorable	Neuroblastoma			1210.0		Male	Hispanic or Latino	White	High Risk	95	Censored	0:LIVING	1210.0	40.0	2015.0					
TARGET-30-PASTHF	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	440	2	2009	Stage 4	Unfavorable	Neuroblastoma			2283.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2283.0	76.0	2015.0					
TARGET-30-PALJVX	ANBL00B1, A3973, ANBL0032, ANBL0621	C74.1	999	Medulla of adrenal gland	1635	5	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	1493.0	2702.0	Male	Hispanic or Latino	White	High Risk	50	Relapse	1:DECEASED	2836.0	94.0	2009.0	50	75/25			
TARGET-30-PALVFV	ANBL00B1, A3973	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1133	4	2002	Stage 4	Unfavorable	Neuroblastoma			933.0		Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1497.0	50.0	2006.0					
TARGET-30-PARCRR		C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1742	5	2007	Stage 4	Unfavorable	Unknown					Female	Not Hispanic or Latino	White	High Risk	70	Unknown					50	70/30			
TARGET-30-PARWBC	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	56	1	2008	Stage 1	Favorable	Neuroblastoma			1666.0		Female	Not Hispanic or Latino	Black or African American	Low Risk	90	Censored	0:LIVING	1666.0	55.0	2012.0					
TARGET-30-PATSJV	ANBL00B1, ANBL0531	C16.9		Stomach, NOS Gastric, NOS	343	1	2010	Stage 3	Favorable	Neuroblastoma			435.0		Male	Not Hispanic or Latino	Black or African American	Intermediate Risk	95	Event	0:LIVING	1566.0	52.0	2014.0					
TARGET-30-PARJEN	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	727	2	2007	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	426.0	775.0	Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	777.0	26.0	2009.0	80-90	80/20			
TARGET-30-PATTDY	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C74.1		  Medulla of adrenal gland	579	2	2010	Stage 4	Unfavorable	Neuroblastoma			1783.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1783.0	59.0	2015.0					
TARGET-30-PARXAX	ANBL00B1	C38.3		 Mediastinum, NOS	280	1	2008	Stage 4	Unknown	Neuroblastoma			2650.0		Female	Not Hispanic or Latino	White	Intermediate Risk	60	Censored	0:LIVING	2650.0	88.0	2015.0	90	60/40			
TARGET-30-PADIEY	3891, B003, E18	Unknown	999	Abdominal adrenal Left side- no intraspinal ext. 4 x 3x3.5 cm. Mets to BM/Bone	1817	5	1992	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	4715.0	4708.0	Female	Not Hispanic or Latino	Not Reported	High Risk		Censored	0:LIVING	4715.0	156.0	2005.0					
TARGET-30-PALETP	ANBL00B1, A3973	C38.2	999	Posterior mediastinum	1466	5	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	251.0	246.0	Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	251.0	9.0	2002.0					
TARGET-30-PAUJVX	ANBL00B1, ANBL0532, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	500	2	2011	Stage 4	Favorable	Neuroblastoma			1374.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1374.0	46.0	2015.0					
TARGET-30-PAMAJT	ANBL00B1, P9641	C38.2	999	Posterior mediastinum	105	1	2002	Stage 1	Favorable	Neuroblastoma	0.0	0.0	2744.0	2276.0	Female	Not Hispanic or Latino	White	Low Risk	70	Censored	0:LIVING	2744.0	91.0	2010.0	30	70/30			
TARGET-30-PAMIZA	ANBL00B1, A3973	C77.0		Lymph nodes of head, face and neck Auricular lymph node Cervical lymph node Facial lymph node Jugular lymph node Mandibular lymph node Occipital lymph node Parotid lymph node Preauricular lymph node Prelaryngeal lymph node Pretracheal lymph node	946	3	2003	Stage 4	Unfavorable	Neuroblastoma			4207.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	4207.0	139.0	2014.0	0				
TARGET-30-PATUNK	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	71	1	2010	Stage 4s	Favorable	Neuroblastoma			51.0		Male	Not Hispanic or Latino	White	Low Risk	80	Progression	0:LIVING	1683.0	56.0	2015.0					
TARGET-30-PASUMG	ANBL00B1, ANBL0532, ANBL0931, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1193	4	2009	Stage 4	Unfavorable	Neuroblastoma			1955.0		Male	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1955.0	65.0	2014.0					
TARGET-30-PASKRX	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	1020	3	2009	Stage 2a	Favorable	Neuroblastoma			2369.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2369.0	78.0	2015.0					
TARGET-30-PARMFA	ANBL00B1, ACCL05C1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1205	4	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2855.0	403.0	Male	Not Hispanic or Latino	White	High Risk	40	Censored	0:LIVING	2855.0	94.0	2015.0	10	40/60			
TARGET-30-PANZPV	ANBL00B1	C22.0	999	Liver Hepatic, NOS	1757	5	2005	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	1013.0	1250.0	Female	Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1261.0	42.0	2009.0					
TARGET-30-PALHCB	ANBL00B1, P9641, AADM01P1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	386	2	2001	Stage 1	Favorable	Neuroblastoma			4408.0		Female	Hispanic or Latino	White	Low Risk		Censored	0:LIVING	4408.0	145.0	2014.0					
TARGET-30-PALFRE	ANBL00B1, ADVL0421	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	918	3	2001	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	751.0	1661.0	Male	Hispanic or Latino	Not Reported	High Risk		Relapse	1:DECEASED	1663.0	55.0	2006.0					
TARGET-30-PALWRG	ANBL00B1, P9641, AADM01P1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	138	1	2002	Stage 1	Favorable	Neuroblastoma			2691.0		Male	Hispanic or Latino	White	Low Risk		Censored	0:LIVING	2691.0	89.0	2010.0					
TARGET-30-PAMANU	ANBL00B1	C47.0		Peripheral nerves and Autonomic nervous system of head, face, and neck (excludes Peripheral nerves and Autonomic nervous system of Orbit C69.6) Peripheral nerves and Autonomic nervous system of (see list under C47): . Cheek . Chin . Face . Forehead .	1398	4	2002	Stage 4	Unfavorable	Neuroblastoma			3571.0		Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3571.0	118.0	2012.0					
TARGET-30-PADLES	3891, B003, B954, E18	Unknown	999	Retroperitoneal abdominal adrenal Left side- no intraspinal ext. Size: 6 x 6x5 cm. Mets to BM/Bone/LN	1787	5	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	350.0	1326.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1342.0	45.0	1996.0					
TARGET-30-PAIHAW	9047	Unknown		ADRENAL GLAND	772	3	1996	Stage 4	Unknown	Unknown			2842.0		Male	Unknown	Black or African American	High Risk	95	Censored	0:LIVING	2842.0	94.0	2003.0	5	90/10			
TARGET-30-PASXNN	ANBL00B1, ANBL0532	C38.3	999	Mediastinum, NOS	3598	10	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1980.0	542.0	Male	Unknown	Unknown	High Risk	80	Censored	0:LIVING	1980.0	66.0	2015.0	10	80/20			
TARGET-30-PAUGNL	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1146	4	2011	Stage 3	Unfavorable	Neuroblastoma			1387.0		Female	Not Hispanic or Latino	Black or African American	High Risk	80	Censored	0:LIVING	1387.0	46.0	2015.0					
TARGET-30-PAUCRL	ANBL00B1, ANBL0532, ANBL0032, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1009	3	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1615.0		Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1615.0	54.0	2015.0					
TARGET-30-PADLDA	3891, B003, 0911, 0925, E18	Unknown	999	Abdominal Right adrenal primary- no intraspinal ext.-Size: 12x10x8cm-Mets: LN, Liver	4594	13	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	165.0	774.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	791.0	27.0	1995.0					
TARGET-30-PAURUR	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	673	2	2011	Stage 4	Unfavorable	Neuroblastoma			572.0		Female	Hispanic or Latino	Unknown	High Risk	95	Relapse	1:DECEASED	583.0	20.0	2013.0					
TARGET-30-PAKRGC	ANBL00B1, P9641	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	78	1	2001	Stage 1	Favorable	Unknown			4835.0		Female	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	4835.0	159.0	2014.0					
TARGET-30-PAKZRF	ANBL00B1, A3973	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1285	4	2001	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	144.0	2651.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	2653.0	88.0	2008.0					
TARGET-30-PAMZMJ	ANBL00B1, P9641	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	195	1	2004	Stage 1	Favorable	Neuroblastoma			2241.0		Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	2241.0	74.0	2010.0					
TARGET-30-PATMSR	ANBL00B1, ANBL0931	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	479	2	2010	Stage 4	Unfavorable	Neuroblastoma			1917.0		Male	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	1917.0	64.0	2015.0					
TARGET-30-PADXAS	3891, B003, B947	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2274	7	1996	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	3691.0	3684.0	Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	3691.0	122.0	2006.0					
TARGET-30-PARCWT	ANBL00B1, ADVL0921, ANBL1021	C38.3	999	Mediastinum, NOS	1026	3	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	968.0	760.0	Male	Not Hispanic or Latino	White	High Risk	20	Event	1:DECEASED	2522.0	83.0	2013.0	10	20/80			
TARGET-30-PASTDT	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1075	3	2009	Stage 3	Favorable	Ganglioneuroma, maturing subtype OR Ganglioneuroblastoma, well differentiated			2002.0		Female	Hispanic or Latino	Not Reported	Intermediate Risk	80	Censored	0:LIVING	2002.0	66.0	2014.0					
TARGET-30-PASFDV	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	42	1	2008	Stage 1	Favorable	Neuroblastoma			2240.0		Female	Hispanic or Latino	Not Reported	Low Risk	90	Censored	0:LIVING	2240.0	74.0	2014.0					
TARGET-30-PALEND	ANBL00B1, A3973	C74.1		Medulla of adrenal gland	737	3	2001	Stage 4	Unfavorable	Neuroblastoma			345.0		Male	Hispanic or Latino	Asian	High Risk	65	Progression	1:DECEASED	353.0	12.0	2002.0	35	90/10			
TARGET-30-PAUYDE	ANBL00B1	C38.2		 Posterior mediastinum	2077	6	2012	Stage 4	Unfavorable	Neuroblastoma			1177.0		Male	Not Hispanic or Latino	White	High Risk	70	Event	0:LIVING	1214.0	40.0	2015.0					
TARGET-30-PATFCY	ANBL00B1, AEPI07N1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1040	3	2010	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	787.0	328.0	Male	Not Hispanic or Latino	White	High Risk	90	Death	1:DECEASED	787.0	26.0	2012.0	10	90/10			
TARGET-30-PALZRG	ANBL00B1, A3973	C38.2	999	Posterior mediastinum	577	2	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	422.0	576.0	Female	Not Hispanic or Latino	White	High Risk	75	Relapse	1:DECEASED	580.0	20.0	2004.0	25	90/10			
TARGET-30-PASTSY	ANBL00B1	C38.2		 Posterior mediastinum	106	1	2009	Stage 1	Favorable	Neuroblastoma			87.0		Female	Not Hispanic or Latino	Asian	Low Risk	70	Relapse	0:LIVING	2026.0	67.0	2014.0					
TARGET-30-PASEDP	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1387	4	2008	Stage 4	Unfavorable	Neuroblastoma			2369.0		Male	Not Hispanic or Latino	White	High Risk	95	Censored	0:LIVING	2369.0	78.0	2015.0					
TARGET-30-PARTCE	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	66	1	2008	Stage 1	Favorable	Neuroblastoma			2438.0		Male	Not Hispanic or Latino	White	Low Risk	70	Censored	0:LIVING	2438.0	81.0	2014.0					
TARGET-30-PAUYXX	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	488	2	2012	Stage 3	Favorable	Neuroblastoma			435.0		Female	Not Hispanic or Latino	White	Intermediate Risk	80	Progression	0:LIVING	1049.0	35.0	2015.0					
TARGET-30-PAMWSV	ANBL00B1, A3973	C38.2		Posterior mediastinum	1190	4	2004	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			3893.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3893.0	128.0	2014.0					
TARGET-30-PASNML	ANBL00B1	C38.3	999	Mediastinum, NOS	8	1	2009	Stage 4s	Favorable	Neuroblastoma	0.0	0.0	2185.0	1098.0	Male	Not Hispanic or Latino	Not Reported	Low Risk	90	Censored	0:LIVING	2185.0	72.0	2015.0					
TARGET-30-PAKDHL	B973, ADVL0018	C74.1	999	Medulla of adrenal gland	1031	3	2000	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1626.0	1626.0	Male	Not Hispanic or Latino	White	High Risk	95	Censored	0:LIVING	1626.0	54.0	2004.0	5	85/15			
TARGET-30-PARZZD	ANBL00B1, ANBL0532	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	664	2	2008	Stage 3	Unfavorable	Neuroblastoma			2300.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2300.0	76.0	2014.0					
TARGET-30-PAMYCE	ANBL00B1, A3973, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1059	3	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	392.0	989.0	Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	995.0	33.0	2006.0					
TARGET-30-PAKYMV	ANBL00B1	C74.1		Medulla of adrenal gland	652	2	2001	Stage 4	Unfavorable	Neuroblastoma			3957.0		Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3957.0	131.0	2012.0					
TARGET-30-PATAFI	ANBL00B1	C38.3		 Mediastinum, NOS	337	1	2009	Stage 1	Favorable	Neuroblastoma			2037.0		Female	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	2037.0	67.0	2015.0					
TARGET-30-PASWIJ	ANBL00B1, ANBL0532, ANBL0931	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2537	7	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	1940.0	660.0	Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1940.0	64.0	2014.0	5	80/20			
TARGET-30-PASEVK	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	103	1	2008	Stage 4s	Unfavorable	Neuroblastoma			2551.0		Female	Not Hispanic or Latino	Black or African American	High Risk	80	Censored	0:LIVING	2551.0	84.0	2015.0					
TARGET-30-PARXLM	ANBL00B1, ANBL0532	C80.9	999	Unknown primary site	658	2	2008	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	516.0	173.0	Female	Not Hispanic or Latino	White	High Risk	30	Progression	1:DECEASED	752.0	25.0	2010.0	10	30/70			
TARGET-30-PATPET	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1519	5	2010	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			150.0		Female	Not Hispanic or Latino	Unknown	High Risk	80	Progression	0:LIVING	1610.0	53.0	2014.0					
TARGET-30-PASYIP	ANBL00B1, ANBL0532, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	828	3	2009	Stage 4	Unfavorable	Neuroblastoma			204.0		Male	Not Hispanic or Latino	White	High Risk	50	Event	1:DECEASED	219.0	8.0	2010.0					
TARGET-30-PAILNU	9047	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	1683	5	1997	Stage 4	Unknown	Unknown	1.0	1.0	647.0	754.0	Male	Unknown	Unknown	High Risk	100	Event	1:DECEASED	761.0	26.0	1999.0	0	80/20			
TARGET-30-PAKVTK	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1011	3	2001	Stage 4	Unknown	Unknown			4460.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	4460.0	147.0	2013.0					
TARGET-30-PADKYP	3891, B003, B954, E18	Unknown	999	Abdominal Left adrenal primary crossing midline . Tumor surrounding aorta,esophagus and extens thru L thoracic outlet into abdomen- no intraspinal ext -Size: 9x8.5cm-Mets: LN	1723	5	1993	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	579.0	1078.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1083.0	36.0	1996.0					
TARGET-30-PASKRS	ANBL00B1, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	473	2	2009	Stage 4	Unknown	Neuroblastoma			2208.0		Male	Not Hispanic or Latino	Not Reported	High Risk	60	Censored	0:LIVING	2208.0	73.0	2015.0					
TARGET-30-PASMNT	ANBL00B1, ANBL0532	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	4802	14	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	233.0	637.0	Female	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	High Risk	85	Progression	1:DECEASED	1696.0	56.0	2013.0	10	85/15			
TARGET-30-PAIRDP	9047, P9462	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	895	3	1998	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	135.0	409.0	Female	Unknown	White	High Risk	95	Event	1:DECEASED	410.0	14.0	1999.0	5	90/10			
TARGET-30-PASLGS	ANBL00B1, ANBL0532, ANBL0931	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1218	4	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	546.0	43.0	Male	Not Hispanic or Latino	Unknown	High Risk	80	Event	1:DECEASED	830.0	28.0	2011.0	10	80/20			
TARGET-30-PATMFL	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	3019	9	2010	Stage 4	Unfavorable	Neuroblastoma			1936.0		Female	Not Hispanic or Latino	Asian	High Risk	90	Censored	0:LIVING	1936.0	64.0	2015.0					
TARGET-30-PAUDIK	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	899	3	2011	Stage 4	Unfavorable	Neuroblastoma			1508.0		Female	Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1508.0	50.0	2015.0					
TARGET-30-PASPVR	ANBL00B1, ANBL0032, AEPI07N1, ADVL0911	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1110	4	2009	Stage 4	Unfavorable	Neuroblastoma			683.0		Male	Not Hispanic or Latino	White	High Risk	60	Relapse	1:DECEASED	1762.0	58.0	2014.0					
TARGET-30-PASFKX	ANBL00B1, ANBL0531, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	269	1	2008	Stage 4	Unfavorable	Neuroblastoma			571.0		Male	Not Hispanic or Latino	White	High Risk	75	Event	0:LIVING	2144.0	71.0	2014.0					
TARGET-30-PAUXIW	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	821	3	2012	Stage 4	Unfavorable	Neuroblastoma			973.0		Female	Not Hispanic or Latino	White	High Risk	70	Relapse	0:LIVING	1118.0	37.0	2015.0					
TARGET-30-PAMCJD	ANBL00B1, A3973, ANBL0322	C47.6		Peripheral nerves and Autonomic nervous system of trunk, NOS Peripheral nerves and Autonomic nervous system of (see list under C47): . Back . Flank . Trunk Lumbar nerve	733	3	2003	Stage 4	Unfavorable	Neuroblastoma			774.0		Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	1638.0	54.0	2007.0					
TARGET-30-PAVCJZ	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1666	5	2012	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1106.0		Male	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1106.0	37.0	2015.0					
TARGET-30-PAUPIC	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	914	3	2011	Stage 4	Unknown	Neuroblastoma			662.0		Male	Not Hispanic or Latino	Black or African American	High Risk	60	Event	0:LIVING	1321.0	44.0	2015.0					
TARGET-30-PASTNT	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1129	4	2009	Stage 3	Unfavorable	Ganglioneuroblastoma, nodular			1833.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1833.0	61.0	2014.0					
TARGET-30-PARUGX	ANBL00B1, ANBL0531	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	254	1	2008	Stage 3	Favorable	Neuroblastoma			2617.0		Male	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	2617.0	87.0	2015.0					
TARGET-30-PASZPI	ANBL00B1, ANBL0532, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	645	2	2009	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	453.0	481.0	Male	Not Hispanic or Latino	White	High Risk	40	Progression	1:DECEASED	1014.0	34.0	2012.0	15	40/60			
TARGET-30-PASVSU	ANBL00B1, ANBL0532, ANBL0931	C38.2		 Posterior mediastinum	651	2	2009	Stage 4	Unfavorable	Neuroblastoma			1976.0		Female	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1976.0	65.0	2014.0					
TARGET-30-PADWIM	3891, B003	Unknown	999	Adrenal primary Stroma rich, Nodular unfavorable histology	2413	7	1995	Stage 4	Unfavorable	Unknown	1.0	1.0	1170.0	1586.0	Female	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1590.0	53.0	2000.0					
TARGET-30-PATUEH	ANBL00B1, ANBL0032	C55.9		Uterus, NOS Uterine, NOS	907	3	2010	Stage 4	Unfavorable	Neuroblastoma			1743.0		Female	Not Hispanic or Latino	Asian	High Risk	70	Censored	0:LIVING	1743.0	58.0	2015.0					
TARGET-30-PARUCM	ANBL00B1	C49.0		 Connective, Subcutaneous and other Soft tissues of head, fac	500	2	2008	Stage 4	Favorable	Neuroblastoma			2232.0		Female	Not Hispanic or Latino	White	Intermediate Risk	85	Censored	0:LIVING	2232.0	74.0	2014.0					
TARGET-30-PASRLC	ANBL00B1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	189	1	2009	Stage 1	Favorable	Neuroblastoma			2241.0		Female	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2241.0	74.0	2015.0					
TARGET-30-PASWVY	ANBL00B1, ANBL0532, ANBL0032	C49.4	999	Connective, Subcutaneous and other Soft tissues of abdomen Connective, Subcutaneous and other Soft tissues of (see list under C49): . Abdomen . abdominal wall . Umbilicus Abdominal aorta Abdominal vena cava Abdominal wall muscle Celiac artery Ilio	2477	7	2009	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	1918.0	612.0	Female	Not Hispanic or Latino	White	High Risk	60	Censored	0:LIVING	1918.0	64.0	2014.0	10	60/40			
TARGET-30-PAPBJT	ANBL00B1	C80.9	999	Unknown primary site	570	2	2005	Stage 4	Unknown	Neuroblastoma	1.0	1.0	196.0	183.0	Male	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	196.0	7.0	2006.0					
TARGET-30-PASYJF	ANBL00B1, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	287	1	2009	Stage 2b	Favorable	Ganglioneuroblastoma, nodular			1301.0		Female	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	1301.0	43.0	2013.0					
TARGET-30-PANUVK	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1031	3	2005	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	1933.0	1260.0	Female	Not Hispanic or Latino	White	High Risk		Death	1:DECEASED	1933.0	64.0	2010.0					
TARGET-30-PASWVD	ANBL00B1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	2510	7	2009	Stage 1	Favorable	Ganglioneuroblastoma, intermixed			1863.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1863.0	62.0	2014.0					
TARGET-30-PARDCK	ANBL00B1, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2060	6	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2991.0	1521.0	Female	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	2991.0	99.0	2015.0	5	90/10			
TARGET-30-PASWKI	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	20	1	2009	Stage 4s	Favorable	Neuroblastoma			1935.0		Male	Not Hispanic or Latino	White	Low Risk	60	Censored	0:LIVING	1935.0	64.0	2014.0					
TARGET-30-PATVDY	ANBL00B1, ANBL0532, AEPI07N1, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1247	4	2010	Stage 4	Unknown	Unknown			647.0		Male	Not Hispanic or Latino	White	High Risk	75	Relapse	0:LIVING	1601.0	53.0	2015.0					
TARGET-30-PATUVB	ANBL00B1, ANBL0531, ANBL0032	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	455	2	2010	Stage 4	Favorable	Neuroblastoma			378.0		Male	Not Hispanic or Latino	Black or African American	High Risk	80	Progression	1:DECEASED	474.0	16.0	2012.0					
TARGET-30-PALTYS	ANBL00B1	C74.1		Medulla of adrenal gland	720	2	2002	Stage 4	Unfavorable	Neuroblastoma			1727.0		Female	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	2195.0	73.0	2008.0					
TARGET-30-PALTEG	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	1367	4	2002	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	523.0	532.0	Male	Not Hispanic or Latino	White	High Risk		Relapse	1:DECEASED	551.0	19.0	2004.0					
TARGET-30-PATSSA	ANBL00B1, ANBL0032, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1290	4	2010	Stage 3	Unfavorable	Neuroblastoma			1807.0		Male	Not Hispanic or Latino	White	High Risk	100	Censored	0:LIVING	1807.0	60.0	2015.0					
TARGET-30-PATPYK	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	633	2	2010	Stage 4	Unfavorable	Neuroblastoma			364.0		Male	Not Hispanic or Latino	White	High Risk	60	Relapse	1:DECEASED	620.0	21.0	2012.0					
TARGET-30-PAVETV	ANBL00B1	C40.2		Long bones of lower limb and associated joints Bone of leg	1100	4	2012	Stage 4	Unfavorable	Neuroblastoma			725.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	725.0	24.0	2014.0					
TARGET-30-PALPGG	ANBL00B1, A3973, ANBL0032	C74.1	999	Medulla of adrenal gland	700	2	2002	Stage 4	Unknown	Unknown	1.0	1.0	381.0	399.0	Female	Not Hispanic or Latino	White	High Risk		Progression	1:DECEASED	400.0	14.0	2003.0					
TARGET-30-PATJET	ANBL00B1, ANBL0531	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	177	1	2010	Stage 4s	Favorable	Neuroblastoma			1769.0		Female	Not Hispanic or Latino	White	Intermediate Risk	60	Censored	0:LIVING	1769.0	59.0	2015.0					
TARGET-30-PALJZV	ANBL00B1, A3973	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1800	5	2002	Stage 4	Unfavorable	Neuroblastoma			4707.0		Male	Not Hispanic or Latino	Black or African American	High Risk		Censored	0:LIVING	4707.0	155.0	2015.0					
TARGET-30-PAIEIF	9047	Unknown	Y4	ABDOMEN/PERITONEUM OR RETROPERITONEUM	1710	5	1995	Stage 4	Unknown	Unknown	1.0	1.0	440.0	436.0	Male	Unknown	Black or African American	High Risk	40	Death	1:DECEASED	440.0	15.0	1996.0	60	90/10			
TARGET-30-PATKGB	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	176	1	2010	Stage 4s	Favorable	Neuroblastoma			1867.0		Male	Not Hispanic or Latino	White	Low Risk	90	Censored	0:LIVING	1867.0	62.0	2015.0					
TARGET-30-PATWWJ	ANBL00B1, ANBL0032, ADVL0912	C38.2		 Posterior mediastinum	535	2	2010	Stage 4	Favorable	Neuroblastoma			259.0		Male	Not Hispanic or Latino	White	Intermediate Risk	90	Relapse	1:DECEASED	785.0	26.0	2013.0					
TARGET-30-PASFXC	ANBL00B1, ANBL0531, AEPI07N1	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	140	1	2008	Stage 3	Favorable	Neuroblastoma			2451.0		Male	Not Hispanic or Latino	Black or African American	Intermediate Risk	90	Censored	0:LIVING	2451.0	81.0	2015.0					
TARGET-30-PATDWN	ANBL00B1, ANBL0032	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1435	4	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	278.0	386.0	Male	Hispanic or Latino	Not Reported	High Risk	70	Censored	0:LIVING	278.0	10.0	2010.0	10	70/30			
TARGET-30-PALKER	ANBL00B1	C74.1		Medulla of adrenal gland	1238	4	2002	Stage 4	Unfavorable	Neuroblastoma			4366.0		Female	Not Hispanic or Latino	White	High Risk	100	Censored	0:LIVING	4366.0	144.0	2014.0	0	95/5			
TARGET-30-PANBJH	ANBL00B1, A3973, ANBL0322, ADVL0524	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1030	3	2004	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	168.0	918.0	Female	Not Hispanic or Latino	Black or African American	High Risk		Progression	1:DECEASED	920.0	31.0	2006.0					
TARGET-30-PATFMU	ANBL00B1, ANBL0531	C22.0		Liver Hepatic, NOS	184	1	2010	Stage 4	Favorable	Neuroblastoma			568.0		Female	Not Hispanic or Latino	Asian	Intermediate Risk	90	Second Malignant Neoplasm	1:DECEASED	819.0	27.0	2012.0					
TARGET-30-PASMET	ANBL00B1, ACCL0431, ACCL05C1, ANBL0032, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	417	2	2009	Stage 3	Unfavorable	Neuroblastoma			2247.0		Male	Not Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	2247.0	74.0	2015.0					
TARGET-30-PAMEHH	ANBL00B1, A3973	C38.2	999	Posterior mediastinum	915	3	2003	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	725.0	923.0	Female	Not Hispanic or Latino	Black or African American	High Risk		Relapse	1:DECEASED	934.0	31.0	2005.0					
TARGET-30-PAUHYY	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	2232	7	2011	Stage 4	Unfavorable	Neuroblastoma			170.0		Male	Not Hispanic or Latino	Black or African American	High Risk	85	Progression	1:DECEASED	323.0	11.0	2012.0					
TARGET-30-PAVABN	ANBL00B1, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	501	2	2012	Stage 3	Unfavorable	Neuroblastoma			1040.0		Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	1040.0	35.0	2015.0					
TARGET-30-PANYUG	AADM01P1, ANBL00B1, A3973	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	614	2	2005	Stage 4	Unfavorable	Neuroblastoma			1417.0		Male	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	1417.0	47.0	2009.0					
TARGET-30-PAUDMU	ANBL00B1, ANBL0532, ANBL0032, ADVL1115	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	983	3	2011	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular			1500.0		Female	Not Hispanic or Latino	Black or African American	High Risk	90	Censored	0:LIVING	1500.0	50.0	2015.0					
TARGET-30-PASNEF	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	696	2	2009	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2213.0	736.0	Female	Hispanic or Latino	Not Reported	High Risk	85	Censored	0:LIVING	2213.0	73.0	2015.0	25	85/15			
TARGET-30-PAVDPE	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1146	4	2012	Stage 4	Unfavorable	Neuroblastoma			233.0		Male	Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	233.0	8.0	2013.0					
TARGET-30-PATNCI	ANBL00B1, ANBL0532	C76.1		Thorax, NOS Axilla, NOS Chest, NOS Chest wall, NOS Intra	2030	6	2010	Stage 4	Unfavorable	Neuroblastoma			287.0		Male	Not Hispanic or Latino	Not Reported	High Risk	90	Death	1:DECEASED	287.0	10.0	2011.0					
TARGET-30-PAPSMC	ANBL00B1, ANBL0032	C74.1	999	Medulla of adrenal gland	1337	4	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	369.0	981.0	Male	Hispanic or Latino	Not Reported	High Risk	100	Relapse	0:LIVING	3070.0	101.0	2015.0	95	100/0			
TARGET-30-PAUWFE	ANBL00B1	C38.2		 Posterior mediastinum	580	2	2012	Stage 2b	Unfavorable	Ganglioneuroblastoma, nodular			1018.0		Male	Not Hispanic or Latino	Native Hawaiian or other Pacific Islander	Low Risk	80	Censored	0:LIVING	1018.0	34.0	2015.0					
TARGET-30-PARZHA	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Per	3	1	2008	Stage 4s	Favorable	Neuroblastoma			2489.0		Male	Unknown	Unknown	Low Risk	90	Censored	0:LIVING	2489.0	82.0	2015.0					
TARGET-30-PALEAC	ANBL00B1, P9641	C74.1	999	Medulla of adrenal gland	66	1	2001	Stage 1	Favorable	Neuroblastoma	0.0	0.0	4263.0	2632.0	Male	Not Hispanic or Latino	White	Low Risk	100	Censored	0:LIVING	4263.0	141.0	2013.0	0	80/20			
TARGET-30-PAKAFK	3891, B003	Unknown	999	Unknown	1509	5	1994	Stage 4	Unfavorable	Neuroblastoma	0.0	0.0	2025.0	2019.0	Male	Unknown	Unknown	High Risk		Censored	0:LIVING	2025.0	67.0	2000.0					
TARGET-30-PARWEV	ANBL00B1, ANBL0531, AEPI07N1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	493	2	2008	Stage 3	Favorable	Neuroblastoma			2621.0		Female	Not Hispanic or Latino	White	Intermediate Risk	80	Censored	0:LIVING	2621.0	87.0	2015.0					
TARGET-30-PASAJU	ANBL00B1, ANBL0532, ANBL0032	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	2140	6	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	0.0	105.0	536.0	Male	Not Hispanic or Latino	Black or African American	High Risk	50	Progression	1:DECEASED	2491.0	82.0	2015.0	10	50/50			
TARGET-30-PAIUJB	9047	Unknown	93	ADRENAL GLAND	549	2	1999	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	703.0	700.0	Female	Unknown	Unknown	High Risk	95	Death	1:DECEASED	703.0	24.0	2001.0	5	80/20			
TARGET-30-PAMLNB	ANBL00B1, P9641	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	6	1	2003	Stage 1	Favorable	Neuroblastoma	0.0	0.0	1880.0	1866.0	Male	Not Hispanic or Latino	White	Low Risk		Censored	0:LIVING	1880.0	62.0	2008.0					
TARGET-30-PATSDR	ANBL00B1, ANBL0532	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	679	2	2010	Stage 4	Unfavorable	Neuroblastoma			280.0		Female	Hispanic or Latino	White	High Risk	90	Relapse	1:DECEASED	902.0	30.0	2013.0					
TARGET-30-PAIVZR	9047	Unknown	71	KIDNEY	1227	4	1999	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	787.0	784.0	Female	Unknown	Unknown	High Risk	65	Death	1:DECEASED	787.0	26.0	2001.0	35	95/5			
TARGET-30-PADRYN	3891, B003	Unknown	999	Abdominal adrenal left-no intraspinal ext. mass extends from diaphragm and depresses kidney downwards. SIZE: 8cm x 9cm x 11.5cm METS; BM, Bone, pleural effusion	670	2	1994	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	423.0	696.0	Male	Not Hispanic or Latino	Black or African American	High Risk		Event	1:DECEASED	698.0	23.0	1996.0					
TARGET-30-PATEPF	ANBL00B1	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1434	4	2010	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	304.0	304.0	Male	Hispanic or Latino	White	High Risk	90	Death	1:DECEASED	304.0	10.0	2010.0	30	90/10			
TARGET-30-PADMVB	3891, B003	Unknown	999	Right sided abdominal adrenal tumor crossing midline - no intrapsinal extn. Size: 13cm x 6cm x 9.5cm, BM,	936	3	1993	Stage 4	Unknown	Unknown	1.0	1.0	219.0	359.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	365.0	12.0	1994.0					
TARGET-30-PATFTN	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	464	2	2010	Stage 4	Favorable	Neuroblastoma			246.0		Male	Not Hispanic or Latino	White	High Risk	95	Relapse	0:LIVING	1797.0	60.0	2014.0					
TARGET-30-PAUFSR	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	679	2	2011	Stage 3	Unfavorable	Neuroblastoma			1409.0		Male	Not Hispanic or Latino	White	High Risk	90	Censored	0:LIVING	1409.0	47.0	2015.0					
TARGET-30-PATYWX	ANBL00B1, ANBL0532, ANBL0032	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1460	4	2011	Stage 4	Unfavorable	Neuroblastoma			1236.0		Male	Hispanic or Latino	White	High Risk	90	Relapse	0:LIVING	1617.0	54.0	2015.0					
TARGET-30-PASCKI	ANBL00B1	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	911	3	2008	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2556.0	1.0	Female	Not Hispanic or Latino	White	High Risk	80	Censored	0:LIVING	2556.0	85.0	2015.0	10	80/20			
TARGET-30-PASFEV	ANBL00B1, AEPI07N1	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	163	1	2008	Stage 4s	Unknown	Neuroblastoma			2416.0		Female	Not Hispanic or Latino	White	Intermediate Risk	90	Censored	0:LIVING	2416.0	80.0	2015.0					
TARGET-30-PATVZB	ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1032	3	2010	Stage 4	Unfavorable	Neuroblastoma			447.0		Male	Not Hispanic or Latino	Black or African American	High Risk	90	Death	1:DECEASED	447.0	15.0	2012.0					
TARGET-30-PASFCG	ANBL00B1, AEPI07N1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	147	1	2008	Stage 1	Favorable	Neuroblastoma			2493.0		Male	Not Hispanic or Latino	White	Low Risk	80	Censored	0:LIVING	2493.0	82.0	2015.0					
TARGET-30-PADPRJ	3891, B003, B903, B954, E18	Unknown	999	Abdominal adrenal Left crosses midline-no intraspinal ext. SIZE: 7cxm x 5cm x 2cm Mets: BM, LN	1423	4	1994	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	1.0	1.0	84.0	1185.0	Male	Not Hispanic or Latino	White	High Risk		Event	1:DECEASED	1188.0	40.0	1997.0					
TARGET-30-PATFTR	ANBL00B1, ANBL0531, AEPI07N1	C49.5		Connective, Subcutaneous and other Soft tissues of pelvis C	192	1	2010	Stage 3	Favorable	Neuroblastoma			1883.0		Male	Not Hispanic or Latino	White	Intermediate Risk	60	Censored	0:LIVING	1883.0	62.0	2015.0					
TARGET-30-PANDGA	ANBL02P1, ANBL00B1	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	666	2	2004	Stage 4	Unfavorable	Neuroblastoma			3320.0		Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3320.0	110.0	2013.0					
TARGET-30-PAVEKN	ANBL00B1, ADVL0912	C64.9		Kidney, NOS Renal, NOS Kidney parenchyma	2053	6	2012	Stage 4	Unfavorable	Neuroblastoma			508.0		Female	Not Hispanic or Latino	White	High Risk	95	Death	1:DECEASED	508.0	17.0	2014.0					
TARGET-30-PADVWW	3891, B003	Unknown	999	LUQ abdominal pancreatic mass extending from left renal hilum medially to the aorta and extending inferiorly down to left common iliac artery. Posteriorly under renal vein and artery up to suprarenal vessels just posterior to the fundus of the stomach w	1988	6	1995	Stage 4	Unfavorable	Unknown	0.0	0.0	3563.0	3551.0	Female	Not Hispanic or Latino	White	High Risk		Censored	0:LIVING	3563.0	118.0	2005.0					
TARGET-30-PASXRG	ANBL00B1, ANBL0532, AEPI07N1, ANBL0931	C48.0	999	Retroperitoneum Periadrenal tissue Perinephric tissue Peripancreatic tissue Perirenal tissue Retrocecal tissue Retroperitoneal tissue	1278	4	2009	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	1749.0	546.0	Female	Unknown	White	High Risk	70-80	Censored	0:LIVING	1749.0	58.0	2014.0	10	70-80/20-30			
TARGET-30-PARABJ	ANBL00B1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	661	2	2007	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	2881.0	1539.0	Female	Not Hispanic or Latino	White	High Risk	25	Censored	0:LIVING	2881.0	95.0	2014.0	10	25/75			
TARGET-30-PATFXV	ANBL00B1, AEPI07N1	C76.2	999	Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	648	2	2010	Stage 4	Unfavorable	Neuroblastoma	1.0	1.0	236.0	296.0	Female	Hispanic or Latino	White	High Risk	70	Progression	1:DECEASED	296.0	10.0	2010.0	10	70/30			
TARGET-30-PAIPGU	9047	Unknown	93	ADRENAL GLAND	898	3	1998	Stage 4	Unknown	Unknown	1.0	1.0	436.0	435.0	Female	Unknown	White	High Risk	90	Death	1:DECEASED	436.0	15.0	1999.0	10	95/5			
TARGET-30-PAPTIP	ANBL00B1, ADVL0912	C74.9	999	Adrenal gland, NOS Suprarenal gland Adrenal, NOS	1208	4	2006	Stage 4	Unfavorable	Neuroblastoma	1.0	0.0	372.0	739.0	Male	Not Hispanic or Latino	White	High Risk	80	Relapse	1:DECEASED	1492.0	50.0	2010.0	0	80/20			
TARGET-30-PANXJL	ANBL00B1	C77.5	999	Pelvic lymph nodes Hypogastric lymph node Iliac lymph node Inferior epigastric lymph node Intrapelvic lymph node Obturator lymph node Paracervical lymph node Parametrial lymph node Presymphysial lymph node Sacral lymph node	5734	16	2005	Stage 4	Unfavorable	Ganglioneuroblastoma, nodular	0.0	0.0	431.0	428.0	Male	Unknown	Unknown	High Risk		Censored	0:LIVING	431.0	15.0	2006.0					
TARGET-30-PATLUI	ANBL00B1, ANBL0532, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	799	3	2010	Stage 3	Unfavorable	Neuroblastoma			1942.0		Male	Hispanic or Latino	White	High Risk	70	Censored	0:LIVING	1942.0	64.0	2015.0					
TARGET-30-PAJYVA	321P2, B003	Unknown	999	Unknown	708	2	1990	Stage 4	Unfavorable	Unknown	1.0	1.0	238.0	303.0	Female	Unknown	Unknown	High Risk		Event	1:DECEASED	306.0	11.0	1991.0					
TARGET-30-PAUGWT	ANBL00B1	C76.2		Abdomen, NOS Abdominal wall, NOS Intra-abdominal site, NOS	190	1	2011	Stage 4s	Favorable	Neuroblastoma			172.0		Male	Not Hispanic or Latino	White	High Risk	70	Death	1:DECEASED	172.0	6.0	2011.0					
TARGET-30-PAUBSW	ANBL00B1, ANBL0532, ANBL0032, ADVL0912	C48.0		Retroperitoneum Periadrenal tissue Perinephric tissue Per	1057	3	2011	Stage 4	Unfavorable	Neuroblastoma			486.0		Female	Not Hispanic or Latino	White	High Risk	70	Relapse	1:DECEASED	700.0	24.0	2013.0					
TARGET-30-PATUNZ	ANBL00B1, ANBL0032	C74.9		Adrenal gland, NOS Suprarenal gland Adrenal, NOS	315	1	2010	Stage 4	Unfavorable	Neuroblastoma			1609.0		Male	Hispanic or Latino	White	High Risk	50	Censored	0:LIVING	1609.0	53.0	2015.0					
